10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2015

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                      to                    

Commission File No. 000-26399

Inventergy Global, Inc.

(Exact name of registrant as specified in its charter)

Delaware	62-1482176
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

900 E. Hamilton Avenue #180 Campbell, CA	95008
(Address of Principal Executive Offices)	(Zip Code)

(408) 389-3510

(Registrant’s telephone number, including area code)

n/a

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes x   No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x  No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

¨   Large accelerated filer	¨    Accelerated filer
¨   Non-accelerated filer	x   Smaller reporting company

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): Yes ¨ No x

As of November 9, 2015, the registrant had 42,220,861 shares of common stock outstanding.

Inventergy Global, Inc. and Subsidiary

Quarterly Report on Form 10-Q

TABLE OF CONTENTS

		Page
Cautionary Note Regarding Forward-Looking Statements		-ii-
PART 1-FINANCIAL INFORMATION		3
Item 1.	Financial Statements (unaudited)	3
	Condensed Consolidated Balance Sheets as of September 30, 2015 (unaudited) and December 31, 2014	3
	Condensed Consolidated Statements of Operations (unaudited) for the three months and nine months ended September 30, 2015 and 2014	4
	Condensed Consolidated Statements of Cash Flows (unaudited) for the nine months ended September 30, 2015 and 2014	5
	Notes to Condensed Consolidated Financial Statements	6
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	27
Item 3.	Quantitative and Qualitative Disclosures about Market Risk	32
Item 4.	Control and Procedures	32
PART II-OTHER INFORMATION		33
Item 1.	Legal Proceedings	33
Item 1A.	Risk Factors	34
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	34
Item 3.	Defaults Upon Senior Securities	34
Item 4.	Mine Safety Disclosures	34
Item 5.	Other Information	34
Item 6.	Exhibits	34
SIGNATURES		35

-i-

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

Certain information set forth in this Quarterly Report on Form 10-Q (“the Quarterly Report”), including in Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and elsewhere herein may address or relate to future events and expectations and as such constitutes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (“the Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (“the Exchange Act”). Statements which are not historical reflect our current expectations and projections about our future results, performance, liquidity, financial condition, prospects and opportunities and are based upon information currently available to us and our management and their interpretation of what is believed to be significant factors affecting our business, including many assumptions regarding future events. Such forward-looking statements include statements regarding, among other things:

· our ability to continue as a going concern;

· anticipated growth and growth strategies;

· the need for additional capital and the availability of financing;

· the ability to secure additional patents;

· the ability to monetize patents or recoup our investment;

· the ability to protect intellectual property rights;

· new legislation, regulations or court rulings related to enforcing patents, that could harm our business and operating results;

· expansion plans and opportunities;

· our ability to attract and retain key members of our management team;

· our anticipated needs for working capital;

· the anticipated trends in our industry;

· our ability to expand operational capabilities; and

· competition existing today or that will likely arise in the future.

Forward-looking statements, which involve assumptions and describe our future plans, strategies, and expectations, are generally identifiable by use of the words “may,” “should,” “would,” “could,” “scheduled,” “expect,” “anticipate,” “estimate,” “believe,” “intend,” “seek,” or “project” or the negative of these words or other variations on these words or comparable terminology. Actual results, performance, liquidity, financial condition and results of operations, prospects and opportunities could differ materially and perhaps substantially from those expressed in, or implied by, these forward-looking statements as a result of various risks, uncertainties and other factors, many of which are described in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2014. These risks and uncertainties could cause actual results to differ materially from those contained in any forward-looking statement. Many of these factors are beyond our ability to control or predict.

In light of these risks and uncertainties there can be no assurance that the forward-looking statements contained herein will in fact occur. Readers should not place undue reliance on any forward-looking statements. Except as expressly required by the federal securities laws, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changed circumstances or any other reason. We advise you to carefully review the reports and documents we file from time to time with the Securities and Exchange Commission (the “SEC”).

-ii-

PART I – FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS.

INVENTERGY GLOBAL, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

	September 30,			December 31,
	2015			2014
	(unaudited)
ASSETS
Current assets
Cash and cash equivalents	$	1,368,118		$	1,443,349
Accounts receivable		39,198			259,049
Inventories		172,584			302,739
Prepaid expenses and other current assets		233,721			212,280
Deferred expenses, current		2,699,167			3,000,000
Total current assets		4,512,788			5,217,417
Property and equipment, net		29,514			42,267
Deferred expenses, patents		13,271,324			12,094,420
Patents, net		9,047,666			10,415,404
Intangible assets, net		414,333			499,083
Goodwill		8,858,504			8,858,504
Debt issuance costs		590,591			729,498
Deposits and other assets		28,993			18,993
Total assets	$	36,753,713		$	37,875,586
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities
Accounts payable	$	1,616,450		$	1,501,938
Accrued expenses and other current liabilities		785,093			301,132
Short-term notes payable, related party		120,000			300,000
Guaranteed payments, current		9,632,958			3,807,084
Fortress notes payable, current		5,202,068			1,421,196
Deferred revenue		400,000			-
Total current liabilities		17,756,569			7,331,350
Deferred revenue, non-current		346,429			-
Guaranteed payments		8,203,908			13,105,857
Derivative liabilities		24,252			30,278
Fortress notes payable, net of discount		2,838,558			6,259,321
Fortress revenue share, net of discount		5,791,823			2,478,057
Total liabilities		34,961,539			29,204,863
Stockholders' equity
Preferred stock, $0.001 par value, 10,000,000 shares authorized
Series A convertible preferred stock: 6,176,748 shares designated, 373,821 and 2,709,690 shares issued and outstanding at September 30, 2015 and December 31, 2014 (aggregate liquidation preference of $391,397 at September 30, 2015 and $2,915,122 at December 31, 2014)		374			2,710
Series B convertible preferred stock: 2,750 shares designated, 1,102 shares issued and  outstanding at September 30, 2015 and December 31, 2014 (aggregate liquidation preference  of $1,102,000 at September 30, 2015 and December 31, 2014		1			1
Common stock, $0.001 par value; 100,000,000 shares authorized, 36,313,509 and 27,997,128 shares issued and outstanding at September 30, 2015 and December 31, 2014		36,314			27,997
Additional paid-in capital		54,324,045			51,713,228
Accumulated deficit		(52,568,560	)		(43,073,213	)
Total stockholders' equity		1,792,174			8,670,723
Total liabilities and stockholders' equity	$	36,753,713		$	37,875,586

See accompanying notes to the condensed consolidated financial statements.

3

INVENTERGY GLOBAL, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited)

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2015			2014			2015			2014
Revenues	$	132,500		$	306,603		$	4,483,303		$	353,646
Operating Expenses
Cost of revenues		51,651			339,795			913,800			418,000
Patent amortization expense		377,742			387,585			1,152,365			1,012,956
General and administrative		1,930,705			2,559,474			5,921,212			8,996,860
Total operating expenses		2,360,098			3,286,854			7,987,377			10,427,816
Loss from operations		(2,227,598	)		(2,980,251	)		(3,504,074	)		(10,074,170	)
Other income (expense)
Loss on extinguishment of notes payable		-			-			(2,268,373	)		(2,403,193	)
Decrease in fair value of derivative liabilities		35,010			271,804			47,331			667,448
Other income		1,600			-			1,637			-
Interest expense, net		(1,279,879	)		(229,231	)		(3,771,868	)		(525,391	)
Total other income (expense), net		(1,243,269	)		42,573			(5,991,273	)		(2,261,136	)
Loss before provision for income taxes		(3,470,867	)		(2,937,678	)		(9,495,347	)		(12,335,306	)
Provision for income taxes		-			-			-			-
Net loss		(3,470,867	)		(2,937,678	)		(9,495,347	)		(12,335,306	)
Net loss available to common shareholders	$	(3,470,867	)	$	(2,937,678	)	$	(9,495,347	)	$	(12,335,306	)
Basic and diluted loss per share	$	(0.10	)	$	(0.15	)	$	(0.29	)	$	(0.79	)
Weighted average shares outstanding, basic and diluted		35,425,200			19,852,019			32,233,484			15,698,206

See accompanying notes to the condensed consolidated financial statements.

4

INVENTERGY GLOBAL, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited)

	Nine Months Ended September 30,
	2015			2014
Cash flows from operating activities
Net loss	$	(9,495,347	)	$	(12,335,306	)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation expense		12,753			5,668
Loss on extinguishment of notes payable		2,268,373			2,403,193
Decrease in fair value of derivative liabilities		(47,331	)		(667,448	)
Amortization of discount on notes payable		2,191,248			298,885
Amortization of patents and acquired contracts		1,237,115			1,102,423
Net cost of patents sold		215,372			-
Stock-based compensation		843,386			2,238,184
Changes in operating assets and liabilities
Accounts receivable		219,851			(245,558	)
Inventories		130,155			47,294
Prepaid expenses and other current assets		(21,441	)		(155,523	)
Deferred expenses		300,833			-
Deposits and other assets		(10,000	)		(17,484	)
Accounts payable		114,512			1,386,113
Accrued expenses and other current liabilities		483,961			549,294
Accrued interest on notes payable		-			73,065
Deferred revenue		746,429			-
Net cash used in operating activities		(810,131	)		(5,317,200	)
Cash flows from investing activities
Restricted cash		-			(3,500,000	)
Purchases of property and equipment		-			(52,186	)
Issuance of short-term note receivable, related party		-			(3,000,000	)
Cash and other assets received in acquisition		-			790,172
Net cash used in investing activities		-			(5,762,014	)
Cash flows from financing activities
Proceeds from issuance of common stock, net of issuance costs		1,835,000			6,487,850
Proceeds from issuance of convertible notes payable, net of issuance costs		-			2,905,128
Proceeds from issuance of notes payable		1,126,900			500,000
Payments on short-term notes payable, related party		(80,000	)		(100,000	)
Payments on Fortress notes payable		(2,147,000	)		-
Net cash provided by financing activities		734,900			9,792,978
Net decrease in cash and cash equivalents		(75,231	)		(1,286,236	)
Cash and cash equivalents, beginning of period		1,443,349			1,518,684
Cash and cash equivalents, end of period	$	1,368,118		$	232,448
Supplemental disclosures of cash flow information
Cash paid for interest	$	631,471		$	159,822
Cash paid for income taxes	$	-
Supplemental disclosures of non-cash investing and financing activities
Accrued guaranteed payments and deferred expenses associated with purchased patent assets	$	923,928		$	3,951,870
Conversion of portion of short-term note payable, related party, to purchase common stock	$	100,000		$	-
Offset of short-term related party notes payable and receivable	$	-		$	3,000,000
Transfer of Series A redeemable convertible preferred stock to preferred stock	$	-		$	3,392,950
Fair value of convertible notes payable redemption derivative liability	$	-		$	316,200
Fair value of common stock warrants	$	41,305		$	145,958
Acquisition of patents	$	-		$	2,653,533

See accompanying notes to the condensed consolidated financial statements.

5

INVENTERGY GLOBAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the Three and Nine Months Ended September 30, 2015 and 2014

1. Organization

Inventergy Global, Inc. (“we”, “us”, “our”, “Inventergy”, or the “Company”) is an intellectual property (IP) investment and licensing company that helps technology-leading corporations attain greater value from their IP assets in support of their business objectives and corporate brands. Inventergy was initially organized as a Delaware limited liability company under the name Silicon Turbine Systems, LLC in January 2012. It subsequently changed its name to Inventergy, LLC in March 2012 and it was converted from a limited liability company into a Delaware corporation in February 2013, at which time it became Inventergy, Inc. On June 6, 2014, a subsidiary (“Merger Sub”) of eOn Communications Corporation (“eOn”) merged with and into Inventergy, Inc. with Inventergy, Inc. emerging as the surviving entity (the “Merger”). As a result of the Merger, eOn changed its name to “Inventergy Global, Inc.” The Company is headquartered in Campbell, California.

The Company operates in a single industry segment. 

2. Summary of Significant Accounting Policies

Basis of presentation

The consolidated financial statements have been prepared on the accrual basis of accounting in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The consolidated financial statements include the accounts of the Company and its subsidiaries. All material intercompany accounts and transactions have been eliminated in consolidation. The accompanying interim financial statements are condensed and should be read in conjunction with the Company’s latest annual financial statements. It is management’s opinion that all adjustments necessary for a fair presentation of the results for the interim periods have been made, and all such adjustments were of a normal recurring nature.

Liquidity and Capital Resources

At September 30, 2015, the Company had an accumulated deficit since inception of $52,568,560 and had negative working capital of $13,243,781. As of November 9, 2015, we had remaining cash of $1,338,926. These factors raise substantial doubt about our ability to continue as a going concern, which is dependent both on achieving additional licensing and sales revenue from our patent portfolios and/or obtaining additional financing on terms acceptable to us. Toward that end, the Company entered into its first license agreement in February 2015, received an additional drawdown from the Fortress Agreement of $1,199,500 as a result of entering into the license agreement, received net proceeds of $1,835,000 from the sale of common stock in April 2015, and received gross proceeds of $4,000,000 from the sale of two patent families in June 2015. We will seek to continue our operations primarily with income received through our patent monetization efforts, including licensing revenues and patent sales, but we may need to seek additional financing through loans, which will be subject to the restrictions of the Fortress Agreement, and/or the sale of securities. If we are required to raise additional financing capital, we cannot assure you that we will be able to obtain such additional capital on terms acceptable to us or at all. Additionally, if we raise capital through the issuance of equity, our current stockholders will experience dilution.

The business will require significant amounts of capital over the next twelve months to sustain operations and make the investments it needs to continue operations and execute its longer term business plan. We believe that cash required for operating expenses, exclusive of litigation costs, will be approximately $4.9 million for the next twelve months, consisting of approximately $1.9 million in employee related costs (an approximate 21% decrease from the level of anticipated employee expenses disclosed in our Quarterly Report on Form 10-Q for the period ended June 30, 2015), $0.8 million in patent maintenance and prosecution fees, and $2.2 million in other operating costs. We anticipate a more aggressive litigation approach will be taken relating to patent enforcement, and estimate litigation expenses of approximately $4.6 million in the next twelve months. In addition, we estimate our debt principal and interest payments will be approximately $5.5 million under the terms of our revenue share and note purchase agreement, as amended and restated (the “Fortress Agreement”) with Fortress Investment Group, LLC and its affiliates (collectively “Fortress”). These amounts payable to Fortress are in addition to revenue sharing amounts expected to be paid from forecasted patent monetization revenues. Based on our existing cash balances, anticipated revenues from patent monetization activities, available financing opportunities, proactive measures to reduce expenses and defer obligations where possible, management believes we have funds sufficient to meet our anticipated operating needs for approximately five months.

6

To date, the Company has acquired approximately 755 currently active patents and patent applications for aggregate purchase payments of $12,109,118. We are required to pay unconditional guaranteed payments to the sellers of the patents of an aggregate of $20 million ($18 million of which is to be paid out of net revenues from patent licensing receipts) through August 31, 2017 (with a net present value of $17.8 million). See Note 10 herein for further information regarding these guaranteed payments.

As of September 30, 2015, the Company had cash and cash equivalents of $1,368,118 (which includes $1,000,000 of minimum cash reserves (see discussion, Note 6), which is intended to serve as additional collateral for the Fortress Agreement) and negative working capital of $13,243,781. The Company’s net loss for the nine months ended September 30, 2015 was $9,495,347 and our accumulated deficit amount was $52,568,560 as of September 30, 2015.

The Company will also require additional financing to purchase additional patent portfolios and to fund its monetization efforts if new attractive opportunities are found. If the Company acquires additional large patent portfolios, in addition to the upfront purchase fee (if any) it is likely that additional resources (business, technical and/or legal) may be required to effectively monetize the portfolio. Resources to analyze new portfolios are already part of the current staffing of the Company. Litigation costs are based primarily on a contingent fee structure (expected to average less than 20% of license revenue for a portfolio) and as such do not scale significantly with the acquisition of new portfolios. Acquisitions or investments may be consummated through the use of cash, equity, seller financing, third party debt, earn-out obligations, revenue sharing, profit sharing, or some combination of two or more of these types of consideration. Due to the dynamic nature of the credit market, the Company is not able to predict with any certainty whether it could obtain debt or equity financing to provide additional sources of liquidity, should the need arise, at favorable rates.

Management estimates and related risks

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions about the reported amounts of assets and liabilities, and disclosures of contingent assets and liabilities, at the dates of the financial statements and the reported amounts of revenues and expenses during the reported periods. Although these estimates reflect management's best estimates, it is at least reasonably possible that a material change to these estimates could occur in the near term.

Revenue Recognition

Revenue is recognized when (i) persuasive evidence of an arrangement exists, (ii) all obligations have been substantially performed pursuant to the terms of the arrangement, (iii) amounts are fixed or determinable, and (iv) the collectability of amounts is reasonably assured.

Licensing Fees

We derive revenue primarily from the monetization of acquired patents, either through licensing agreements or outright sales of patents. In general, licensing arrangements provide for the payment of contractually determined fees in consideration for the grant of certain intellectual property rights for patented technologies owned or controlled by the Company. These rights typically include some combination of the following: (i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patented technologies, (ii) a covenant-not-to-litigate, (iii) the release of the licensee from certain claims, and (iv) the dismissal of any pending litigation. The intellectual property rights granted may be perpetual in nature, extending until the expiration of the related patents, or can be granted for a defined period of time, with the licensee possessing the right to renew the agreement at the end of each contractual term for additional payments. The Company recognizes licensing fees when there is persuasive evidence of a licensing arrangement, fees are fixed or determinable, delivery has occurred and collectability is reasonably assured.

7

Patent Sales

The Company’s patent monetization efforts also include the sale of select patent assets. As patent sales represents a component of the Company’s ongoing major or central operations and activities, the Company records the related proceeds as revenue. The Company recognizes the patent sales revenue when there is persuasive evidence of a sales arrangement, fees are fixed or determinable, delivery has occurred and collectability is reasonably assured. These requirements are generally fulfilled upon closing of the patent sale transaction.

Amounts related to revenue arrangements that do not meet the revenue recognition criteria described above are deferred until the revenue recognition criteria are met.

The Company assesses the collectability of fees receivable based on a number of factors, including past transaction history and credit-worthiness of licensees. If it is determined that collection is not reasonably assured, the fee is recognized when collectability becomes reasonably assured, assuming all other revenue recognition criteria have been met.

Cost of Revenues

Cost of revenues primarily include the costs of patents sold, and other amounts paid to third parties, including technical consultants and intellectual property counsel, under revenue sharing agreements. These costs are included under the caption “Cost of Revenues” in the accompanying Condensed Consolidated Statements of Operations.

Contingent Legal and Consulting Fees

Contingent legal fees are expensed in the Condensed Consolidated Statements of Operations in the period that such fees are determined to be probable, usually when the related revenues are recognized. In instances where there are no recoveries from potential infringers, no contingent legal and consulting fees are paid; however, the Company may be liable for certain out of pocket legal and consulting costs incurred pursuant to the underlying legal and consulting services agreement.

Cash and cash equivalents

The Company considers all highly liquid financial instruments with original maturities of three months or less at the time of purchase to be cash equivalents.

Accounts Receivable

Accounts receivable are stated net of allowances for doubtful accounts. The Company typically grants standard credit terms to customers in good credit standing. The Company generally reserves for estimated uncollectible accounts on a customer-by-customer basis, which requires making a judgment about each individual customer’s ability and intention to fully pay account balances. The Company makes these judgments based on its knowledge of and relationships with each of its customers, as well as current economic trends, and updates these estimates on a monthly basis. Any changes in estimate, which can be significant, are included in earnings in the period in which the change in estimate occurs. As of September 30, 2015, the Company has not established any reserves for uncollectable accounts.

8

Inventories

Inventories consist of finished goods and some component and spare parts. Inventory is valued at the lower of cost or market with cost determined utilizing standard cost which approximates the first-in, first-out (FIFO) method. The Company performs an analysis of slow-moving or obsolete inventory on a regular basis and any changes in valuation reserves, which could potentially be significant, are included in earnings in the period in which the evaluations are completed.

Property and equipment

Property and equipment are recorded at cost less accumulated depreciation and amortization. Depreciation and amortization are computed using the straight-line method over the estimated useful lives of the assets (or the term of the lease, if shorter), which range from three to five years. Routine maintenance and repair costs are expensed as incurred. The costs of major additions, replacements and improvements are capitalized. Upon retirement or sale, the cost of assets disposed and the related accumulated depreciation is removed and any resulting gain or loss is credited or charged to operations.

Patents

Patents, including acquisition costs, are stated at cost, less accumulated amortization. Amortization is computed using the straight-line method over the estimated useful lives of the respective assets, generally 7 - 10 years. Upon retirement or sale, the cost of assets disposed and the related accumulated amortization are removed from the accounts and any resulting gain or loss is credited or charged to operations. Patents are utilized for the purpose of generating licensing revenue.

Intangible Assets

Intangible assets consist of certain contract rights acquired in the Merger. Intangible assets are amortized on a straight-line basis over their estimated useful life of five years.

Goodwill

Goodwill represents the excess of the aggregate purchase price over the fair value of the net tangible and identifiable intangible assets acquired by the Company. The carrying amount of goodwill will be tested for impairment annually or more frequently if facts and circumstances warrant a review. The Company determined that it is a single reporting unit for the purpose of goodwill impairment tests. For purposes of assessing the impairment of goodwill, the Company estimates the value of the reporting unit using its market capitalization as the best evidence of fair value. This fair value is then compared to the carrying value of the reporting unit.

Impairment of long-lived assets

The Company evaluates the carrying value of long-lived assets on an annual basis, or more frequently should circumstances indicate a long-lived asset may be impaired. When indicators of impairment exist, the Company estimates future undiscounted cash flows attributable to such assets. In the event cash flows are not expected to be sufficient to recover the recorded value of the assets, the assets are written down to their estimated fair value. On December 31, 2014, the Company recorded an impairment charge of $686,350 as a result of terminating an acquired contract in the first quarter of 2015 that provided distribution services of facility security and access control products that the Company inherited as part of the Merger.

Concentration of credit risk

Financial instruments that potentially subject the Company to a concentration of credit risk consist of cash and cash equivalents. Cash and cash equivalents are deposited with high quality financial institutions. Periodically, such balances are from time to time in excess of federally insured limits.

9

Stock-based compensation

The Company has a stock option plan under which incentive and non-qualified stock options and restricted stock awards (“RSAs”) are granted primarily to employees. All share-based payments to employees, including grants of employee stock options and RSAs, are recognized in the financial statements based on their respective grant date fair values. The benefits of tax deductions in excess of recognized compensation cost are reported as a financing cash flow.

The Company estimates the fair value of share-based payment awards on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense ratably over the requisite service periods in the Company’s statements of comprehensive income or loss. The Company has estimated the fair value of each option award as of the date of grant using the Black-Scholes option pricing model. The fair value of RSAs is calculated as the fair value of the underlying stock multiplied by the number of shares awarded. The awards issued consist of fully-vested stock awards, performance-based restricted shares, and service-based restricted shares.

Expenses related to stock-based awards issued to non-employees are recognized at fair value on a recurring basis in the periods those awards are expected to vest. The Company estimates the fair value of the awards using the Black-Scholes option pricing model.

Income taxes

The Company accounts for income taxes using the asset and liability method whereby deferred tax asset and liability account balances are determined based on temporary differences between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to affect taxable income. A valuation allowance is established when it is more likely than not that deferred tax assets will not be realized. Realization of deferred tax assets is dependent upon future pretax earnings, the reversal of temporary differences between book and tax income, and the expected tax rates in future periods. The Company has a full valuation allowance on all deferred tax assets.

The Company is required to evaluate the tax positions taken in the course of preparing its tax returns to determine whether tax positions are “more-likely-than-not” of being sustained by the applicable tax authority. Tax benefits of positions not deemed to meet the more-likely-than-not threshold would be recorded as a tax expense in the current year. The amount recognized is subject to estimate and management judgment with respect to the likely outcome of each uncertain tax position. The amount that is ultimately sustained for an individual uncertain tax position or for all uncertain tax positions in the aggregate could differ from the amount that is initially recognized.

Fair value measurements

The Company defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs within the fair value hierarchy. Observable inputs are inputs that market participants would use in pricing the asset or liability developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company’s own assumptions about what market participants would use in pricing the asset or liability developed based on the best information available in the circumstances.

The following methods and assumptions were used to estimate the fair value of financial instruments:

¨ Level 1 - Valuation is based upon quoted prices for identical instruments traded in active markets.

¨ Level 2 - Valuation is based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market.

10

¨ Level 3 - Valuation is generated from model-based techniques that use significant assumptions not observable in the market. These unobservable assumptions reflect management’s estimates of assumptions that market participants would use in pricing the asset or liability. Valuation techniques include use of option pricing models, discounted cash flow models and similar techniques.

The category within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.

Recently Issued Accounting Standards

In May 2014, the FASB issued a new financial accounting standard which outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes current revenue recognition guidance. ASU 2014-09 Revenue from Contracts with Customers is effective for annual reporting periods (including interim reporting periods within those periods) beginning after December 15, 2017. Early adoption is not permitted. We are currently evaluating the impact of this accounting standard.

In August 2014, the FASB issued a new accounting standard which requires management to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern for each annual and interim reporting period and to provide related footnote disclosures in certain circumstances. ASU 2014-15 Presentation of Financial Statements - Going Concern is effective for annual reporting periods (including interim reporting periods within those periods) beginning after December 15, 2016. Early adoption is permitted. We are currently evaluating the impact of this accounting standard.

In April 2015, the FASB issued a new accounting standard which changes the presentation of debt issuance costs in financial statements.  Under the new standard, an entity presents such costs in the balance sheet as a direct deduction from the related debt liability rather than as an asset.  Amortization of the costs is reported as interest expense.  The accounting standard is effective for annual reporting periods beginning after December 15, 2015 and interim periods beginning after December 15, 2016.  Early adoption is allowed for all entities so long as they are for financial statements that have not been previously issued.  The adoption of this standard is not expected to have a material impact on the Company’s consolidated financial statements.

3. Business Combination

The Merger was consummated on June 6, 2014, as a result of which Inventergy, Inc. merged with and into Merger Sub and holders of Inventergy, Inc. securities were issued securities of the Company. Upon the consummation of the Merger, the Company changed its name from “eOn Communications Corporation” to “Inventergy Global, Inc.” and effected a one-for-two reverse stock split of the Company’s common stock (the “Reverse Split”). The primary reason for the Merger was to allow the Company access to the public equity market for financing.

In connection with the consummation of the Merger:

(i) each share of the pre-Merger Inventergy, Inc. common stock was exchanged for 1.4139 shares of Company common stock on a post-Reverse Split basis (the “Exchange Ratio”);

(ii) the pre-Merger Inventergy, Inc. Series A Preferred Stock was exchanged for a like number of newly-created Company Series A Preferred Stock (as defined below);

(iii) options and restricted shares of pre-Merger Inventergy, Inc. common stock awarded pursuant to the Inventergy 2014 Stock Plan (such stock plan being adopted by the stockholders of the Company in connection with the Merger) and outstanding immediately prior to the consummation of the Merger were converted into awards of options to purchase Company common stock and restricted shares of Company common stock with terms and conditions identical to the terms and conditions of the corresponding options to purchase Inventergy, Inc. common stock and awards of restricted shares of Inventergy, Inc. common stock (as adjusted for the Exchange Ratio); and

(iv) outstanding warrants to purchase pre-Merger Inventergy, Inc. common stock were exchanged for warrants to acquire Company common stock with terms and conditions identical to the terms and conditions of the corresponding warrants to purchase Inventergy, Inc. common stock (as adjusted for the Exchange Ratio).

11

Immediately following the consummation of the Merger, the Company had 20,018,028 shares of common stock, 6,176,748 shares of Series A Preferred Stock and 2,231 shares of Series B Preferred Stock issued and outstanding. In addition, it had outstanding warrants to purchase 700,937 shares of common stock and outstanding placement agent warrants to purchase 238,412 shares of common stock.

The Transition Transactions

In connection with the Merger, on December 17, 2013, eOn, Cortelco Systems Holding Corp., a Delaware corporation and wholly-owned subsidiary of eOn (“Cortelco Holding”), eOn Communications Systems, Inc., a Delaware corporation and wholly-owned subsidiary of eOn (“eOn Subsidiary”), and Cortelco, Inc., a Delaware corporation and wholly-owned subsidiary of Cortelco Holding (“Cortelco”) entered into a transition agreement (the “Transition Agreement”). The Transition Agreement provided for several transactions among eOn and its subsidiaries in connection with, and subject to the completion of, the Merger. Each of these transactions were consummated at the time the Merger became effective (the “Effective Time”), including the following (collectively, the “Transition Transactions”):

(1) eOn and Cortelco each transferred certain contracts and other assets to eOn Subsidiary, and eOn Subsidiary assumed the liabilities associated with such contracts on and after the date of assumption;

(2) eOn Subsidiary purchased from Cortelco certain inventory for a purchase price equal to Cortelco’s book value of such inventory;

(3) eOn and Cortelco Holding redeemed in full certain contingent notes in the maximum initial amount of $11 million (collectively, the “Contingent Note”) in consideration of paying the holders of the Contingent Note either cash in the aggregate amount of $300,000 or shares of Cortelco Holding owned by eOn;

(4) Cortelco entered into a fulfillment services agreement with eOn Subsidiary providing for certain services to be conducted on behalf of eOn Subsidiary after the Merger;

(5) the Company transferred to Cortelco Holding (i) all of its ownership in Cortelco Systems Puerto Rico, Inc., and Symbio Investment Corp., and (ii) eOn’s right to require David S. Lee, former Chairman of eOn, to purchase its investment in Symbio Investment Corp.; and

(6) the Company and Cortelco Holding entered into an indemnity agreement providing that Cortelco will indemnify the Company from and against any future losses arising from the Contingent Note and certain other matters.

Upon completion of the Merger and the Transition Transactions, the Company owned all of the outstanding stock of Inventergy, Inc. and eOn Subsidiary, transferred certain assets held prior to the Merger and no longer owned an interest in Cortelco Holding, Cortelco, Cortelco Systems Puerto Rico, Inc., or Symbio Investment Corp.

12

The total purchase consideration and the purchase price allocation were as follows:

Fair value of assumed equity allocated to purchase consideration	$	10,985,867
Total purchase consideration	$	10,985,867
Goodwill	$	8,858,504
Intangible asset contract rights		1,342,000
Other assets acquired		816,045
Liabilities assumed		(30,682	)
Total purchase allocation	$	10,985,867

Goodwill of $8,858,504, which is not deductible for tax purposes, was recognized as a result of the Merger. Goodwill was based on the fair value of eOn stock on the date of purchase less the net assets that were acquired. Intangible assets of $1,342,000 consist of certain contractual rights acquired in the Merger. Intangible assets are amortized on a straight-line basis over their estimated useful life of five years. There was an impairment of $686,350 on one of the acquired contracts recognized December 31, 2014.

Acquisition-related costs directly attributable to the Merger totaling $1,237,641 were expensed as incurred in the consolidated statements of operations.

The consideration in the Merger was based on fair value of equity retained by eOn shareholders on June 6, 2014, the date of the Merger close. The historical financial information is that of Inventergy, Inc.

4. Patents

Patent intangible assets consist of the following at September 30, 2015:

	Weighted Average Useful Life	Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount
Amortizable intangible assets:
Patents	8.0	$	11,893,745	$	(2,846,079	)	$	9,047,666
Total patent intangible assets		$	11,893,745	$	(2,846,079	)	$	9,047,666

The Company expects amortization expense to be approximately $1,510,977 per year for each of the next six years and a pro rata portion in the last year.

5. Fair Value Measurements 

The following tables summarize the Company's assets and liabilities measured at fair value on a recurring basis at September 30, 2015 and December 31, 2014:

September 30, 2015	Fair Value		(Level 1)		(Level 2)		(Level 3)
Common stock warrants	$	24,252	$	-	$	-	$	24,252
Total	$	24,252	$	-	$	-	$	24,252

December 31, 2014	Fair Value		(Level 1)		(Level 2)		(Level 3)
Common stock warrants	$	30,278	$	-	$	-	$	30,278
Total	$	30,278	$	-	$	-	$	30,278

13

Prior to the Merger, the Company issued senior secured promissory notes (the “Senior Secured Notes”) with an aggregate principal amount of $5,000,000 which were redeemable upon an event of default. The Senior Secured Notes were later exchanged in favor of amended senior secured promissory notes (the “Amended Secured Convertible Notes”), resulting in an extinguishment of the related derivative liability for the prior Senior Secured Notes. The Company then issued new secured convertible notes (the “New Secured Convertible Notes”, and together with the Amended Secured Convertible Notes, the “Secured Convertible Notes”) with an aggregate principal amount of $3,000,000 which may be redeemed upon an event of default. Since the Secured Convertible Notes were issued at a substantial discount and the event of default clause may require accelerated repayment, the Secured Convertible Notes include an embedded derivative that is not clearly and closely related to the host contract. Accordingly, the Company bifurcated the embedded derivative from the host contract and recognized a derivative liability at fair value upon issuance of the Secured Convertible Notes. The Company estimated the fair value of the derivative liability using a valuation model which included the weighted probability of the amount of redemption and the time until redemption occurs over the note term. The Secured Convertible Notes were paid in full on October 2, 2014, resulting in an extinguishment of the related derivative liability, see Note 6 below.

In May 2013, the Company sold Series A-1 redeemable convertible preferred stock (“Series A-1 Preferred Stock”) which contained provisions for anti-dilution protection in the event the Company issues common stock at a price below a price per share formula, as defined. At September 30, 2015, the threshold price was $0.289 per share. The anti-dilution protection requires the Company to issue the holders of Series A-1 Preferred Stock shares of common stock or in the event that not enough shares of common stock are authorized and unissued, cash. The anti-dilution provision represents an embedded derivative as it is not clearly and closely related to the host contract. Accordingly, the Company bifurcated the embedded derivative from the host contract and recognized a derivative liability at fair value upon issuance of the Series A-1 Preferred Stock. The Company estimated the fair value of the derivative liability using the Monte Carlo option pricing valuation model which included a probability weighted present value calculation. Post-Merger, the Series A-1 Preferred Stock are no longer redeemable.

As discussed in Note 7, in January 2014, the Company issued warrants to purchase 238,412 shares common stock at an exercise price of $3.04 to a placement agent. The exercise price is subject to adjustment and the warrants may be exercised without cash consideration by forfeiting a portion of shares. Accordingly, the Company recognized a derivative liability at fair value upon issuance of the warrants. The exercise price was reduced to its floor of $2.27 as a result of the sale of the Fortress Shares in October 2014 (see Note 6). The Company estimated the fair value of the derivative liability using the Black-Scholes option pricing model. The fair value of the derivative liability as of September 30, 2015 was estimated using the following assumptions:

Expected volatility	60	%
Risk free rate	0.96	%
Dividend yield	0	%
Expected term (in years)	3.3253

The assumptions utilized were derived in a similar manner as discussed in Note 7 related to the fair value of stock options.

The Company revalues the derivative liabilities at the end of each reporting period using the same models as at issuance, updated for new facts and circumstances, and recognizes the change in the fair value in the statements of operations as other income (expense). The following sets forth a summary of changes in fair value of the Company’s level 3 liabilities measured on a recurring basis for the nine months ended September 30, 2014 and September 30, 2015:

14

	Convertible Notes Payable Derivative Liability			Series A-1 Preferred Stock Derivative Liability			Common Stock Warrants
Balance at December 31, 2013	$	534,975		$	56,926		$	-
Extinguishment		(118,300	)		-			-
Fair value at issuance		189,300			-			466,706
Change in fair value		(289,775	)		(56,926	)		(320,748	)
Balance at September 30, 2014	$	316,200		$	-		$	145,958

	Convertible Notes Payable Derivative Liability		Series A-1 Preferred Stock Derivative Liability		Common Stock Warrants
Balance at December 31, 2014	$	-	$	-	$	30,278
Fair value at issuance		-		-		41,305
Change in fair value		-		-		(47,331	)
Balance at September 30, 2015	$	-	$	-	$	24,252

6. Borrowing Arrangements 

On March 26, 2014, notes payable which have since been retired were amended and restated to allow for conversion to common stock and to amend the interest rate. In conjunction with the amendment, the Company recorded a loss on extinguishment of the notes payable of $2,403,193 in the accompanying statements of operations.

On September 23, 2014, the Company entered into a Share Purchase Agreement with the Company’s Chief Executive Officer pursuant to which the Company agreed to issue to the Chief Executive Officer up to 233,640 shares of our common stock at a purchase price of $2.14 per share for aggregate consideration to us of up to $500,000. Pursuant to the terms of such Share Purchase Agreement and concurrently with the execution of the agreement, the Chief Executive Officer made an initial payment of $300,000 to the Company towards the aggregate purchase price. The shares were only to be issued if we did not obtain $6 million or more in debt financing within ten business days of the execution of the agreement. As a result of the Fortress Agreement, the Company was required to return the $300,000 in cash previously prepaid by the Chief Executive Officer. During the quarter ended June 30, 2015, the Company’s Board of Directors approved the application of $100,000 of this amount towards the purchase of shares of the Company’s common stock at price per share equal to the greater of $0.46 per share or a 15% premium to the market price. As a result, on June 26, 2015, the Company sold 217,392 shares of previously unissued common stock at a price of $0.46 per share to the Chief Executive Officer. As of September 30, 2015, repayments of $80,000 have been made to the Chief Executive Officer and the remaining balance of $120,000 has been recorded as a related party loan payable.

On October 1, 2014, the Company entered into the original Fortress Agreement with Fortress, including a Note Purchaser (as defined below) who also serves as collateral agent (the “Collateral Agent”) and a Revenue Participant (as defined below). Pursuant to the original Fortress Agreement, the Company issued an aggregate of $11,000,000 in notes (the “Original Notes”) to the purchasers identified in the Fortress Agreement (the “Note Purchasers”). As a result of the issuance of the Original Notes and the sale of the Fortress Shares (as defined below), after the payment of all purchaser-related fees and expenses relating to the issuance of the Original Notes and Fortress Shares, the Company received net proceeds of $9,964,868 (less issuance costs of $450,253). The Company used the net proceeds to pay off the Secured Convertible Notes and the unsecured promissory note payable from First Republic Bank with an aggregate principal amount of $500,000 and for general working capital purposes. The unpaid principal amount of the Original Notes bears cash interest equal to LIBOR plus 7%. In addition, a 3% per annum paid-in-kind (“PIK”) interest will be paid by increasing the principal amount of the Original Notes by the amount of such interest. The PIK interest shall be treated as principal of the Original Notes for all purposes of interest accrual or calculation of any premium payment.

15

The principal of the Original Notes and all unpaid interest thereon or other amounts owing hereunder shall be paid in full in cash by the Company on September 30, 2017 (the “Maturity Date”). The Company may prepay the Original Notes in whole or in part, generally without penalty or premium, except that any optional prepayments of the Original Notes prior to October 1, 2015 will be accompanied by a prepayment premium equal to 5% of the principal amount prepaid. In addition, upon the earlier of the date on which the all obligations of the Original Notes are paid in full, or become due, the Company will pay to the Note Purchasers a termination fee equal to $770,000. This was accounted for as a discount on notes payable.

Upon receipt of any revenues generated from the monetization of the Patents (the “Monetization Revenue”) of the patents identified in the Fortress Agreement (the “Patents”), the Company is required to apply, towards its obligations pursuant to the Original Notes, 86% of the difference between (a) any revenues generated from the Monetization Revenue less (b) any litigation or licensing related third party expenses (including fees paid to the original patent owners) reasonably incurred by the Company to earn Monetization Revenue, subject to certain limits (such difference defined as “Monetization Net Revenues”). If Monetization Net Revenue is applied to outstanding principal of the Original Notes (defined as “Mandatory Prepayments”), such Mandatory Prepayments are not subject to the prepayment premium described above. To the extent that any obligations under the Original Notes are past due, including if such payments are past due as a result of the acceleration of the Original Notes or certain conditions of breach or alleged breach have occurred, the percentage will increase from 86% to 100%.

In addition to the Mandatory Prepayments, beginning on the last business day of October 2015 (subsequently amended to December 1, 2015 - See Note 11), the Company shall make monthly amortization payments (the “Amortization Payments”) in an amount equal to (x) the then outstanding principal amount of the Original Notes divided by (y) the number of months left until the Maturity Date.

In connection with the execution of the Fortress Agreement, on October 1, 2014, the Company paid the Note Purchasers a structuring fee of $385,000. This was accounted for as a discount on notes payable.

Pursuant to the Fortress Agreement, the Company granted to the purchasers identified in the Fortress Agreement (“Revenue Participants”) a right to receive a portion of the Company’s Monetization Revenues totaling $5,500,000 (unless the Revenue Participants have not received $5,500,000 by the Maturity Date, in which case the Revenue Participants have a right to receive a portion of Monetization Revenues totaling $8,250,000) (the “Revenue Stream”). The Revenue Participants will not receive any portion of the Revenue Stream until all obligations under the Original Notes are paid in full. Following payment in full of the Original Notes, the Company will pay to the Revenue Participants their proportionate share of the Monetization Net Revenues. The Revenue Participants’ proportionate share is equal to (a) 46% of Monetization Net Revenues until $2,750,000 has been paid to the Revenue Participants, (b) 31% of Monetization Net Revenues until the next $2,750,000 has been paid to the Revenue Participants and (c) 6% of Monetization Net Revenues until the next $2,750,000 has been paid to the Revenue Participants if (a) and (b) have not been fully paid by the Maturity Date. All Revenue Stream Payments will be payable on a monthly basis in arrears. The rights of the Revenue Participants to the Revenue Stream are secured by all of the Company’s patent assets as of October 1, 2014 and the Cash Collateral Account, in each case junior in priority to the rights of the Note Purchasers. In connection with the Revenue Participants’ right to receive a portion of the Company’s Monetization Revenues, the Company has recorded a net liability of $2,478,057, which represents the fair value of the expected Monetization Revenues, discounted 20% over the expected life of the revenue share agreement. 

As part of the Fortress Agreement, the Company and the Collateral Agent entered into a Patent License Agreement (the “Patent License Agreement”), under which the Company agreed to grant to the Collateral Agent a non-exclusive, royalty-free, and worldwide license to certain of its Patents (the “Licensed Patents”), which can only be used by the Collateral Agent following an occurrence and during the continuance of an event of default of the Fortress Agreement. When the Fortress Notes (as defined below) and Revenue Stream are paid in full, the Patent License Agreement will terminate.

As part of the transaction, the Company granted the Note Purchaser and Revenue Participant a first priority security interest in all of the Company’s patent assets owned as of October 1, 2014 and all proceeds thereof, as well as a general security interest in all of the assets of the Company and its subsidiaries. The Note Purchaser and Revenue Participant do not have a security interest in any future patent purchases by the Company.

16

As part of the transaction, the Company is required to maintain a minimum $1,000,000 in cash reserves. Failure to maintain that minimum cash balance can constitute an event of default under the Fortress Agreement. If we were to default under the Fortress Agreement and were unable to obtain a waiver for such a default, interest on the obligations would accrue at an increased rate. In the case of a default, Fortress could accelerate our obligations under the Fortress Agreement.

Effective February 25, 2015, the Company entered into an Amended and Restated Revenue Sharing and Note Purchase Agreement (the “Fortress Amended Agreement” and together with the original Fortress Agreement, sometimes referred to as the “Fortress Agreement”) with Fortress, under which Fortress agreed to make available to the Company up to an additional $3,000,000 between February 25, 2015 and December 31, 2015 (the “Additional Available Credit”). The Additional Available Credit would be drawn down in the form of senior secured notes (the “Additional Notes” and, together with the Original Notes, the “Fortress Notes”) and the additional amount loaned would be based on revenue the Company generates from certain near-term existing and future license agreements (“Draw Down Licenses”). On February 25, 2015, the Company drew down $1,199,500 from the Additional Available Credit and issued Additional Notes in that principal amount to Fortress. In connection with the issuance of the Additional Available Credit, the Company sold 500,000 warrants to purchase shares of the Company’s common stock. After the payment of all transaction-related fees and expenses relating to such issuances, which amounted to $72,600, the Company received net proceeds of $1,126,900. The Company is using these net proceeds for general working capital purposes.

In connection with the issuance of the Additional Notes and the Revenue Participants’ right to receive a portion of the Company’s Monetization Revenues, the Company has recorded a net liability of $335,762, which represents the fair value of the expected Monetization Revenues, discounted 18% over the expected life of the revenue share agreement. 

In addition to the issuance of the Additional Notes, the Fortress Amended Agreement amended the original Fortress Agreement as follows:

¨ The structuring fee equal to 3.5% of the original principal amount of any such Additional Notes is waived.

¨ The Additional Notes will be repaid from the future licensing payments on the Draw Down Licenses received from those specific Draw Down licensee(s), while the requirements otherwise to pay 86% of the Monetization Net Revenues towards the Original Notes for (i) the upfront payment of the initial Draw Down License and (ii) the remaining future payments of Draw Down Licenses are waived in general.

¨ The Revenue Participants are entitled to receive $7,700,000 (adjusted from the terms of the Original Notes) plus 70% of the Additional Notes as a portion of the Revenue Stream Basis (as defined below) if the Notes and Revenue Stream payments are paid in full by the Maturity Date or $9,350,000 (adjusted from the terms of the Original Notes) plus 85% of the Additional Notes as a portion of the Revenue Stream Basis if the Fortress Notes and Revenue Stream payments are not paid in full by the Maturity Date. The Revenue Stream payments will begin after all obligations on the Fortress Notes are paid in full. The Company is required to apply specified decreasing percentages (46% to 31% to 6%) of its net revenues (net of monetization costs) from monetizing its intellectual property assets on an ongoing basis to meet the Revenue Stream payment obligations. Payment of the full Revenue Stream payments in addition to the Fortress Note obligations by the Maturity Date would ordinarily occur after the Company receives approximately $60,000,000 in gross licensing revenues, assuming an average monetization cost of 33%.

¨ The Company shall not be required to apply the initial installment payment under the first Draw Down License to the Company’s obligations under the Fortress Notes or the Revenue Stream under the Fortress Amended Agreement.

In connection with the February 25, 2015 modification to the original Fortress Agreement and Revenue Participants’ right to receive a portion of the Company’s Monetization Revenues, the Company has recorded a loss of $2,268,373, for the resultant change in the fair value of the expected Monetization Revenues. 

The Fortress Agreement also contemplates the issuance of up to an additional $2,000,000 in notes beyond the Additional Available Credit.

17

Except as described above, the terms of the Additional Notes are identical to the terms of the original Notes issued pursuant to the original Fortress Agreement. Except as described above, the terms of the Original Fortress Agreement, and the Original Notes and warrants issued thereunder, remain in full force and effect, including the existing Monetization Revenue payments for the original Notes and the calculation of the termination fee based on the principal of the Original Notes.

Unregistered Sales of Equity Securities.

In connection with the execution of the original Fortress Agreement, the Company issued 500,000 shares of its common stock at $2.00 per share to the Revenue Participant for an aggregate purchase price of $1,000,000 (“the Fortress Shares”). The Fortress Shares were issued pursuant to a subscription agreement dated October 1, 2014. The shares were issued by the Company under the exemption from registration afforded by Section 4(a)(2) of the Securities Act and Regulation D promulgated thereunder, as they were issued to accredited investors, without a view to distribution, and were not issued through any general solicitation or advertisement.

On October 1, 2014, the Company paid the holders of the Amended Secured Convertible Notes and the New Secured Convertible Notes $8,000,000, plus interest of $187,351 and issued an aggregate of 1,804,030 shares of common stock to the note holders (who otherwise had the right to convert the existing notes into 1,508,162 shares of common stock until July 2018) as consideration for a waiver from such Secured Convertible Note holders in order for the Company to prepay the remaining outstanding principal and interest on the Secured Convertible Notes. Immediately following the prepayment of the Secured Convertible Notes and the issuance of the shares, the Secured Convertible Notes were deemed paid in full. Further, as a result of the termination of the Secured Convertible Notes, $3,500,000 previously held in a cash collateral account in connection with the Secured Convertible Notes was released to the Company.

In connection with the closing of the transactions contemplated by the original Fortress Agreement, the Company paid a closing fee of $330,000. As discussed in Note 7, the Company also issued a 5 year warrant to purchase 247,500 shares common stock at an exercise price of $2.00 to National Securities Corporation, a wholly-owned subsidiary of National Holdings, Inc. (“National”), who acted as advisor to the Company with respect to the transaction. The warrant meets the requirements to be accounted for as an equity warrant. The Company estimated the fair value of the warrant to be $153,759, using the Black-Scholes option pricing model. The fair value of the warrant as of November 1, 2014, the issue date of the warrant, was estimated using the following assumptions:

Expected volatility	60	%
Risk free rate	1.62	%
Dividend yield	0	%
Expected term (in years)	5.00

The assumptions utilized were derived in a similar manner as discussed in Note 7 related to the fair value of stock options.

On February 27, 2015, in connection with the execution of the original Fortress Amended Agreement, at closing of the transactions with Fortress, the Company sold 500,000 seven-year warrants to purchase shares of the Company’s common stock at an exercise price of $1.14 per share to Fortress for an aggregate purchase price of $40,000. The warrant was issued by the Company under the exemption from registration afforded by Section 4(a)(2) of the Securities Act and Regulation D promulgated thereunder, as they were issued to accredited investors, without a view to distribution, and were not issued through any general solicitation or advertisement.

On February 27, 2015, in connection with the closing of the transactions contemplated by the Fortress Amended Agreement, the Company paid a closing fee of $35,985 and issued a 5-year warrant for the purchase of 26,989 shares of the Company’s common stock with an exercise price of $2.00 per share to National Securities Corporation, a wholly-owned subsidiary of National Holdings, Inc. (“National”). National acted as advisor to the Company with respect to the transaction.

The warrant issuances on February 27, 2015 meet the requirements to be accounted for as equity with a fair value of $172,319 and $4,960, respectively, using the Black-Scholes option pricing model. The fair value of the issued warrants as of February 27, 2015, were estimated using the following assumptions:

18

	Fortress			National Securities  Corporation
Expected volatility		60	%		60	%
Risk free rate		1.7	%		1.5	%
Dividend yield		0	%		0	%
Expected term (in years)		5.00			7.00

7. Stockholders’ Equity

Common stock

The Company is authorized to issue up to 110,000,000 shares, of which 100,000,000 shares have been designated as common stock and 10,000,000 shares have been designated as preferred stock. Holders of the Company's common stock are entitled to dividends if and when declared by the Board of Directors. The holders of each share of common stock shall have the right to one vote for each share.

Shares of common stock reserved for future issuance were as follows as of September 30, 2015:

Series A convertible preferred stock	528,548
Series B convertible preferred stock	2,395,653
Options to purchase common stock	2,134,291
Shares reserved for issuance pursuant to 2014 Stock Plan	2,278,889
Warrants	1,795,447
Total	9,132,828

On March 31, 2015, the Company entered into a securities purchase agreement (“Purchase Agreement”) with certain investors (the “Purchasers”) pursuant to which the Company sold 4,673,914 shares of its common stock (the “Shares”) at a purchase price of $0.46 per share resulting in gross proceeds to the Company of $2.15 million (the “Registered Direct Offering”). The Registered Direct Offering was effected as a takedown off the Company’s shelf registration statement on Form S-3 (File No. 333-199647), which was declared effective on November 10, 2014, and a related prospectus supplement dated April 2, 2015 in connection with the Registered Direct Offering. The Registered Direct Offering closed on April 6, 2015.

In connection with the Registered Direct Offering, the Company entered into a placement agent agreement (the “Placement Agent Agreement”) with Ladenburg Thalmann & Co. Inc. (the “Placement Agent”) to act as its exclusive placement agent. Pursuant to the Placement Agent Agreement, the Company paid to the Placement Agent $106,000 in cash, issued to the Placement Agent 57,611 five-year warrants with an exercise price of $0.575 per share (the “RD Warrants”) and reimbursed the Placement Agent for certain expenses. In addition, the Company paid to Laidlaw & Company (UK) Ltd. $50,000 in cash and issued 108,697 RD Warrants in connection with certain tail fees owed as a result of the Registered Direct Offering. The RD Warrants allow for cashless exercise in certain situations and contain piggyback registration rights for the seven year period commencing on March 31, 2015.

In addition, the Placement Agent will also be entitled to a tail fee if, within twelve months after the termination of expiration of the Placement Agent Agreement, the Company sells securities to any investor that was introduced to the Company by the Placement Agent and purchased shares in the Registered Direct Offering. The tail fee will be the same as the placement agent’s fee received by the Placement Agent in the Registered Direct Offering, subject to certain reductions described in the Placement Agent Agreement.

In connection with the Registered Direct Offering, the Company entered into a separate waiver agreement with one of its current stockholders pursuant to which the holder waived its right of participation in the Registered Direct Offering (the “Right of Participation”). In consideration for such waiver, the Company paid to the holder $35,000 in cash and waived any trading volume limitations or other lock-up provisions or restrictions imposed on the holder pursuant to an existing securities purchase agreement and an existing lock-up agreement the holder entered into with the Company. The Company also agreed that in the event that the Company obtains a consent, release amendment, settlement or waiver of the Right of Participation from any other stockholder holding such right i​n connection with the Registered Direct Offering on more favorable terms than in the waiver agreement prior to expiration of the Right of Participation of the holder, the holder will be entitled to the benefit of the more favorable terms. The holder’s Right of Participation terminated on September 8, 2015.

19

Convertible preferred stock

Convertible preferred stock as of September 30, 2015 consisted of the following:

Convertible   Preferred Stock	Original  Issue Price		Shares  Designated		Shares Originally Issued		Shares  Outstanding		Liquidation  Preference
Series A-1	$	0.0100		5,000,000		5,000,000		212,466	$	117,158
Series A-2	$	1.6996		1,176,748		1,176,748		161,355	$	274,239
Series B	$	1,000.00		2,750		2,750		1,102	$	1,102,000

During the nine months ended September 30, 2015, 2,168,624 shares of Series A-1 Preferred Stock and 167,245 shares of Series A-2 redeemable convertible preferred stock (the “Series A-2 Preferred Stock”, and together with the Series A-1 Preferred Stock, the “Series A Preferred Stock”) were converted into common stock. See “Note 11. Subsequent Event” below for additional information relating to the conversion of the Series A Preferred Stock and the Series B Preferred Stock to common stock in October 2015.

In conjunction with the issuance of Series A-1 Preferred Stock and Series A-2 Preferred Stock, proceeds of $4,950,000 were received in exchange for the issuance of promissory notes payable. Total proceeds from this transaction were allocated to each instrument using the relative fair value method. Proceeds allocated to Series A-1 Preferred Stock and Series A-2 Preferred Stock were $3,308,874 and $1,134,016, respectively. Following the allocation of fair value, the effective conversion prices per share upon issuance of Series A-1 Preferred Stock and Series A-2 Preferred Stock were $0.55 and $0.96, respectively.

On December 17, 2013, in contemplation of the Merger, the Company issued 2,750 shares of its Series B Preferred Stock (the “Series B Preferred Stock” and collectively with the Series A Preferred Stock, the “Preferred Stock”) at a price of $1,000 per share, subject to the terms of its Certificate of Designations for the Series B Preferred Stock (the “Certificate of Designations”), and warrants to purchase an aggregate of 700,937 shares of the Company’s common stock to certain accredited investors in a private offering transaction for proceeds of $2,750,000. The warrants have an exercise price of $2.66 per common share and expire in June 2016.

The Series B Preferred Stock was repriced at fair value in conjunction with the Merger. The revaluation did not impact earnings per share.

A complete description of the rights, preferences, privileges and restrictions of the Series A Preferred Stock and Series B Preferred Stock are included in the Company’s Fifth Amended and Restated Articles of Incorporation (the “Charter”). The following is a summary of certain rights, privileges, preferences and restrictions:

Liquidation preference

In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Company, the holders of Series A Preferred Stock are entitled to receive an amount equal to the sum of (i) the greater of (x) the product of (I) $0.01 in the event of Series A-1 or $1.6996 in the event of Series A-2 and (II) the number of shares of Series A Preferred Stock then held by each holder and (y) the product of (I) the fair market value of one share of common stock, as mutually determined by the Company and the Preferred Stock holders and (II) the number of shares of common stock issuable upon conversion of such Series A Preferred Stock, and (ii) any declared accrued and unpaid dividends, prior and in preference to any distributions made to the holders of common stock.

20

In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Company, the holders of Series B Preferred Stock are entitled to receive an amount equal to $1,000 per share. After full payment to the holders of Series A Preferred Stock and Series B Preferred Stock, holders of Series B Preferred Stock shall be entitled to participate in the distribution of any remaining assets of the Company on an as converted basis pari passu with the holders of common stock.

If the assets and funds distributed among the holders of the Preferred Stock are insufficient to permit payment to such holders of the full preferential amount, then the entire assets and funds of the Company legally available for distribution shall be distributed ratably among the holders of the Series A Preferred Stock and Series B Preferred Stock in proportion to the preferential amount each such holder is otherwise entitled to receive.

Conversion

All shares of Series A Preferred Stock are convertible into common stock at the option of the holder at any time after the date of issuance by dividing the stated value of such preferred shares by $0.007073 (reflecting the Reverse Split) in the event of Series A-1 or $1.202065 (reflecting the Reverse Split) in the event of Series A-2 by the conversion amount, each subject to adjustment (including the Reverse Split). All Series B Preferred Stock are convertible, into common stock at the option of the holder, at any time after the date of issuance, by multiplying the conversion amount by the quotient of (x) $1,000 divided by (y) 2.00, each subject to similar adjustment. Each share of the Series A Preferred Stock and Series B Preferred Stock will automatically be converted into common stock, at the then-effective applicable conversion price, upon the occurrence of both i) the full collateralization of the Secured Convertible Notes, and ii) upon the closing of the sale of the Company’s common stock in a firm-commitment, underwritten public offering registered under the Securities Act which results in aggregate proceeds to the Company of at least $20,000,000 at a price per share exceeding such threshold as defined in the Company’s Charter (currently $0.289).

Anti-dilution

Holders of Series A-1 Preferred Stock are entitled to receive certain shares of common stock if and when the Company issues or sells any shares of common stock for a consideration per share less than a certain threshold price (currently $0.289).

As a result of the issuance of the Fortress Shares and warrants as discussed in Note 6, and the Registered Direct Offering (as defined above), the conversion price for the Series B Preferred Stock is $0.46. The conversion price will be further reduced (and the holders of Series B Preferred Stock will be entitled to receive additional shares of common stock upon conversion) if and when the Company issues or sells securities for a consideration per share less than the current conversion price.

Voting rights

Holders of the Series A Preferred Stock are entitled to one vote for each share of common stock into which their shares can be converted. Holders of Series B Preferred Stock are entitled to 403.5 votes for each share of Series B Preferred Stock held.

Substantial Holder Rights

The Certificate of Designations, Preferences and Rights for the Series A Preferred Stock contemplates certain rights for any holder of Series A Preferred Stock that purchased a certain threshold number of shares of Series A Preferred Stock for as long as that holder continued to hold at least twenty percent of shares of Series A Preferred Stock originally purchased (such holders referred to as “Substantial Holders”). As of September 30, 2015, there were no longer any Substantial Holders and the rights afforded to such Substantial Holders are no longer in effect.

Warrants

In January 2014, the Company issued warrants to purchase 238,412 shares of common stock at an exercise price of $3.04 to a placement agent. The warrants expire in January 2019. The exercise price was reduced to its floor of $2.27 as a result of the sale of the Fortress Shares. The warrants may be exercised without cash consideration by forfeiting a portion of shares. The fair value of the warrants at issuance was $348,963, estimated using the Black-Scholes option pricing model. The fair value of the warrants was revalued at September 30, 2015 as discussed in Note 5.

21

In connection with the Merger, the Company issued warrants to purchase 700,937 shares of common stock at an exercise price of $2.66, of which 586,238 warrants remain outstanding as of September 30, 2015. The warrants expire in June 2016.

On November 1, 2014 the Company issued 277,500 warrants to purchase common stock to advisors in connection with the Fortress Agreement. The warrants have a weighted average exercise price of $2.07, and the fair value of the warrants at issuance was $164,196.

On February 27, 2015, in connection with the Fortress Amended Agreement, the Company sold 500,000 warrants to purchase common stock with an exercise price of $1.14 and issued 26,989 warrants to purchase common stock with an exercise price of $2.00. The fair value of the warrants at issuance was $172,319 and $4,960, respectively.

Common stock warrants outstanding as of September 30, 2015 are listed as follows:

Warrants Outstanding		Remaining Contractual Life (years)		Weighted Average Exercise
	500,000		6.42	$	1.14
	108,697		4.52	$	0.46
	57,611		4.52	$	0.58
	26,989		4.41	$	2.00
	247,500		4.09	$	2.00
	238,412		3.34	$	2.27
	30,000		2.09	$	2.66
	586,238		0.75	$	2.66
	1,795,447		3.56	$	1.88

8. Stock-Based Compensation 

In November 2013, the Board of Directors authorized the 2013 Stock Plan (such plan has since been adopted by the stockholders of the Company in connection with the Merger and renamed the “Inventergy Global, Inc. 2014 Stock Plan”, the “Plan” or the “2014 Plan”). Under the Plan, the Board of Directors may grant incentive stock awards to employees and directors, and non-statutory stock options to employees, directors and consultants as well as restricted stock. The Plan provides for the grant of stock options, restricted stock, and other stock-related and performance awards that may be settled in cash, stock, or other property. An additional 1,700,000 shares were added to the 2014 Plan in September 2015. Following such addition, the Board of Directors reserved 5,305,445 shares of common stock for issuance over the term of the Plan. The exercise price of an option cannot be less than the fair value of one share of common stock on the date of grant for incentive stock options or non-statutory stock options. The exercise price of an incentive stock option cannot be less than 110% of the fair value of one share of common stock on the date of grant for stockholders owning more than 10% of all classes of stock. Options are exercisable over periods not to exceed ten years (five years for incentive stock options granted to holders of 10% or more of the voting stock) from the grant date. Options may be granted with vesting terms as determined by the Board of Directors which generally include a one to five year period or performance conditions or both. The pre-existing options were subsumed under the Plan.

22

As of September 30, 2015, stock option and restricted stock award activity under the Plan was as follows:

				Options and RSAs Outstanding
	Shares Available for Grant			Number of Shares			Weighted Average Exercise Price Per Share
Balance at December 31, 2014		689,529			2,417,918		$	2.59
Additions to 2014 Stock Plan		1,700,000
Options Granted		(1,908,661	)		1,908,661		$	1.02
Options Forfeited		646,514			(646,514	)	$	1.14
Options Expired		113,113			(113,113	)	$	2.63
Options Cancelled		1,432,661			(1,432,661	)	$	2.73
Restricted Stock Granted		(394,267	)		394,267		$	0.39
Restricted Stock Vested		-			(394,267	)	$	0.39
Balance at September 30, 2015		2,278,889			2,134,291		$	1.53
Total vested and expected to vest shares (options)					2,134,291		$	1.53
Total vested shares (options)					1,021,911		$	2.13

As of September 30, 2015, all of the restricted stock granted under the plan had vested. The aggregate intrinsic value of stock options outstanding, stock options vested and expected to vest, and exercisable at September 30, 2015 was $0.

Prior to the plan being established, the Company granted the equivalent of 7,167,585 restricted stock awards (“RSAs”) to employees and non-employees in exchange for services with vesting schedules specific to each individual award. As of September 30, 2015, 4,509,238 shares were vested, and 629,453 shares were cancelled or forfeited (unvested).

As part of the Merger, 15,000 fully vested options with an exercise price of $14.30 were assumed by Inventergy Global, Inc. and remained outstanding as of September 30, 2015.

Cancellation and Issuance of Options

On March 25, 2015, the Company cancelled certain unvested options (totaling 1,432,661) granted to employees and directors under the Company’s 2014 Stock Plan, which had exercise prices ranging from $2.05 to $3.85, 10 year terms and one to four year vesting terms. In addition, on March 25, 2015, the Company issued new options to the same employees and directors under the 2014 Stock Plan. The Company granted an aggregate of 1,269,845 options to its employees, the vesting schedules of which were increased by 12 months as compared to the cancelled options – an increase from an average vesting schedule spanning 2.1 years to 3.1 years. The Company also granted an aggregate of 162,816 options to its directors, the vesting schedules of which were left substantially unchanged as compared to the cancelled options which had been set to align with the service period of each board member. The new options have an exercise price of $1.14 per share, which is a 48% premium to the closing price of the Company’s common stock as of March 25, 2015. This cancellation and issuance of new options resulted in an increase in stock compensation expense of $272,720 which is being recognized over the remaining average vesting period of 3.1 years.

23

The following table summarizes information with respect to stock options outstanding at September 30, 2015:

Options Outstanding								Options Vested
Exercise  Price Per Share		Shares Outstanding		Weighted-  Average  Remaining  Contractual  Life (Years)		Weighted-  Average  Exercise  Price		Shares Exercisable		Weighted-  Average  Exercise  Price Per Share
$	0.56		25,000		1.58	$	0.56		25,000	$	0.56
$	0.69		316,000		9.32	$	0.69		43,250	$	0.69
$	0.77		150,000		9.18	$	0.77		25,000	$	0.77
$	1.14		974,168		8.03	$	1.14		259,538	$	1.14
$	2.05		17,800		8.84	$	2.05		17,800	$	2.05
$	2.27		525,628		8.13	$	2.27		525,628	$	2.27
$	3.04		70,695		1.58	$	3.04		70,695	$	3.04
$	3.85		40,000		7.35	$	3.85		40,000	$	3.85
$	14.30		15,000		0.71	$	14.30		15,000	$	14.30
			2,134,291		7.98	$	1.53		1,021,911	$	2.13

Stock-based compensation expense

The fair value of employee stock options granted was estimated using the following weighted-average assumptions for the nine months ended September 30, 2015:

	2015
Expected volatility		64	%
Risk free rate		1.48	%
Dividend yield		0	%
Expected term (in years)		6.06

The expected term of the options is based on the average period the stock options are expected to remain outstanding based on the option’s vesting term and contractual terms. The expected stock price volatility assumptions for the Company’s stock options were determined by examining the historical volatilities for industry peers, as the Company did not have any trading history for the Company’s common stock. The risk-free interest rate assumption is based on the U.S. Treasury instruments whose term was consistent with the expected term of the Company’s stock options. The expected dividend assumption is based on the Company’s history and expectation of dividend payouts. Forfeitures were estimated based on the Company’s estimate of future cancellations.

Stock-based compensation for employees and non-employees related to options and RSAs recognized:

	For the three months ended September 30				For the nine months ended September 30
	2015		2014		2015		2014
General and administrative	$	246,485	$	376,530	$	843,386	$	2,238,184

In November 2014, the Company modified the terms to an option granted to a former director. The Company determined that there was no incremental compensation expense associated with the modification.

No income tax benefit has been recognized related to stock-based compensation expense and no tax benefits have been realized from exercised stock awards. As of September 30, 2015, there were total unrecognized compensation costs of $1,187,274 related to these stock awards. These costs are expected to be recognized over a period of approximately 1.25 years.

24

Non-employee stock-based compensation expense

For the three and nine months ended September 30, 2015 and 2014, the Company issued options and restricted stock awards to non-employees in exchange for services with vesting specific to each individual award. Non-employee stock-based compensation expense is recognized as the awards vest and totaled $41,381 and $258,053 for the three and nine months ended September 30, 2015, respectively, and $(67,910) and $1,312,993 for the three and nine months ended September 30, 2014, respectively. The fair value of RSAs is calculated as the fair value of the underlying stock multiplied by the number of shares awarded.

9. Income Taxes

On a quarterly basis, the Company records income tax expense or benefit based on year-to-date results and expected results for the remainder of the year. The Company recorded no provision for income taxes for the three- and nine- month periods ended September 30, 2015 and 2014.

Deferred income taxes reflect the tax effect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Based on the Company’s historical net losses during its development stage, the Company has provided a full valuation allowance against its deferred tax assets as of September 30, 2015 and 2014.

The use of the Company’s net operating loss carryforwards is subject to certain annual limitations and may be subject to further limitations as a result of changes in ownership as defined by the Internal Revenue Code and similar state provisions. Such limitations could result in the expiration of net operating loss carryforwards prior to utilization.

The Company files U.S. federal and state tax returns. As of September 30, 2015 and 2014, all tax years remain open in most jurisdictions. The Company is not currently under examination by income tax authorities in federal or state jurisdictions.

10. Commitments and Contingencies

Operating lease

In March 2014, the Company entered into a non-cancelable thirty-eight month lease agreement for offices in Campbell, California commencing June 1, 2014 with escalating rent payments ranging from approximately $9,200 to $9,800 per month and one option to extend the lease term for an additional three years. Included in the lease agreement was a full rent abatement period of two months. Rent expense is recognized on a straight line basis. The Company paid a security deposit of $18,993. The future minimum payments related to this lease are as follows:

Years ending December 31:
2015		28,568
2016		116,201
2017		68,587
Total	$	213,356

Rent expense was approximately $27,152, and $36,202 for the three months ended September 30, 2015 and 2014, respectively, and approximately $81,472, and $81,221 for the nine months ended September 30, 2015 and 2014, respectively.

25

Guaranteed payments

The Company has entered into agreements to purchase certain patent assets. The Company will be required to pay the remaining future unconditional guaranteed payments of $20,000,000 ($18 million of which is to be paid out of net revenues from patent licensing receipts) through August 31, 2017, such payments representing the purchase of patents and minimum revenue sharing from the Company’s licensing arrangements and/or similar transactions regarding the purchased patents to other parties. The guaranteed payments are accrued on the Company’s accompanying balance sheet as of September 30, 2015 at net present value using a discount rate of 12%. The associated discount is being amortized using the effective interest method. Expenses related to minimum revenue sharing payments are deferred as of September 30, 2015 and will be amortized in correlation with the future payment schedule. Minimum revenue sharing payments are generally due sixty days after fully earned. Future guaranteed payments associated with these agreements are payable as follows:

Years ending December 31:
2015		4,667,415
2016		5,000,000
2017		10,000,000
Less: discount to present value		(1,830,549	)
Guaranteed payments, net of discount	$	17,836,866

Pursuant to the patent purchase agreement with Panasonic Corporation (“Panasonic”), a significant portion of the above guaranteed payments are owed to Panasonic.  If the Company’s market capitalization falls below the aggregate dollar amount that the Company owes at that relevant point in time to Panasonic (but only prior to full payment), Panasonic may exercise a limited right to repurchase the Panasonic patent portfolio assets at a purchase price at least equal to the amount the Company paid to purchase the Panasonic patent portfolio. During the three months ended September 30, 2015, the Company was in compliance with the terms of the agreement.

Fortress Notes payable

Pursuant to the Fortress Agreement (as described in Note 6), future debt payments owed to Fortress with respect to the Fortress Notes are as follows:

Years ending December 31:
2015		1,306,629
2016		5,327,055
2017		4,102,810
Total	$	10,736,494

11. Subsequent Events

Conversion of Preferred Stock

In October 2015, the Company entered into agreements with holders of all of the outstanding Series A and Series B Preferred Stock pursuant to which the holders agreed to exchange all of their outstanding shares of Series A and Series B Preferred Stock for common stock. As a result, as of October 13, 2015, there were no remaining shares of Series A or Series B Preferred Stock outstanding. The previously-outstanding Preferred Stock amounts, along with the newly-issued common stock amounts, are as follows:

	Outstanding as of Sept. 30, 2015		Newly-Issued Common Stock
Series A-1		212,466		1,412,613
Series A-2		161,355		285,179
Series B		1,102		4,209,560

Modification of Fortress Amended Agreement

On October 30, 2015, the Company and Fortress amended the Fortress Amended Agreement. The amendment deferred the initial Amortization Payment and suspended the requirement to maintain a $1 million minimum cash balance until December 1, 2015. In addition, the parties agreed to decrease the exercise price on the 500,000 warrants issued to Fortress in February 2015 to $0.254 per share.

Settlement of Litigation

On October 27, 2015, the Company and Genband US LLC (“Genband”) settled a patent infringement action brought by Inventergy, Inc. The settlement agreement required Genband, among other provisions, to pay a confidential settlement fee to Inventergy, Inc.

Modification of Patent Payment Terms

On October 30, 2015, the Company and a third party from whom the Company purchased one of its patent portfolios agreed to amend the terms of the original patent purchase agreement under which the Company was required to make a $2,000,000 payment by December 1, 2015. The amendment provides that the Company will make a $550,000 payment on January 31, 2016 and a $1,650,000 payment on July 1, 2016, which amounts include $95,000 in additional interest. These payments may be paid at a 10% discount if paid 45 days or more in advance of their respective due dates.

26

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

The following discussion should be read in conjunction with the financial statements of the Company and the notes thereto.

Overview

The Company is an IP investment and licensing company that helps technology-leading corporations attain greater value from their IP assets in support of their business objectives and corporate brands. Inventergy, Inc., our wholly-owned subsidiary, was initially organized as a Delaware limited liability company under the name Silicon Turbine Systems, LLC in January 2012. It subsequently changed its name to Inventergy, LLC in March 2012 and it was converted from a limited liability company into a Delaware corporation in February 2013, at which time it became Inventergy, Inc. On June 6, 2014, a subsidiary of the Company merged with and into Inventergy, Inc. with Inventergy, Inc. becoming a wholly-owned subsidiary of the Company. As a result of the Merger, the Company changed its name to “Inventergy Global, Inc.”

The Company works to develop long-term relationships with global companies seeking to strategically realize an appropriate return on IP assets in which they have invested a significant amount of research and development (IP value creation). The Company offers clients a professional corporate licensing model for IP value creation that provides both short term returns and attractive, long-term licensing revenue. The Company has focused initially on developing relationships with companies in the telecommunications industry but its business purpose is not limited to this industry. We aspire to be a market-leader in IP value creation across various technology and market segments.

The core strategy of the Company is to acquire significant patent portfolios from Global Fortune 500 companies who are leaders or major players in their industries and to generate value from these portfolios through licensing or sales of these patents. The patents are generally purchased for a fee as well as a percentage of the net revenue (revenue after deduction of litigations costs, if any). As a result of such purchase agreements, the Company has full ownership of the patent portfolios, including the rights to past damages, and has the sole right to determine the best strategy to derive value from the portfolios. Accordingly, the Company remains independent of the clients from which we have acquired the patent portfolios.

Critical Accounting Policies

See Note 2 of the Notes to Condensed Consolidated Financial Statements included in Item 1 of this Quarterly Report for a summary of significant accounting policies and information on recently adopted accounting standards.

Results of Operations

For the Three Months Ended September 30, 2015 compared to the Three Months Ended September 30, 2014

Revenue

Revenue for the three months ended September 30, 2015 was $132,500 and consisted of $100,000 from a patent licensing contract (having a total value of approximately $2 million over five years), and $32,500 from our access control security product/service lines acquired in the Merger. Revenue for the three months ended September 30, 2014 was $306,603 and was generated entirely from our access control security product/service lines.

Cost of Revenue

Cost of revenue for the three months ended September 30, 2015 was $51,651, consisting of $20,875 in third party payments related to patent licensing revenue, $28,250 of amortization of contracts acquired, and $2,526 of freight out related to our access control security product line. Cost of revenue for the three months ended September 30, 2014 was $339,795 and included the cost of access products sold of $242,695, cost of fulfillment services of $30,000, and amortization of $67,100 for contracts acquired in the Merger.

27

Patent Amortization Expense

Amortization expense for the three months ended September 30, 2015 and September 30, 2014 was $377,742 and $387,585, respectively, for the amortization of patents acquired.

General and Administrative Expense

General and administrative (‘G&A”) expenses for the three months ended September 30, 2015 were $1,930,705 compared to $2,559,474 for the three months ended September 30, 2014. G&A expenses for the three months ended September 30, 2015 included $205,104 and $41,381 of equity compensation expense for restricted stock awards and stock options for employees and non-employees, respectively, compared to $444,440 in equity compensation expense for employees and an expense offset of $67,910 for non-employees for the three months ended September 30, 2014. Salaries, wages and other personnel expenses were $686,609 and $795,394 for the three months ended September 30, 2015, and September 30, 2014, respectively, a decrease of $108,785 as a result of five employees who left the Company during the first three quarters of 2015. Investor relations expense was $63,192 and $104,823 for the three months ended September 30, 2015, and September 30, 2014, respectively, a decrease of $41,631 as a result of decreased costs for investor relations, communications, media and related services in 2015, compared to higher costs in these areas following the Merger in 2014. Patent fees were $249,695 and $513,664 for the three months ended September 30, 2015, and September 30, 2014, respectively, primarily as a result of lower patent research and consulting costs in 2015. Legal expenses were $427,903 for the three months ended September 30, 2015, compared to $354,402 for the three months ended September 30, 2014. This increase of $73,501 was primarily due to two ongoing litigation matters in 2015. Other G&A expenses were $256,821 and $414,661 for the three months ended September 30, 2015, and September 30, 2014, respectively, representing a decrease of $157,840 primarily as a result of lower consulting fees and reduced business travel.

Interest Expense, Net

Interest expense, net, for the three months ended September 30, 2015 and September 30, 2014 was $1,279,879 and $229,231, respectively. Interest expense, net, for the three months ended September 30, 2015 includes interest expense on patents purchased of $261,131, and interest expense and an amortization of discount on Fortress Notes of $1,018,758. Of these amounts, $218,791 was paid in cash. Interest expense, net, for the three months ended September 30, 2014 includes interest expense on patents purchased of $129,615, amortization of the Secured Convertible Notes discount of $17,050, and interest expense of $82,591, less interest income of $25.

For the Nine Months Ended September 30, 2015 compared to the Nine Months Ended September 30, 2014

Revenue

Revenue for the nine months ended September 30, 2015 was $4,483,303 and consisted of $4,000,000 from a sale of two patent families, $253,571 from a patent licensing contract (having a total value of approximately $2 million over 5 years), and $229,732 from our access control security product/service lines acquired in the Merger. Revenue for the nine months ended September 30, 2014 was $353,646 and was entirely from our access control security product/service lines.

Cost of Revenue

Cost of revenue for the nine months ended September 30, 2015 was $913,800, and consisted of $215,372 for cost of patents sold, $572,430 related to patent sale and licensing revenue, $41,248 of product costs related to access control security product/service lines and amortization of $84,750 for contracts acquired in the Merger. Cost of revenue for the nine months ended September 30, 2014 was $418,000 and consisted of cost of products related to our access control security product/service lines of $290,533, fulfillment costs and services of $38,000, and amortization of $89,467 for contracts acquired in the Merger.

28

Patent Amortization Expense

Amortization expense of $1,152,365, and $1,012,956 for the nine months ended September 30, 2015 and September 30, 2014, respectively, was for the amortization of patents acquired.

General and Administrative Expense

General and administrative (“G&A”) expenses for the nine months ended September 30, 2015 were $5,921,212 compared to $8,996,860 for the nine months ended September 30, 2014. G&A expenses for the nine months ended September 30, 2015 included $585,333 and $258,053 of equity compensation expense for restricted stock awards and stock options for employees and non-employees, respectively, compared to $925,190 and $1,312,993 for the nine months ended September 30, 2014. Salaries, wages and other personnel expenses were $2,296,542 and $2,323,557 for the nine months ended September 30, 2015, and September 30, 2014, respectively, a decrease of $27,015 primarily as a result of a departure of five people in the nine months ended September 30, 2015. Investor relations expense was $467,245 and $590,914 for the nine months ended September 30, 2015, and September 30, 2014, respectively, a decrease of $123,669 as a result of decreased costs for investor relations, communications, media and related services in 2015, compared to higher costs in these areas following the Merger in 2014. Patent fees were $606,303 and $1,404,165 for the nine months ended September 30, 2015, and September 30, 2014, respectively, primarily as a result of lower patent research, renewal and consulting costs in 2015. Legal expenses were $701,898 for the nine months ended September 30, 2015, compared to $1,146,808 for the nine months ended September 30, 2014. This decrease of $444,910 was primarily due to eliminating an accrual for contingent legal fees as of June 30, 2015, partially offset by ongoing litigation matters. The Company’s policy related to contingent legal fees is to recognize such fees in the period in which such fees are determined to be probable, usually when the related revenue is recognized. During the six months ended June 30, 2015, the Company discovered certain legal fees had been expensed in prior periods which were contingent in nature and whose probability had not yet been determined. Such fees, which were not material to the individual prior periods, were reversed in the six month period ended June 30, 2015. Other G&A expenses were $1,005,838 and $1,293,233 for the nine months ended September 30, 2015, and September 30, 2014, respectively, representing a decrease of $287,395, primarily as a result of lower consulting fees, reduced business travel, lower liability insurance costs and other general expense savings.

Loss on Extinguishment of Notes Payable

In connection with the Fortress Amended Agreement, the Company recorded a loss of $2,268,373 in the nine month period ended September 30, 2015. See Note 6 to our financial statements contained in Item 1 herein.

On March 26, 2014, the Company amended and restated certain Senior Secured Notes with an aggregate original principal amount of $5,000,000 issued on May 10, 2013 and also issued $3,000,000 in New Secured Convertible Notes for a total of $8,000,000 of Secured Convertible Notes. The Senior Secured Notes were amended to allow for their conversion into common stock and to amend the interest rate. In conjunction with the amendment to the Senior Secured Notes, in 2014 the Company recorded a loss on extinguishment of $2,403,193. See Note 6 to our financial statements contained in Item 1 herein.

Decrease in Fair Value of Derivative Liabilities

Decrease in fair value of derivatives liabilities was $47,331 and $667,448 for the nine months ended September 30, 2015 and September 30, 2014, respectively. The change for the nine months ended September 30, 2015 was entirely due to a decrease in the common stock warrant value. The change for the nine months ended September 30, 2014 was the result of the decrease in the fair value of the Secured Convertible Note derivative liability of $289,775, the Series A-1 Preferred Stock derivative liability of $56,926, and the common stock warrant value of $320,748. See Note 5 to our financial statements contained in Item 1 herein.

Interest Expense, Net

Interest expense, net, for the nine months ended September 30, 2015 and September 30, 2014 was $3,771,868 and $525,391, respectively. For the nine months ended September 30, 2015, this amount includes interest expense on patents purchased of $627,021, interest expense and amortization of discount on Fortress Notes of $2,444,227, and interest expense of $700,620. Of these amounts, $631,471 was paid in cash and the remaining amounts were accrued. Interest expense, net, for the nine months ended September 30, 2014 includes interest expense on patents purchased of $129,615, amortization of the Secured Convertible Notes discount of $185,474, and interest expense of $210,954, less interest income of $652.

29

Liquidity and Capital Resources

At September 30, 2015, the Company had an accumulated deficit since inception of $52,568,560 and had negative working capital of $13,243,781. As of November 9, 2015, we had remaining cash of $1,338,926. These factors raise substantial doubt about our ability to continue as a going concern, which is dependent both on achieving additional licensing or sales revenue from our patent portfolios and/or obtaining additional financing on terms acceptable to us. Toward that end, the Company entered into its first licensing agreement in February 2015, received net proceeds from an additional drawdown from the Fortress Agreement of $1,126,900 as a result of entering into the license agreement, received net proceeds of $1,835,000 from the sale of common stock in April 2015, and received gross proceeds of $4,000,000 from the sale of two patent families in June 2015. We will seek to continue our operations primarily with income received through our patent monetization efforts, including licensing revenues and patent sales, but we may need to seek additional financing through loans, which will be subject to the restrictions of the Fortress Agreement, and/or the sale of our securities. If we are required to raise additional capital, we cannot assure you that we will be able to obtain such capital on terms acceptable to us or at all.

The Company may require significant amounts of capital over the next twelve months to sustain our operations and make the investments needed to continue operations and execute its longer term business plan. We estimate operating expenses, exclusive of litigation costs, will be approximately $4.9 million over the next twelve months, consisting of approximately $1.9 million in employee related costs (an approximate 21% decrease from the level of anticipated employee expenses disclosed in our Quarterly Report on Form 10-Q for the period ended June 30, 2015), $0.8 million in patent maintenance and prosecution fees, and $2.2 million in other operating costs. We anticipate a more aggressive litigation approach will be taken relating to patent enforcement, and estimate litigation expenses of approximately $4.6 million in the next twelve months. In addition, we estimate our debt principal and interest payments will be approximately $5.5 million to Fortress. These amounts payable to Fortress are in addition to any revenue sharing amounts expected to be paid from forecasted patent monetization revenues. Based on our existing cash balances, anticipated revenues from patent monetization activities, available financing opportunities, proactive measures to reduce expenses and defer obligations where possible, management believes we have funds sufficient to meet our anticipated operating needs for approximately five months.

To date, the Company has acquired approximately 755 currently active patents and patent applications for aggregate purchase payments of $12,109,118. We will be required to pay unconditional guaranteed payments to the sellers of the patents of an aggregate of $20 million ($18 million of which to be paid out of net revenues from patent licensing receipts) through August 31, 2017 (with a net present value of $17.8 million). See Note 10 in the accompanying financial statements for further information regarding these guaranteed payments.

On February 11, 2015, the Company entered into its first license agreement, in which we expect to receive an aggregate of $2,000,000 of proceeds over the course of the five-year license. In connection therewith, on February 25, 2015, the Company amended and restated the Fortress Agreement pursuant to which Fortress agreed to make available to the Company an additional $3,000,000 of credit between February 25, 2015 and December 31, 2015, which can be drawn down in the form of additional senior secured notes with the same terms and conditions as the Original Notes. On February 25, 2015, we drew down $1,199,500 from the Additional Available Credit, which after the payment of transaction-related fees and expenses, netted $1,126,900 in proceeds to the Company. The Company may seek to raise additional capital in the form of further draw downs on the remaining Additional Available Credit, which would require the Company to obtain Fortress’ consent.

On June 25, 2015, the Company closed a sale of two of its patent families to an undisclosed third party for which we received gross proceeds of $4,000,000. Following expected payments to third parties and Fortress under revenue share agreements, the Company will retain approximately $1,666,500, which will be used to fund future operating activities.

30

In addition to our capital needs over the next twelve months, which are detailed above, our future capital requirements will depend on many factors, including our levels of net sales and licensing revenues, as well as the timing and extent of expenditures to support our patent infringement litigation. If we issue equity or equity equivalents to raise additional funds, our existing stockholders could experience substantial dilution and the new holders of securities may have rights, preferences and privileges senior to those of our existing stockholders. If adequate capital is not available when needed, we will be required to significantly modify our business model and operations to reduce spending to a sustainable level. It could cause us to be unable to execute our business plan, take advantage of future opportunities or respond to competitive pressures or customer requirements. It may also cause us to delay, scale back or eliminate some or all of our research and development programs, to reduce or cease operations or to default under the Fortress Agreement, which could lead to the repossession of our patent portfolios by Fortress.

As of September 30, 2015, the Company had cash and cash equivalents of $1,368,118 (which includes $1,000,000 of minimum cash reserves (see discussion, Note 6), which is intended to serve as additional collateral for the Fortress Agreement). Also as of September 30, 2015, the Company had negative working capital of $13,243,781. The Company’s net loss for the nine months ended September 30, 2015 was $9,495,347 and our accumulated deficit amount was $52,568,560 as of September 30, 2015. Our cash and cash equivalents as of September 30, 2015 consisted primarily of the $4,000,000 proceeds from the sale of two patent families and net proceeds of $1,835,000 (after issuance costs of $315,000) received from the Registered Direct Offering, offset by expenditures for general operating purposes. A detailed description of the Registered Direct Offering is set forth in Note 7 of Item 1 herein.

As of September 30, 2015, the Company had cash and cash equivalents of $1,368,118 compared to $1,443,349 as of December 31, 2014. The decrease in cash and cash equivalents of $75,231 for the nine months ended September 30, 2015 was attributable to net cash used in operating activities of $810,131, partially offset by net cash provided by financing activities of $734,900.

Cash Flows – Operating Activities

The Company’s operating activities for the nine months ended September 30, 2015 resulted in net cash used of $810,131. Net cash used in operating activities consisted of a net loss of $ $9,495,347, partially offset by non-cash expenses consisting of depreciation expense of $12,753, loss on extinguishment of notes payable of $2,268,373, amortization of discount on notes payable of $2,191,248, amortization of patents and acquired contracts of $1,237,115, stock-based compensation of $843,386, and net cost of patents sold of $215,372. These non-cash expenses were partially offset by non-cash income from a decrease in fair value of derivative liabilities of $47,331. Changes in operating assets and liabilities provided cash of $1,964,300, from a decrease in accounts receivable of $219,851, a decrease in inventories of $130,155, a decrease in deferred expenses of $300,833, an increase in accounts payable of $114,512, an increase in accrued expenses and other current liabilities of $483,961, and an increase in deferred revenue of $746,429, partially offset by an increase in prepaid expenses and other current assets totaling $21,441 and an increase in deposits and other assets of $10,000.

The Company’s operating activities for the nine months ended September 30, 2014 resulted in net cash used of $5,317,200. Net cash used from operations consisted of a net loss of $12,335,306, partially offset by non-cash expenses of depreciation expense of $5,668, loss on extinguishment of notes payable of $2,403,193, amortization of discount on notes payable of $298,885, amortization of patents and acquired contracts of $1,102,423, and stock-based compensation of $2,238,184. These non-cash expenses were partially offset by non-cash income from a decrease in fair value of derivative liabilities of $667,448. Changes in operating assets and liabilities provided cash of $1,637,201, consisting of a decrease in inventories of $47,294, an increase in accounts payable of $1,386,113, an increase in accrued expenses and other current liabilities of $549,294, and an increase in accrued interest on notes payable of $73,065, partially offset by an increase in accounts receivable of $245,558, an increase in prepaid expenses and other current assets of $155,523, and an increase in deposits and other assets of $17,484.

Cash Flows – Investing Activities

The Company had no investing activities during the nine months ended September 30, 2015. For the nine months ended September 30, 2014, investing activities resulted in net cash used of $5,762,014, which consisted of an increase in restricted cash of $3,500,000, purchases of property and equipment of $52,186 and the issuance of a short-term note receivable to a related party of $3,000,000, partially offset by cash and other assets received in the Merger of $790,172.

Cash Flows – Financing Activities

The Company’s financing activities for the nine months ended September 30, 2015 resulted in net cash received of $734,900, consisting of $1,835,000 received from the sale of common stock (net of $315,000 of issuance costs) and $1,126,900 from issuance of notes payable, partially offset by repayments of Fortress notes of $2,147,000 and repayments of $80,000 of short-term notes payable to a related party.

31

The Company’s financing activities for the nine months ended September 30, 2014 resulted in net cash received of $9,792,978. Net cash was provided by proceeds from the issuance of common stock of $6,487,850, net cash proceeds from the issuance of convertible notes payable of $2,905,128, and net cash proceeds of $500,000 from the issuance of notes payable, partially offset by payments of $100,000 on short-term notes payable to a related party.

The Company will require additional financing for the purchase of additional patent portfolios and to fund its monetization efforts if new attractive opportunities are found. If the Company acquires additional large patent portfolios, in addition to the cost of the upfront purchase fee (if any) it is likely that additional resources (business, technical or legal) may need to be hired to effectively monetize the portfolio. Resources to analyze new portfolios are already part of the current staffing of the Company. Litigation costs are based primarily on a contingent fee structure (expected to average less than 20% of license revenue for a portfolio) and as such does not scale significantly with the acquisition of new portfolios. Acquisitions or investments may be consummated through the use of cash, equity, seller financing, third party debt, earn-out obligations, revenue sharing, profit sharing, or some combination of two or more of these types of consideration. Due to the dynamic credit market, the Company is not able to predict with any certainty whether it could obtain debt or equity financing to provide additional sources of liquidity at favorable rates should the need arise.

Off Balance Sheet Arrangements

None.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

We are a smaller reporting company and therefore are not required to provide the information for this item for Form 10-Q.

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures 

As of the end of the period covered by this Quarterly Report, our Chief Executive Officer and Chief Financial Officer (the “Certifying Officers”), conducted evaluations of our disclosure controls and procedures. As defined under Sections 13a – 15(e) and 15d – 15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), the term “disclosure controls and procedures” means controls and other procedures of an issuer that are designed to ensure that information required to be disclosed by the issuer in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC. Disclosure controls and procedures include without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including the Certifying Officers, to allow timely decisions regarding required disclosures.

Based on their evaluation, the Certifying Officers have concluded that, as of September 30, 2015, our disclosure controls and procedures were effective.

Changes in internal control over financial reporting.

On April 20, 2015, the Company reorganized its financial operations in an effort to address a previous material weakness. The Company terminated its then current Chief Financial Officer and replaced this position and certain services of an outside accounting firm utilized by the Company with consulting services from The Brenner Group, Inc., a financial consultancy firm (the “The Brenner Group”). Accordingly, on April 20, 2015, the Board appointed John Niedermaier as the Company’s Chief Financial Officer pursuant to the terms of an agreement with The Brenner Group. We believe that the hiring of The Brenner Group and Mr. Niedermaier specifically addresses our material weakness. Based on this change and on other improvements in internal review procedures implemented since April 2015, the Certifying Officers concluded that a material weakness no longer existed as of September 30, 2015.

32

Limitations on the Effectiveness of Internal Controls

Readers are cautioned that our management does not expect that our disclosure controls and procedures or our internal control over financial reporting will necessarily prevent all fraud and material error. An internal control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our control have been detected. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any control design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate.

PART II- OTHER INFORMATION

Item 1. Legal Proceedings.

On July 14, 2014, Inventergy, Inc., a wholly-owned subsidiary of the Company, filed a complaint in the Federal Court for the Eastern District of Texas, against Genband US LLC (“Genband”) over the infringement of five patents owned by Inventergy, Inc. On October 27, 2015, Inventergy, Inc. entered into a settlement agreement with Genband pursuant to which, among other provisions, Genband pays an undisclosed settlement fee to Inventergy, Inc.

On January 23, 2015, Sonus Networks, Inc., filed a declaratory judgment complaint in the Northern District of California (the “California Action”) naming the Company and Inventergy, Inc. as defendants and alleging non-infringement of seven patents from Inventergy, Inc.’s IMS/VOIP patent portfolio. The complaint was amended on March 10 and May 11, 2015, further alleging unfair competition, breach of contract and a RICO claim under 18 USC 1961. The Company and Inventergy, Inc. counterclaimed on August 6, 2015 for infringement of the same seven patents, which was answered by Sonus on August 31, 2015. The parties are currently engaged in court-ordered mediation discussions.

33

Item 1A. Risk Factors.

We are a smaller reporting company and are not required to provide the information required by this item.

Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds.

None.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

None.

Item 5. Other Information.

None.

Item 6. Exhibits.

No.	Description of Exhibit
31.1	Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1	Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2	Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS	XBRL Instance Document
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document
101.SCH	XBRL Taxonomy Extension Schema Document
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	XBRL Taxonomy Extension Labels Linkbase Document
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document

34

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date:  November 10, 2015	Inventergy Global, Inc.
	By:	/s/ Joseph W. Beyers
	Name:	Joseph W. Beyers
	Title:	Chief Executive Officer
	By:	/s/ John G. Niedermaier
	Name:	John G. Niedermaier
	Title:	Chief Financial Officer

35

EX-31.1

Exhibit 31.1

Certification of Chief Executive Officer

Pursuant to Rule 13a-14(a)

I, Joseph A. Beyers, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Inventergy Global, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 10, 2015

/s/ Joseph A. Beyers

Joseph A. Beyers

Chief Executive Officer

EX-31.2

Exhibit 31.2

Certification of Chief Financial Officer

Pursuant to Rule 13a-14(a)

I, John Niedermaier, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Inventergy Global, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 10, 2015

/s/ John Niedermaier

John Niedermaier

Chief Financial Officer

EX-32.1

Exhibit 32.1

INVENTERGY GLOBAL, INC.

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Inventergy Global, Inc. (the “Company”) on Form 10-Q for the period ending September 30, 2015, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Joseph A. Beyers, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. ss.1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

/s/ Joseph A. Beyers

Joseph A. Beyers

Chief Executive Officer

November 10, 2015

EX-32.2

Exhibit 32.2

INVENTERGY GLOBAL, INC.

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Inventergy Global, Inc. (the “Company”) on Form 10-Q for the period ending September 30, 2015, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, John Niedermaier, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. ss.1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

/s/ John Niedermaier

John Niedermaier

Chief Financial Officer

November 10, 2015

XML

Redeemable convertible preferred stock (Detail)	Sep. 30, 2015 USD ($) $ / shares shares
Redeemable Convertible Preferred Stock Series A-1 [Member]
Temporary Equity [Line Items]
Original Issue Price | $ / shares	$ 0.0100
Shares Designated	5,000,000
Shares Originally Issued	5,000,000
Shares Outstanding	212,466
Liquidation Preference | $	$ 117,158
Redeemable Convertible Preferred Stock Series A-2 [Member]
Temporary Equity [Line Items]
Original Issue Price | $ / shares	$ 1.6996
Shares Designated	1,176,748
Shares Originally Issued	1,176,748
Shares Outstanding	161,355
Liquidation Preference | $	$ 274,239
Series B Convertible Preferred Share [Member]
Temporary Equity [Line Items]
Original Issue Price | $ / shares	$ 1,000.00
Shares Designated	2,750
Shares Originally Issued	2,750
Shares Outstanding	1,102
Liquidation Preference | $	$ 1,102,000

XML

Schedule of Future Guaranteed Payments (Detail)	Sep. 30, 2015 USD ($)
Liabilities for Guarantees on Long-Duration Contracts [Line Items]
2015	$ 4,667,415
2016	5,000,000
2017	10,000,000
Less: discount to present value	(1,830,549)
Guaranteed payments, net of discount	$ 17,836,866

XML

Commitments and Contingencies - Additional Information (Detail) - USD ($)	1 Months Ended	3 Months Ended		9 Months Ended		32 Months Ended
	Mar. 31, 2014	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	Aug. 31, 2017
Commitments and Contingencies [Line Items]
Security Deposit	$ 18,993
Operating Leases, Rent Expense		$ 27,152	$ 36,202	$ 81,472	$ 81,221
Future unconditional guarantee paid				$ 20,000,000
Discount Rate				12.00%
Patents [Member]
Commitments and Contingencies [Line Items]
Future unconditional guarantee paid				$ 20,000,000
Payments for Fees				$ 18,000,000
Subsequent Event [Member] | Patents [Member]
Commitments and Contingencies [Line Items]
Payments for Fees						$ 18,000,000
Minimum [Member]
Commitments and Contingencies [Line Items]
Operating lease rent	9,200
Maximum [Member]
Commitments and Contingencies [Line Items]
Operating lease rent	$ 9,800

XML

Estimated Fair Value Of Derivative Liability (Detail)	9 Months Ended
	Sep. 30, 2015
Fair Value Of Derivative Liability [Line Items]
Expected volatility	60.00%
Risk free rate	0.96%
Dividend yield	0.00%
Expected term (in years)	3 years 3 months 27 days

XML

Subsequent Events (Tables)

9 Months Ended

Sep. 30, 2015

Subsequent Events [Abstract]

Schedule of Subsequent Events

The previously-outstanding Preferred Stock amounts, along with the newly-issued common stock amounts, are as follows:

	Outstanding as of Sept. 30, 2015		Newly-Issued Common Stock
Series A-1		212,466		1,412,613
Series A-2		161,355		285,179
Series B		1,102		4,209,560

XML

Outstanding Preferred Stock with the Newly-Issued Common Stock (Detail) - shares	1 Months Ended	9 Months Ended
	Oct. 31, 2015	Sep. 30, 2015
Redeemable Convertible Preferred Stock Series A One [Member]
Stock Issued During Period, Shares, Conversion of Convertible Securities		212,466
Redeemable Convertible Preferred Stock Series A Two [Member]
Stock Issued During Period, Shares, Conversion of Convertible Securities		161,355
Common Stock Series A One [Member] | Subsequent Event [Member]
Stock Issued During Period, Shares, Conversion of Convertible Securities	1,412,613
Common Stock Series A Two [Member] | Subsequent Event [Member]
Stock Issued During Period, Shares, Conversion of Convertible Securities	285,179
Common Stock Series B [Member] | Subsequent Event [Member]
Stock Issued During Period, Shares, Conversion of Convertible Securities	4,209,560
Series B Convertible Preferred Share [Member]
Stock Issued During Period, Shares, Conversion of Convertible Securities		1,102

XML

Common Stock Option and Restricted Stock Award Activity (Detail)	9 Months Ended
	Sep. 30, 2015 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Shares, Options Granted	7,167,585
Number Of Shares, Options Forfeited	(629,453)
Number of Shares, Total vested shares (options)	4,509,238
Weighted Average Exercise Price Per share, End of year | $ / shares	$ 1.53
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares Available for Grant, Beginning of year	689,529
Shares Available For Grant, Additions to 2014 Stock Plan	1,700,000
Shares Available For Grant, Options Granted	(1,908,661)
Shares Available For Grant, Options Forfeited	646,514
Shares Available For Grant, Options Expired	113,113
Shares Available For Grant, Options canceled	1,432,661
Shares Available For Grant, Restricted Stock Granted	(394,267)
Shares Available For Grant, Restricted Stock Vested	0
Shares Available for Grant, End of year	2,278,889
Number of Shares, Beginning of Year	2,417,918
Number of Shares, Options Granted	1,908,661
Number Of Shares, Options Forfeited	(646,514)
Number Of Shares, Options Expired	(113,113)
Number Of Shares, Options canceled	(1,432,661)
Number of Shares, Restricted Stock Granted	394,267
Number of Shares, Restricted Stock Vested	(394,267)
Number of Shares, End of Year	2,134,291
Number of Shares, Total vested and expected to vest shares (options)	2,134,291
Number of Shares, Total vested shares (options)	1,021,911
Weighted Average Exercise Price Per share, Beginning of year | $ / shares	$ 2.59
Weighted Average Exercise Price Per Share, Options Granted | $ / shares	1.02
Weighted Average Exercise Price Per Share, Options Forfeited | $ / shares	1.14
Weighted Average Exercise Price Per Share, Options Expired | $ / shares	2.63
Weighted Average Exercise Price Per Share, Options canceled | $ / shares	2.73
Weighted Average Exercise Price Per Share, Restricted Stock Granted | $ / shares	0.39
Weighted Average Exercise Price Per Share, Restricted Stock Vested | $ / shares	0.39
Weighted Average Exercise Price Per share, End of year | $ / shares	1.53
Weighted Average Exercise Price Per Share, Total vested and expected to vest shares (options) | $ / shares	1.53
Weighted Average Exercise Price Per Share, Total vested shares (options) | $ / shares	$ 2.13

XML

Stockholders' Equity - Additional Information (Detail) - USD ($)		1 Months Ended				9 Months Ended
	Nov. 01, 2014	Mar. 31, 2015	Feb. 27, 2015	Jan. 31, 2014	Dec. 17, 2013	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2014	Oct. 31, 2014	Jun. 06, 2014
Class of Stock [Line Items]
Common stock, par value						$ 0.001		$ 0.001
Common Stock, Shares Authorized						100,000,000		100,000,000
Preferred Stock, Shares Authorized						10,000,000		10,000,000
Class of Warrant or Right, Exercise Price of Warrants or Rights				$ 3.04	$ 2.66
Warrants To Purchase Shares Of Common Stock					700,937
Preferred Stock, Par or Stated Value Per Share						$ 0.001		$ 0.001
Proceeds from Issuance of Private Placement					$ 2,750,000
Proceeds from Issuance of Common Stock						$ 1,835,000	$ 6,487,850
Cash Paid To Holder For Waiver						$ 35,000
Class of Warrant or Right, Outstanding										700,937
Ladenburg Thalmann Co. Inc [Member]
Class of Stock [Line Items]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights						57,611
Class of Warrant or Right, Exercise Price of Warrants or Rights						$ 0.575
Cash Paid To Placement Agent						$ 106,000
Additional Cash paid to Placement Agent						$ 50,000
Additional Class Of Warrant Or Right Issued						108,697
Purchase Agreement [Member]
Class of Stock [Line Items]
Sale of Stock, Price Per Share		$ 0.46
Proceeds from Issuance of Common Stock		$ 2,150,000
Stock Issued During Period, Shares, New Issues		4,673,914
Warrant [Member]
Class of Stock [Line Items]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights				238,412
Fair Value Adjustment of Warrants	$ 164,196		$ 172,319	$ 348,963
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 2.07			$ 3.04		$ 2.66
Warrants To Purchase Shares Of Common Stock	277,500					700,937
Class of Warrant or Right, Outstanding						586,238
Warrant [Member] | Fortress Agreement [Member]
Class of Stock [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights			$ 1.14	$ 2.27
Warrants To Purchase Shares Of Common Stock			500,000
Warrant One [Member]
Class of Stock [Line Items]
Fair Value Adjustment of Warrants			$ 4,960
Warrant One [Member] | Fortress Agreement [Member]
Class of Stock [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights			$ 2.00
Warrants To Purchase Shares Of Common Stock			26,989
Preferred Stock Series A-1 [Member]
Class of Stock [Line Items]
Common stock, par value						$ 0.007073
Proceeds from Issuance of Convertible Preferred Stock						$ 3,308,874
Temporary Equity, Redemption Price Per Share						$ 0.55
Temporary Equity, Liquidation Preference Per Share						0.01
Debt Instrument Convertible Threshold Stock Price						$ 0.289
Conversion of Stock, Shares Converted						2,168,624
Preferred Stock Series A-2 [Member]
Class of Stock [Line Items]
Common stock, par value						$ 1.202065
Proceeds from Issuance of Convertible Preferred Stock						$ 1,134,016
Temporary Equity, Redemption Price Per Share						$ 0.96
Temporary Equity, Liquidation Preference Per Share						$ 1.6996
Redeemable Convertible Preferred Stock [Member]
Class of Stock [Line Items]
Proceeds from Issuance of Convertible Preferred Stock						$ 4,950,000
Series B Preferred Stock [Member]
Class of Stock [Line Items]
Common stock, par value						$ 1,000
Preferred Stock, Shares Issued					2,750
Preferred Stock, Par or Stated Value Per Share					$ 1,000
Debt Instrument, Convertible, Conversion Price						2.00
Series A Preferred Stock [Member]
Class of Stock [Line Items]
Preferred Stock, Shares Issued										6,176,748
Debt Instrument Convertible Threshold Stock Price						$ 0.289
Proceeds from Issuance of Common Stock						$ 20,000,000
Series A-2 redeemable convertible preferred stock [Member]
Class of Stock [Line Items]
Conversion of Stock, Shares Converted						167,245
Maximum [Member]
Class of Stock [Line Items]
Common Stock, Shares Authorized						110,000,000
Minimum [Member]
Class of Stock [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights									$ 2.27
Minimum [Member] | Series B Preferred Stock [Member]
Class of Stock [Line Items]
Debt Instrument, Convertible, Conversion Price						$ 0.46

XML

Future Minimum Annual Lease Payments (Detail)	Sep. 30, 2015 USD ($)
Commitments and Contingencies [Line Items]
2015	$ 28,568
2016	116,201
2017	68,587
Total	$ 213,356

XML

Patents

9 Months Ended

Sep. 30, 2015

Goodwill and Intangible Assets Disclosure [Abstract]

Patents

4. Patents

Patent intangible assets consist of the following at September 30, 2015:

	Weighted
	Average	Gross Carrying		Accumulated		Net Carrying
	Useful Life	Amount		Amortization		Amount
Amortizable intangible assets:
Patents	8.0	$	11,893,745	$	(2,846,079)	$	9,047,666
Total patent intangible assets		$	11,893,745	$	(2,846,079)	$	9,047,666

The Company expects amortization expense to be approximately $1,510,977 per year for each of the next six years and a pro rata portion in the last year.

XML

Summarizes Information with Respect to Stock Options Outstanding (Detail) - $ / shares	9 Months Ended
	Sep. 30, 2015	Jan. 31, 2014	Dec. 17, 2013
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price Per Share		$ 3.04	$ 2.66
Outstanding Options, Shares	2,134,291
Outstanding Options, Weighted- Average Remaining Contractual Term	7 years 11 months 23 days
Weighted Average- Exercise Price	$ 1.53
Exercisable Options, Shares	1,021,911
Exercisable Options, Weighted- Average Exercise Price	$ 2.13
Range of Exercise Prices - Range 1 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price Per Share	$ 0.56
Outstanding Options, Shares	25,000
Outstanding Options, Weighted- Average Remaining Contractual Term	1 year 6 months 29 days
Weighted Average- Exercise Price	$ 0.56
Exercisable Options, Shares	25,000
Exercisable Options, Weighted- Average Exercise Price	$ 0.56
Range of Exercise Prices - Range 2 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price Per Share	$ 0.69
Outstanding Options, Shares	316,000
Outstanding Options, Weighted- Average Remaining Contractual Term	9 years 3 months 25 days
Weighted Average- Exercise Price	$ 0.69
Exercisable Options, Shares	43,250
Exercisable Options, Weighted- Average Exercise Price	$ 0.69
Range of Exercise Prices - Range 3 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price Per Share	$ 0.77
Outstanding Options, Shares	150,000
Outstanding Options, Weighted- Average Remaining Contractual Term	9 years 2 months 5 days
Weighted Average- Exercise Price	$ 0.77
Exercisable Options, Shares	25,000
Exercisable Options, Weighted- Average Exercise Price	$ 0.77
Range of Exercise Prices - Range 4 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price Per Share	$ 1.14
Outstanding Options, Shares	974,168
Outstanding Options, Weighted- Average Remaining Contractual Term	8 years 11 days
Weighted Average- Exercise Price	$ 1.14
Exercisable Options, Shares	259,538
Exercisable Options, Weighted- Average Exercise Price	$ 1.14
Range of Exercise Prices - Range 5 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price Per Share	$ 2.05
Outstanding Options, Shares	17,800
Outstanding Options, Weighted- Average Remaining Contractual Term	8 years 10 months 2 days
Weighted Average- Exercise Price	$ 2.05
Exercisable Options, Shares	17,800
Exercisable Options, Weighted- Average Exercise Price	$ 2.05
Range Of Exercise Prices - Range 6 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price Per Share	$ 2.27
Outstanding Options, Shares	525,628
Outstanding Options, Weighted- Average Remaining Contractual Term	8 years 1 month 17 days
Weighted Average- Exercise Price	$ 2.27
Exercisable Options, Shares	525,628
Exercisable Options, Weighted- Average Exercise Price	$ 2.27
Range Of Exercise Prices - Range 7 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price Per Share	$ 3.04
Outstanding Options, Shares	70,695
Outstanding Options, Weighted- Average Remaining Contractual Term	1 year 6 months 29 days
Weighted Average- Exercise Price	$ 3.04
Exercisable Options, Shares	70,695
Exercisable Options, Weighted- Average Exercise Price	$ 3.04
Range Of Exercise Prices - Range 8 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price Per Share	$ 3.85
Outstanding Options, Shares	40,000
Outstanding Options, Weighted- Average Remaining Contractual Term	7 years 4 months 6 days
Weighted Average- Exercise Price	$ 3.85
Exercisable Options, Shares	40,000
Exercisable Options, Weighted- Average Exercise Price	$ 3.85
Range Of Exercise Prices - Range 9 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price Per Share	$ 14.30
Outstanding Options, Shares	15,000
Outstanding Options, Weighted- Average Remaining Contractual Term	8 months 16 days
Weighted Average- Exercise Price	$ 14.30
Exercisable Options, Shares	15,000
Exercisable Options, Weighted- Average Exercise Price	$ 14.30

XML

Patents - Additional Information (Detail)	9 Months Ended
	Sep. 30, 2015 USD ($)
Expected Amortization Expense of Intangible Assets for Each of Next Six Years	$ 1,510,977

XML

Purchase Consideration And Purchase Price Allocation (Detail)	9 Months Ended
	Sep. 30, 2015 USD ($)
Purchase Price Allocation [Line Items]
Fair value of assumed equity allocated to purchase consideration	$ 10,985,867
Total purchase consideration	10,985,867
Goodwill	8,858,504
Intangible asset contract rights	1,342,000
Other assets acquired	816,045
Liabilities assumed	(30,682)
Total purchase allocation	$ 10,985,867

XML

Fair Value of Employee Stock Options Granted was Estimated Using Weighted Average Assumptions (Detail)	9 Months Ended
	Sep. 30, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility	64.00%
Risk free rate	1.48%
Dividend yield	0.00%
Expected term (in years)	6 years 22 days

XML

Patent Intangible Assets (Detail) - USD ($)	9 Months Ended
	Sep. 30, 2015	Dec. 31, 2014
Gross Carrying Amount	$ 11,893,745
Accumulated Amortization	(2,846,079)
Net Carrying Amount	$ 9,047,666	$ 10,415,404
Patents [Member]
Weighted Average Useful Life	8 years
Gross Carrying Amount	$ 11,893,745
Accumulated Amortization	(2,846,079)
Net Carrying Amount	$ 9,047,666

XML

Fair Value Measurements - Additional Information (Detail) - USD ($)	9 Months Ended
	Sep. 30, 2015	Oct. 31, 2014	Jan. 31, 2014	Dec. 17, 2013
Fair Value Disclosure [Line Items]
Purchase of warrants to common stock			$ 238,412
Class of Warrant or Right, Exercise Price of Warrants or Rights			$ 3.04	$ 2.66
Debt Instrument, Debt Default, Amount	$ 5,000,000
Debt Conversion, Converted Instrument, Amount	$ 3,000,000
Minimum [Member]
Fair Value Disclosure [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights		$ 2.27
Series A Preferred Stock [Member]
Fair Value Disclosure [Line Items]
Debt instrument convertible threshold stock price	$ 0.289

XML

Business Combination

9 Months Ended

Sep. 30, 2015

Business Combinations [Abstract]

Business Combination

3. Business Combination

The Merger was consummated on June 6, 2014, as a result of which Inventergy, Inc. merged with and into Merger Sub and holders of Inventergy, Inc. securities were issued securities of the Company. Upon the consummation of the Merger, the Company changed its name from “eOn Communications Corporation” to “Inventergy Global, Inc.” and effected a one-for-two reverse stock split of the Company’s common stock (the “Reverse Split”). The primary reason for the Merger was to allow the Company access to the public equity market for financing.

In connection with the consummation of the Merger:

(i) each share of the pre-Merger Inventergy, Inc. common stock was exchanged for 1.4139 shares of Company common stock on a post-Reverse Split basis (the “Exchange Ratio”);

(ii) the pre-Merger Inventergy, Inc. Series A Preferred Stock was exchanged for a like number of newly-created Company Series A Preferred Stock (as defined below);

(iii) options and restricted shares of pre-Merger Inventergy, Inc. common stock awarded pursuant to the Inventergy 2014 Stock Plan (such stock plan being adopted by the stockholders of the Company in connection with the Merger) and outstanding immediately prior to the consummation of the Merger were converted into awards of options to purchase Company common stock and restricted shares of Company common stock with terms and conditions identical to the terms and conditions of the corresponding options to purchase Inventergy, Inc. common stock and awards of restricted shares of Inventergy, Inc. common stock (as adjusted for the Exchange Ratio); and

(iv) outstanding warrants to purchase pre-Merger Inventergy, Inc. common stock were exchanged for warrants to acquire Company common stock with terms and conditions identical to the terms and conditions of the corresponding warrants to purchase Inventergy, Inc. common stock (as adjusted for the Exchange Ratio).

Immediately following the consummation of the Merger, the Company had 20,018,028 shares of common stock, 6,176,748 shares of Series A Preferred Stock and 2,231 shares of Series B Preferred Stock issued and outstanding. In addition, it had outstanding warrants to purchase 700,937 shares of common stock and outstanding placement agent warrants to purchase 238,412 shares of common stock.

The Transition Transactions

In connection with the Merger, on December 17, 2013, eOn, Cortelco Systems Holding Corp., a Delaware corporation and wholly-owned subsidiary of eOn (“Cortelco Holding”), eOn Communications Systems, Inc., a Delaware corporation and wholly-owned subsidiary of eOn (“eOn Subsidiary”), and Cortelco, Inc., a Delaware corporation and wholly-owned subsidiary of Cortelco Holding (“Cortelco”) entered into a transition agreement (the “Transition Agreement”). The Transition Agreement provided for several transactions among eOn and its subsidiaries in connection with, and subject to the completion of, the Merger. Each of these transactions were consummated at the time the Merger became effective (the “Effective Time”), including the following (collectively, the “Transition Transactions”):

(1) eOn and Cortelco each transferred certain contracts and other assets to eOn Subsidiary, and eOn Subsidiary assumed the liabilities associated with such contracts on and after the date of assumption;

(2) eOn Subsidiary purchased from Cortelco certain inventory for a purchase price equal to Cortelco’s book value of such inventory;

(3) eOn and Cortelco Holding redeemed in full certain contingent notes in the maximum initial amount of $11 million (collectively, the “Contingent Note”) in consideration of paying the holders of the Contingent Note either cash in the aggregate amount of $300,000 or shares of Cortelco Holding owned by eOn;

(4) Cortelco entered into a fulfillment services agreement with eOn Subsidiary providing for certain services to be conducted on behalf of eOn Subsidiary after the Merger;

(5) the Company transferred to Cortelco Holding (i) all of its ownership in Cortelco Systems Puerto Rico, Inc., and Symbio Investment Corp., and (ii) eOn’s right to require David S. Lee, former Chairman of eOn, to purchase its investment in Symbio Investment Corp.; and

(6) the Company and Cortelco Holding entered into an indemnity agreement providing that Cortelco will indemnify the Company from and against any future losses arising from the Contingent Note and certain other matters.

Upon completion of the Merger and the Transition Transactions, the Company owned all of the outstanding stock of Inventergy, Inc. and eOn Subsidiary, transferred certain assets held prior to the Merger and no longer owned an interest in Cortelco Holding, Cortelco, Cortelco Systems Puerto Rico, Inc., or Symbio Investment Corp.

The total purchase consideration and the purchase price allocation were as follows:

Fair value of assumed equity allocated to purchase consideration	$	10,985,867
Total purchase consideration	$	10,985,867
Goodwill	$	8,858,504
Intangible asset contract rights		1,342,000
Other assets acquired		816,045
Liabilities assumed		(30,682)
Total purchase allocation	$	10,985,867

Goodwill of $8,858,504, which is not deductible for tax purposes, was recognized as a result of the Merger. Goodwill was based on the fair value of eOn stock on the date of purchase less the net assets that were acquired. Intangible assets of $1,342,000 consist of certain contractual rights acquired in the Merger. Intangible assets are amortized on a straight-line basis over their estimated useful life of five years. There was an impairment of $686,350 on one of the acquired contracts recognized December 31, 2014.

Acquisition-related costs directly attributable to the Merger totaling $1,237,641 were expensed as incurred in the consolidated statements of operations.

The consideration in the Merger was based on fair value of equity retained by eOn shareholders on June 6, 2014, the date of the Merger close. The historical financial information is that of Inventergy, Inc.

XML

Fair Value Assets And Liabilities Measured On Recurring Basis (Detail) - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Liabilities Measured on Recurring Basis [Line Items]
Financial Liabilities Fair Value Disclosure, Total	$ 24,252	$ 30,278
Common stock warrants [Member]
Liabilities Measured on Recurring Basis [Line Items]
Financial Liabilities Fair Value Disclosure, Total	24,252	30,278
Fair Value, Inputs, Level 1 [Member]
Liabilities Measured on Recurring Basis [Line Items]
Financial Liabilities Fair Value Disclosure, Total	0	0
Fair Value, Inputs, Level 1 [Member] | Common stock warrants [Member]
Liabilities Measured on Recurring Basis [Line Items]
Financial Liabilities Fair Value Disclosure, Total	0	0
Fair Value, Inputs, Level 2 [Member]
Liabilities Measured on Recurring Basis [Line Items]
Financial Liabilities Fair Value Disclosure, Total	0	0
Fair Value, Inputs, Level 2 [Member] | Common stock warrants [Member]
Liabilities Measured on Recurring Basis [Line Items]
Financial Liabilities Fair Value Disclosure, Total	0	0
Fair Value, Inputs, Level 3 [Member]
Liabilities Measured on Recurring Basis [Line Items]
Financial Liabilities Fair Value Disclosure, Total	24,252	30,278
Fair Value, Inputs, Level 3 [Member] | Common stock warrants [Member]
Liabilities Measured on Recurring Basis [Line Items]
Financial Liabilities Fair Value Disclosure, Total	$ 24,252	$ 30,278

XML

Common stock warrants outstanding (Detail)	9 Months Ended
	Sep. 30, 2015 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrants Outstanding | shares	1,795,447
Remaining Contractual Life (years)	3 years 6 months 22 days
Weighted Average Exercise	$ 1.88
Warrant One [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrants Outstanding | shares	500,000
Remaining Contractual Life (years)	6 years 5 months 1 day
Weighted Average Exercise	$ 1.14
Warrant Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrants Outstanding | shares	108,697
Remaining Contractual Life (years)	4 years 6 months 7 days
Weighted Average Exercise	$ 0.46
Warrant Three [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrants Outstanding | shares	57,611
Remaining Contractual Life (years)	4 years 6 months 7 days
Weighted Average Exercise	$ 0.58
Warrant Four [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrants Outstanding | shares	26,989
Remaining Contractual Life (years)	4 years 4 months 28 days
Weighted Average Exercise	$ 2.00
Warrant Five [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrants Outstanding | shares	247,500
Remaining Contractual Life (years)	4 years 1 month 2 days
Weighted Average Exercise	$ 2.00
Warrant Six [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrants Outstanding | shares	238,412
Remaining Contractual Life (years)	3 years 4 months 2 days
Weighted Average Exercise	$ 2.27
Warrant Seven [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrants Outstanding | shares	30,000
Remaining Contractual Life (years)	2 years 1 month 2 days
Weighted Average Exercise	$ 2.66
Warrant Eight [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrants Outstanding | shares	586,238
Remaining Contractual Life (years)	9 months
Weighted Average Exercise	$ 2.66

XML

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Current assets
Cash and cash equivalents	$ 1,368,118	$ 1,443,349
Accounts receivable	39,198	259,049
Inventories	172,584	302,739
Prepaid expenses and other current assets	233,721	212,280
Deferred expenses, current	2,699,167	3,000,000
Total current assets	4,512,788	5,217,417
Property and equipment, net	29,514	42,267
Deferred expenses, patents	13,271,324	12,094,420
Patents, net	9,047,666	10,415,404
Intangible assets, net	414,333	499,083
Goodwill	8,858,504	8,858,504
Debt issuance costs	590,591	729,498
Deposits and other assets	28,993	18,993
Total assets	36,753,713	37,875,586
Current liabilities
Accounts payable	1,616,450	1,501,938
Accrued expenses and other current liabilities	785,093	301,132
Short-term notes payable, related party	120,000	300,000
Guaranteed payments, current	9,632,958	3,807,084
Fortress notes payable, current	5,202,068	1,421,196
Deferred revenue	400,000	0
Total current liabilities	17,756,569	7,331,350
Deferred revenue, non-current	346,429	0
Guaranteed payments	8,203,908	13,105,857
Derivative liabilities	24,252	30,278
Fortress notes payable, net of discount	2,838,558	6,259,321
Fortress revenue share, net of discount	5,791,823	2,478,057
Total liabilities	34,961,539	29,204,863
Stockholders' equity
Common stock, $0.001 par value; 100,000,000 shares authorized, 36,313,509 and 27,997,128 shares issued and outstanding at September 30, 2015 and December 31, 2014	36,314	27,997
Additional paid-in capital	54,324,045	51,713,228
Accumulated deficit	(52,568,560)	(43,073,213)
Total stockholders' equity	1,792,174	8,670,723
Total liabilities and stockholders' equity	36,753,713	37,875,586
Series A Convertible Preferred Stock [Member]
Stockholders' equity
Preferred stock, $0.001 par value, 10,000,000 shares authorized	374	2,710
Series B Convertible Preferred Stock [Member]
Stockholders' equity
Preferred stock, $0.001 par value, 10,000,000 shares authorized	$ 1	$ 1

XML

Employees and Non-Employees Related to Options and RSAs Recognized (Detail) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Operating expenses
General and administrative	$ 246,485	$ 376,530	$ 843,386	$ 2,238,184

XML

Organization

9 Months Ended

Sep. 30, 2015

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Organization

1. Organization

Inventergy Global, Inc. (“we”, “us”, “our”, “Inventergy”, or the “Company”) is an intellectual property (IP) investment and licensing company that helps technology-leading corporations attain greater value from their IP assets in support of their business objectives and corporate brands. Inventergy was initially organized as a Delaware limited liability company under the name Silicon Turbine Systems, LLC in January 2012. It subsequently changed its name to Inventergy, LLC in March 2012 and it was converted from a limited liability company into a Delaware corporation in February 2013, at which time it became Inventergy, Inc. On June 6, 2014, a subsidiary (“Merger Sub”) of eOn Communications Corporation (“eOn”) merged with and into Inventergy, Inc. with Inventergy, Inc. emerging as the surviving entity (the “Merger”). As a result of the Merger, eOn changed its name to “Inventergy Global, Inc.” The Company is headquartered in Campbell, California.

The Company operates in a single industry segment. 

XML

Borrowing Arrangements - Additional Information (Detail) - USD ($)	1 Months Ended						3 Months Ended			9 Months Ended		12 Months Ended
	Jun. 26, 2015	Feb. 27, 2015	Feb. 25, 2015	Oct. 01, 2014	Sep. 23, 2014	Mar. 26, 2014	Sep. 30, 2015	Jun. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2014
Borrowing Arrangements [Line Items]
Debt Instrument, Face Amount							$ 5,500,000			$ 5,500,000
Gains (Losses) on Extinguishment of Debt, Total						$ 2,403,193	0		$ 0	(2,268,373)	$ (2,403,193)
Debt Conversion, Converted Instrument, Shares Issued				1,804,030								1,508,162
Debt Instrument, Description of Variable Rate Basis				LIBOR plus 7%. In addition, a 3% per annum paid-in-kind (PIK) interest will be paid by increasing the principal amount of the Original Notes by the amount of such interest.
Proceeds from Notes Payable										$ 1,126,900	$ 500,000
National Securities Corporation [Member]
Borrowing Arrangements [Line Items]
Share Price		$ 2.00		$ 2.00
Warrants Exercisable Term		5 years		5 years
Debt Instrument, Fee Amount		$ 35,985		$ 330,000
Warrants Not Settleable in Cash, Fair Value Disclosure		$ 4,960		$ 153,759
Stock Issued During Period, Shares, New Issues		26,989		247,500
Fortress Agreement [Member]
Borrowing Arrangements [Line Items]
Proceeds from Issuance of Senior Long-term Debt				$ 9,964,868
Debt Instrument, Redemption Price, Percentage										5.00%
Stock Issued During Period, Value, Issued for Services				1,000,000
Share Price		$ 1.14
Termination Fee Payable										$ 770,000
Gross Proceeds From Senior Long Term Debt				11,000,000
Contract Claims Description										the Company is required to apply, towards its obligations pursuant to the Original Notes, 86% of the difference between (a) any revenues generated from the Monetization Revenue less (b) any litigation or licensing related third party expenses (including fees paid to the original patent owners) reasonably incurred by the Company to earn Monetization Revenue, subject to certain limits (such difference defined as Monetization Net Revenues). If Monetization Net Revenue is applied to outstanding principal of the Original Notes (defined as Mandatory Prepayments), such Mandatory Prepayments are not subject to the prepayment premium described above. To the extent that any obligations under the Original Notes are past due, including if such payments are past due as a result of the acceleration of the Original Notes or certain conditions of breach or alleged breach have occurred, the percentage will increase from 86% to 100%.
Payments for Fees				$ 385,000
Revenue Recognition Under Agreement Description				the Company granted to the purchasers identified in the Fortress Agreement (Revenue Participants) a right to receive a portion of the Companys Monetization Revenues totaling $5,500,000 (unless the Revenue Participants have not received $5,500,000 by the Maturity Date, in which case the Revenue Participants have a right to receive a portion of Monetization Revenues totaling $8,250,000) (the Revenue Stream).
Revenue Recognition of Participants Under Proportionate Share Agreement Description										The Revenue Participants will not receive any portion of the Revenue Stream until all obligations under the Original Notes are paid in full. Following payment in full of the Original Notes, the Company will pay to the Revenue Participants their proportionate share of the Monetization Net Revenues. The Revenue Participants proportionate share is equal to (a) 46% of Monetization Net Revenues until $2,750,000 has been paid to the Revenue Participants, (b) 31% of Monetization Net Revenues until the next $2,750,000 has been paid to the Revenue Participants and (c) 6% of Monetization Net Revenues until the next $2,750,000 has been paid to the Revenue Participants if (a) and (b) have not been fully paid by the Maturity Date. All Revenue Stream Payments will be payable on a monthly basis in arrears. The rights of the Revenue Participants to the Revenue Stream are secured by all of the Companys patent assets as of October 1, 2014 and the Cash Collateral Account, in each case junior in priority to the rights of the Note Purchasers. In connection with the Revenue Participants right to receive a portion of the Companys Monetization Revenues, the Company has recorded a net liability of $2,478,057, which represents the fair value of the expected Monetization Revenues, discounted 20% over the expected life of the revenue share agreement
Warrants To Purchase Common Stock		500,000
Proceeds from Issuance of Warrants		$ 40,000
Warrants Not Settleable in Cash, Fair Value Disclosure		$ 172,319
Debt Issuance Cost				$ 450,253
Fortress Agreement [Member] | Common Stock [Member]
Borrowing Arrangements [Line Items]
Share Price				$ 2.00
Stock Issued During Period, Shares, New Issues				500,000
Stock Issued During Period, Value, New Issues				$ 1,000,000
Share Purchase Agreement [Member]
Borrowing Arrangements [Line Items]
Share Price	$ 0.46							$ 0.46
Stock Issued During Period, Value, Other					$ 6,000,000
Proceeds from Issuance or Sale of Equity								$ 100,000
Stock Issued During Period, Shares, New Issues	217,392
Additional Available Credit [Member] | Fortress Agreement [Member]
Borrowing Arrangements [Line Items]
Revenue Recognition of Participants Under Proportionate Share Agreement Description			The Revenue Participants are entitled to receive $7,700,000 (adjusted from the terms of the Original Notes) plus 70% of the Additional Notes as a portion of the Revenue Stream Basis (as defined below) if the Notes and Revenue Stream payments are paid in full by the Maturity Date or $9,350,000 (adjusted from the terms of the Original Notes) plus 85% of the Additional Notes as a portion of the Revenue Stream Basis if the Fortress Notes and Revenue Stream payments are not paid in full by the Maturity Date. The Revenue Stream payments will begin after all obligations on the Fortress Notes are paid in full. The Company is required to apply specified decreasing percentages (46% to 31% to 6%) of its net revenues (net of monetization costs) from monetizing its intellectual property assets on an ongoing basis to meet the Revenue Stream payment obligations. Payment of the full Revenue Stream payments in addition to the Fortress Note obligations by the Maturity Date would ordinarily occur after the Company receives approximately $60,000,000 in gross licensing revenues, assuming an average monetization cost of 33%.
Line of Credit Facility, Remaining Borrowing Capacity			$ 3,000,000
Debt Instrument Percentage Of Monetization Of Net Revenue			18.00%
Proceeds from Notes Payable			$ 1,199,500
Warrants To Purchase Common Stock			500,000
Proceeds from Issuance or Sale of Equity			$ 1,126,900
Payments of Stock Issuance Costs			72,600
Derivative Liability, Fair Value, Amount Not Offset Against Collateral			$ 335,762
Debt Instrument, Fee			The structuring fee equal to 3.5% of the original principal amount of any such Additional Notes is waived.
Monetization Of Revenue Loss From Change In Fair Value			$ 2,268,373
Line Of Credit Facility Additional Borrowing Capacity			$ 2,000,000
Chief Executive Officer [Member] | Share Purchase Agreement [Member]
Borrowing Arrangements [Line Items]
Due to Related Parties							$ 120,000			$ 120,000
Repayments of Related Party Debt										$ 80,000
Joseph W. Beyers [Member] | Share Purchase Agreement [Member]
Borrowing Arrangements [Line Items]
Share Price					$ 2.14
Stock Issued During Period, Shares, Other					233,640
Stock Issued During Period, Value, Other					$ 500,000
Proceeds from Related Party Debt					300,000
Due to Related Parties					$ 300,000
First Republic Bank [Member]
Borrowing Arrangements [Line Items]
Debt Instrument, Face Amount				500,000
Convertible Notes Payable [Member]
Borrowing Arrangements [Line Items]
Debt Conversion Original Debt Interest Amount				187,351
Debt Conversion, Original Debt, Amount				8,000,000
Debt Instrument, Collateral Amount				$ 3,500,000

XML

Stockholders' Equity (Tables)

9 Months Ended

Sep. 30, 2015

Stockholders Equity Note [Abstract]

Shares of common stock reserved for future issuance

Shares of common stock reserved for future issuance were as follows as of September 30, 2015:

Series A convertible preferred stock	528,548
Series B convertible preferred stock	2,395,653
Options to purchase common stock	2,134,291
Shares reserved for issuance pursuant to 2014 Stock Plan	2,278,889
Warrants	1,795,447
Total	9,132,828

Redeemable Convertible preferred stock

Convertible preferred stock as of September 30, 2015 consisted of the following:

Convertible	Original		Shares		Shares Originally		Shares		Liquidation
Preferred Stock	Issue Price		Designated		Issued		Outstanding		Preference
Series A-1	$	0.0100		5,000,000		5,000,000		212,466	$	117,158
Series A-2	$	1.6996		1,176,748		1,176,748		161,355	$	274,239
Series B	$	1,000.00		2,750		2,750		1,102	$	1,102,000

Common stock warrants

Common stock warrants outstanding as of September 30, 2015 are listed as follows:

Warrants		Remaining Contractual		Weighted Average
Outstanding		Life (years)		Exercise
	500,000		6.42	$	1.14
	108,697		4.52	$	0.46
	57,611		4.52	$	0.58
	26,989		4.41	$	2.00
	247,500		4.09	$	2.00
	238,412		3.34	$	2.27
	30,000		2.09	$	2.66
	586,238		0.75	$	2.66
	1,795,447		3.56	$	1.88

XML

Borrowing Arrangements (Detail) - Warrant [Member]	1 Months Ended
	Feb. 27, 2015	Nov. 01, 2014
Share-based Goods and Nonemployee Services Transaction [Line Items]
Expected volatility		60.00%
Risk free rate		1.62%
Dividend yield		0.00%
Expected term (in years)		5 years
Fortress Agreement [Member]
Share-based Goods and Nonemployee Services Transaction [Line Items]
Expected volatility	60.00%
Risk free rate	1.70%
Dividend yield	0.00%
Expected term (in years)	5 years
National Securities Corporation [Member]
Share-based Goods and Nonemployee Services Transaction [Line Items]
Expected volatility	60.00%
Risk free rate	1.50%
Dividend yield	0.00%
Expected term (in years)	7 years

XML

Commitments and Contingencies (Tables)

9 Months Ended

Sep. 30, 2015

Commitments and Contingencies Disclosure [Abstract]

Future minimum annual lease payments

The future minimum payments related to this lease are as follows:

Years ending December 31:
2015		28,568
2016		116,201
2017		68,587
Total	$	213,356

Future guaranteed payments

Future guaranteed payments associated with these agreements are payable as follows:

Years ending December 31:
2015		4,667,415
2016		5,000,000
2017		10,000,000
Less: discount to present value		(1,830,549)
Guaranteed payments, net of discount	$	17,836,866

Notes payable future debt payments

Pursuant to the Fortress Agreement (as described in Note 6), future debt payments owed to Fortress with respect to the Fortress Notes are as follows:

Years ending December 31:
2015		1,306,629
2016		5,327,055
2017		4,102,810
Total	$	10,736,494

XML

Summary of Significant Accounting Policies

9 Months Ended

Sep. 30, 2015

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

2. Summary of Significant Accounting Policies

Basis of presentation

The consolidated financial statements have been prepared on the accrual basis of accounting in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The consolidated financial statements include the accounts of the Company and its subsidiaries. All material intercompany accounts and transactions have been eliminated in consolidation. The accompanying interim financial statements are condensed and should be read in conjunction with the Company’s latest annual financial statements. It is management’s opinion that all adjustments necessary for a fair presentation of the results for the interim periods have been made, and all such adjustments were of a normal recurring nature.

Liquidity and Capital Resources

At September 30, 2015, the Company had an accumulated deficit since inception of $52,568,560 and had negative working capital of $13,243,781. As of November 9, 2015, we had remaining cash of $1,338,926. These factors raise substantial doubt about our ability to continue as a going concern, which is dependent both on achieving additional licensing and sales revenue from our patent portfolios and/or obtaining additional financing on terms acceptable to us. Toward that end, the Company entered into its first license agreement in February 2015, received an additional drawdown from the Fortress Agreement of $1,199,500 as a result of entering into the license agreement, received net proceeds of $1,835,000 from the sale of common stock in April 2015, and received gross proceeds of $4,000,000 from the sale of two patent families in June 2015. We will seek to continue our operations primarily with income received through our patent monetization efforts, including licensing revenues and patent sales, but we may need to seek additional financing through loans, which will be subject to the restrictions of the Fortress Agreement, and/or the sale of securities. If we are required to raise additional financing capital, we cannot assure you that we will be able to obtain such additional capital on terms acceptable to us or at all. Additionally, if we raise capital through the issuance of equity, our current stockholders will experience dilution.

The business will require significant amounts of capital over the next twelve months to sustain operations and make the investments it needs to continue operations and execute its longer term business plan. We believe that cash required for operating expenses, exclusive of litigation costs, will be approximately $4.9 million for the next twelve months, consisting of approximately $1.9 million in employee related costs (an approximate 21% decrease from the level of anticipated employee expenses disclosed in our Quarterly Report on Form 10-Q for the period ended June 30, 2015), $0.8 million in patent maintenance and prosecution fees, and $2.2 million in other operating costs. We anticipate a more aggressive litigation approach will be taken relating to patent enforcement, and estimate litigation expenses of approximately $4.6 million in the next twelve months. In addition, we estimate our debt principal and interest payments will be approximately $5.5 million under the terms of our revenue share and note purchase agreement, as amended and restated (the “Fortress Agreement”) with Fortress Investment Group, LLC and its affiliates (collectively “Fortress”). These amounts payable to Fortress are in addition to revenue sharing amounts expected to be paid from forecasted patent monetization revenues. Based on our existing cash balances, anticipated revenues from patent monetization activities, available financing opportunities, proactive measures to reduce expenses and defer obligations where possible, management believes we have funds sufficient to meet our anticipated operating needs for approximately five months.

To date, the Company has acquired approximately 755 currently active patents and patent applications for aggregate purchase payments of $12,109,118. We are required to pay unconditional guaranteed payments to the sellers of the patents of an aggregate of $20 million ($18 million of which is to be paid out of net revenues from patent licensing receipts) through August 31, 2017 (with a net present value of $17.8 million). See Note 10 herein for further information regarding these guaranteed payments.

As of September 30, 2015, the Company had cash and cash equivalents of $1,368,118 (which includes $1,000,000 of minimum cash reserves (see discussion, Note 6), which is intended to serve as additional collateral for the Fortress Agreement) and negative working capital of $13,243,781. The Company’s net loss for the nine months ended September 30, 2015 was $9,495,347 and our accumulated deficit amount was $52,568,560 as of September 30, 2015.

The Company will also require additional financing to purchase additional patent portfolios and to fund its monetization efforts if new attractive opportunities are found. If the Company acquires additional large patent portfolios, in addition to the upfront purchase fee (if any) it is likely that additional resources (business, technical and/or legal) may be required to effectively monetize the portfolio. Resources to analyze new portfolios are already part of the current staffing of the Company. Litigation costs are based primarily on a contingent fee structure (expected to average less than 20% of license revenue for a portfolio) and as such do not scale significantly with the acquisition of new portfolios. Acquisitions or investments may be consummated through the use of cash, equity, seller financing, third party debt, earn-out obligations, revenue sharing, profit sharing, or some combination of two or more of these types of consideration. Due to the dynamic nature of the credit market, the Company is not able to predict with any certainty whether it could obtain debt or equity financing to provide additional sources of liquidity, should the need arise, at favorable rates.

Management estimates and related risks

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions about the reported amounts of assets and liabilities, and disclosures of contingent assets and liabilities, at the dates of the financial statements and the reported amounts of revenues and expenses during the reported periods. Although these estimates reflect management's best estimates, it is at least reasonably possible that a material change to these estimates could occur in the near term.

Revenue Recognition

Revenue is recognized when (i) persuasive evidence of an arrangement exists, (ii) all obligations have been substantially performed pursuant to the terms of the arrangement, (iii) amounts are fixed or determinable, and (iv) the collectability of amounts is reasonably assured.

Licensing Fees

We derive revenue primarily from the monetization of acquired patents, either through licensing agreements or outright sales of patents. In general, licensing arrangements provide for the payment of contractually determined fees in consideration for the grant of certain intellectual property rights for patented technologies owned or controlled by the Company. These rights typically include some combination of the following: (i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patented technologies, (ii) a covenant-not-to-litigate, (iii) the release of the licensee from certain claims, and (iv) the dismissal of any pending litigation. The intellectual property rights granted may be perpetual in nature, extending until the expiration of the related patents, or can be granted for a defined period of time, with the licensee possessing the right to renew the agreement at the end of each contractual term for additional payments. The Company recognizes licensing fees when there is persuasive evidence of a licensing arrangement, fees are fixed or determinable, delivery has occurred and collectability is reasonably assured.

Patent Sales

The Company’s patent monetization efforts also include the sale of select patent assets. As patent sales represents a component of the Company’s ongoing major or central operations and activities, the Company records the related proceeds as revenue. The Company recognizes the patent sales revenue when there is persuasive evidence of a sales arrangement, fees are fixed or determinable, delivery has occurred and collectability is reasonably assured. These requirements are generally fulfilled upon closing of the patent sale transaction.

Amounts related to revenue arrangements that do not meet the revenue recognition criteria described above are deferred until the revenue recognition criteria are met.

The Company assesses the collectability of fees receivable based on a number of factors, including past transaction history and credit-worthiness of licensees. If it is determined that collection is not reasonably assured, the fee is recognized when collectability becomes reasonably assured, assuming all other revenue recognition criteria have been met.

Cost of Revenues

Cost of revenues primarily include the costs of patents sold, and other amounts paid to third parties, including technical consultants and intellectual property counsel, under revenue sharing agreements. These costs are included under the caption “Cost of Revenues” in the accompanying Condensed Consolidated Statements of Operations.

Contingent Legal and Consulting Fees

Contingent legal fees are expensed in the Condensed Consolidated Statements of Operations in the period that such fees are determined to be probable, usually when the related revenues are recognized. In instances where there are no recoveries from potential infringers, no contingent legal and consulting fees are paid; however, the Company may be liable for certain out of pocket legal and consulting costs incurred pursuant to the underlying legal and consulting services agreement.

Cash and cash equivalents

The Company considers all highly liquid financial instruments with original maturities of three months or less at the time of purchase to be cash equivalents.

Accounts Receivable

Accounts receivable are stated net of allowances for doubtful accounts. The Company typically grants standard credit terms to customers in good credit standing. The Company generally reserves for estimated uncollectible accounts on a customer-by-customer basis, which requires making a judgment about each individual customer’s ability and intention to fully pay account balances. The Company makes these judgments based on its knowledge of and relationships with each of its customers, as well as current economic trends, and updates these estimates on a monthly basis. Any changes in estimate, which can be significant, are included in earnings in the period in which the change in estimate occurs. As of September 30, 2015, the Company has not established any reserves for uncollectable accounts.

Inventories

Inventories consist of finished goods and some component and spare parts. Inventory is valued at the lower of cost or market with cost determined utilizing standard cost which approximates the first-in, first-out (FIFO) method. The Company performs an analysis of slow-moving or obsolete inventory on a regular basis and any changes in valuation reserves, which could potentially be significant, are included in earnings in the period in which the evaluations are completed.

Property and equipment

Property and equipment are recorded at cost less accumulated depreciation and amortization. Depreciation and amortization are computed using the straight-line method over the estimated useful lives of the assets (or the term of the lease, if shorter), which range from three to five years. Routine maintenance and repair costs are expensed as incurred. The costs of major additions, replacements and improvements are capitalized. Upon retirement or sale, the cost of assets disposed and the related accumulated depreciation is removed and any resulting gain or loss is credited or charged to operations.

Patents

Patents, including acquisition costs, are stated at cost, less accumulated amortization. Amortization is computed using the straight-line method over the estimated useful lives of the respective assets, generally 7 - 10 years. Upon retirement or sale, the cost of assets disposed and the related accumulated amortization are removed from the accounts and any resulting gain or loss is credited or charged to operations. Patents are utilized for the purpose of generating licensing revenue.

Intangible Assets

Intangible assets consist of certain contract rights acquired in the Merger. Intangible assets are amortized on a straight-line basis over their estimated useful life of five years.

Goodwill

Goodwill represents the excess of the aggregate purchase price over the fair value of the net tangible and identifiable intangible assets acquired by the Company. The carrying amount of goodwill will be tested for impairment annually or more frequently if facts and circumstances warrant a review. The Company determined that it is a single reporting unit for the purpose of goodwill impairment tests. For purposes of assessing the impairment of goodwill, the Company estimates the value of the reporting unit using its market capitalization as the best evidence of fair value. This fair value is then compared to the carrying value of the reporting unit.

Impairment of long-lived assets

The Company evaluates the carrying value of long-lived assets on an annual basis, or more frequently should circumstances indicate a long-lived asset may be impaired. When indicators of impairment exist, the Company estimates future undiscounted cash flows attributable to such assets. In the event cash flows are not expected to be sufficient to recover the recorded value of the assets, the assets are written down to their estimated fair value. On December 31, 2014, the Company recorded an impairment charge of $686,350 as a result of terminating an acquired contract in the first quarter of 2015 that provided distribution services of facility security and access control products that the Company inherited as part of the Merger.

Concentration of credit risk

Financial instruments that potentially subject the Company to a concentration of credit risk consist of cash and cash equivalents. Cash and cash equivalents are deposited with high quality financial institutions. Periodically, such balances are from time to time in excess of federally insured limits.

Stock-based compensation

The Company has a stock option plan under which incentive and non-qualified stock options and restricted stock awards (“RSAs”) are granted primarily to employees. All share-based payments to employees, including grants of employee stock options and RSAs, are recognized in the financial statements based on their respective grant date fair values. The benefits of tax deductions in excess of recognized compensation cost are reported as a financing cash flow.

The Company estimates the fair value of share-based payment awards on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense ratably over the requisite service periods in the Company’s statements of comprehensive income or loss. The Company has estimated the fair value of each option award as of the date of grant using the Black-Scholes option pricing model. The fair value of RSAs is calculated as the fair value of the underlying stock multiplied by the number of shares awarded. The awards issued consist of fully-vested stock awards, performance-based restricted shares, and service-based restricted shares.

Expenses related to stock-based awards issued to non-employees are recognized at fair value on a recurring basis in the periods those awards are expected to vest. The Company estimates the fair value of the awards using the Black-Scholes option pricing model.

Income taxes

The Company accounts for income taxes using the asset and liability method whereby deferred tax asset and liability account balances are determined based on temporary differences between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to affect taxable income. A valuation allowance is established when it is more likely than not that deferred tax assets will not be realized. Realization of deferred tax assets is dependent upon future pretax earnings, the reversal of temporary differences between book and tax income, and the expected tax rates in future periods. The Company has a full valuation allowance on all deferred tax assets.

The Company is required to evaluate the tax positions taken in the course of preparing its tax returns to determine whether tax positions are “more-likely-than-not” of being sustained by the applicable tax authority. Tax benefits of positions not deemed to meet the more-likely-than-not threshold would be recorded as a tax expense in the current year. The amount recognized is subject to estimate and management judgment with respect to the likely outcome of each uncertain tax position. The amount that is ultimately sustained for an individual uncertain tax position or for all uncertain tax positions in the aggregate could differ from the amount that is initially recognized.

Fair value measurements

The Company defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs within the fair value hierarchy. Observable inputs are inputs that market participants would use in pricing the asset or liability developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company’s own assumptions about what market participants would use in pricing the asset or liability developed based on the best information available in the circumstances.

The following methods and assumptions were used to estimate the fair value of financial instruments:

¨ Level 1 - Valuation is based upon quoted prices for identical instruments traded in active markets.

¨ Level 2 - Valuation is based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market.

¨ Level 3 - Valuation is generated from model-based techniques that use significant assumptions not observable in the market. These unobservable assumptions reflect management’s estimates of assumptions that market participants would use in pricing the asset or liability. Valuation techniques include use of option pricing models, discounted cash flow models and similar techniques.

The category within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.

Recently Issued Accounting Standards

In May 2014, the FASB issued a new financial accounting standard which outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes current revenue recognition guidance. ASU 2014-09 Revenue from Contracts with Customers is effective for annual reporting periods (including interim reporting periods within those periods) beginning after December 15, 2017. Early adoption is not permitted. We are currently evaluating the impact of this accounting standard.

In August 2014, the FASB issued a new accounting standard which requires management to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern for each annual and interim reporting period and to provide related footnote disclosures in certain circumstances. ASU 2014-15 Presentation of Financial Statements - Going Concern is effective for annual reporting periods (including interim reporting periods within those periods) beginning after December 15, 2016. Early adoption is permitted. We are currently evaluating the impact of this accounting standard.

In April 2015, the FASB issued a new accounting standard which changes the presentation of debt issuance costs in financial statements.  Under the new standard, an entity presents such costs in the balance sheet as a direct deduction from the related debt liability rather than as an asset.  Amortization of the costs is reported as interest expense.  The accounting standard is effective for annual reporting periods beginning after December 15, 2015 and interim periods beginning after December 15, 2016.  Early adoption is allowed for all entities so long as they are for financial statements that have not been previously issued.  The adoption of this standard is not expected to have a material impact on the Company’s consolidated financial statements.

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000,000	10,000,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	36,313,509	27,997,128
Common Stock, Shares, Outstanding	36,313,509	27,997,128
Series A Convertible Preferred Stock [Member]
Preferred stock shares designated	6,176,748	6,176,748
Preferred stock, shares issued	373,821	2,709,690
Preferred stock, shares outstanding	373,821	2,709,690
Temporary equity, liquidation preference	$ 391,397	$ 2,915,122
Series B Convertible Preferred Stock [Member]
Preferred stock shares designated	2,750	2,750
Preferred stock, shares issued	1,102	1,102
Preferred stock, shares outstanding	1,102	1,102
Temporary equity, liquidation preference	$ 1,102,000	$ 1,102,000

XML

Summary of Significant Accounting Policies (Policies)

9 Months Ended

Sep. 30, 2015

Accounting Policies [Abstract]

Basis of presentation

Basis of presentation

The consolidated financial statements have been prepared on the accrual basis of accounting in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The consolidated financial statements include the accounts of the Company and its subsidiaries. All material intercompany accounts and transactions have been eliminated in consolidation. The accompanying interim financial statements are condensed and should be read in conjunction with the Company’s latest annual financial statements. It is management’s opinion that all adjustments necessary for a fair presentation of the results for the interim periods have been made, and all such adjustments were of a normal recurring nature.

Liquidity and Capital Resources

Liquidity and Capital Resources

At September 30, 2015, the Company had an accumulated deficit since inception of $52,568,560 and had negative working capital of $13,243,781. As of November 9, 2015, we had remaining cash of $1,338,926. These factors raise substantial doubt about our ability to continue as a going concern, which is dependent both on achieving additional licensing and sales revenue from our patent portfolios and/or obtaining additional financing on terms acceptable to us. Toward that end, the Company entered into its first license agreement in February 2015, received an additional drawdown from the Fortress Agreement of $1,199,500 as a result of entering into the license agreement, received net proceeds of $1,835,000 from the sale of common stock in April 2015, and received gross proceeds of $4,000,000 from the sale of two patent families in June 2015. We will seek to continue our operations primarily with income received through our patent monetization efforts, including licensing revenues and patent sales, but we may need to seek additional financing through loans, which will be subject to the restrictions of the Fortress Agreement, and/or the sale of securities. If we are required to raise additional financing capital, we cannot assure you that we will be able to obtain such additional capital on terms acceptable to us or at all. Additionally, if we raise capital through the issuance of equity, our current stockholders will experience dilution.

The business will require significant amounts of capital over the next twelve months to sustain operations and make the investments it needs to continue operations and execute its longer term business plan. We believe that cash required for operating expenses, exclusive of litigation costs, will be approximately $4.9 million for the next twelve months, consisting of approximately $1.9 million in employee related costs (an approximate 21% decrease from the level of anticipated employee expenses disclosed in our Quarterly Report on Form 10-Q for the period ended June 30, 2015), $0.8 million in patent maintenance and prosecution fees, and $2.2 million in other operating costs. We anticipate a more aggressive litigation approach will be taken relating to patent enforcement, and estimate litigation expenses of approximately $4.6 million in the next twelve months. In addition, we estimate our debt principal and interest payments will be approximately $5.5 million under the terms of our revenue share and note purchase agreement, as amended and restated (the “Fortress Agreement”) with Fortress Investment Group, LLC and its affiliates (collectively “Fortress”). These amounts payable to Fortress are in addition to revenue sharing amounts expected to be paid from forecasted patent monetization revenues. Based on our existing cash balances, anticipated revenues from patent monetization activities, available financing opportunities, proactive measures to reduce expenses and defer obligations where possible, management believes we have funds sufficient to meet our anticipated operating needs for approximately five months.

To date, the Company has acquired approximately 755 currently active patents and patent applications for aggregate purchase payments of $12,109,118. We are required to pay unconditional guaranteed payments to the sellers of the patents of an aggregate of $20 million ($18 million of which is to be paid out of net revenues from patent licensing receipts) through August 31, 2017 (with a net present value of $17.8 million). See Note 10 herein for further information regarding these guaranteed payments.

As of September 30, 2015, the Company had cash and cash equivalents of $1,368,118 (which includes $1,000,000 of minimum cash reserves (see discussion, Note 6), which is intended to serve as additional collateral for the Fortress Agreement) and negative working capital of $13,243,781. The Company’s net loss for the nine months ended September 30, 2015 was $9,495,347 and our accumulated deficit amount was $52,568,560 as of September 30, 2015.

The Company will also require additional financing to purchase additional patent portfolios and to fund its monetization efforts if new attractive opportunities are found. If the Company acquires additional large patent portfolios, in addition to the upfront purchase fee (if any) it is likely that additional resources (business, technical and/or legal) may be required to effectively monetize the portfolio. Resources to analyze new portfolios are already part of the current staffing of the Company. Litigation costs are based primarily on a contingent fee structure (expected to average less than 20% of license revenue for a portfolio) and as such do not scale significantly with the acquisition of new portfolios. Acquisitions or investments may be consummated through the use of cash, equity, seller financing, third party debt, earn-out obligations, revenue sharing, profit sharing, or some combination of two or more of these types of consideration. Due to the dynamic nature of the credit market, the Company is not able to predict with any certainty whether it could obtain debt or equity financing to provide additional sources of liquidity, should the need arise, at favorable rates.

Management estimates and related risks

Management estimates and related risks

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions about the reported amounts of assets and liabilities, and disclosures of contingent assets and liabilities, at the dates of the financial statements and the reported amounts of revenues and expenses during the reported periods. Although these estimates reflect management's best estimates, it is at least reasonably possible that a material change to these estimates could occur in the near term.

Revenue Recognition

Revenue Recognition

Revenue is recognized when (i) persuasive evidence of an arrangement exists, (ii) all obligations have been substantially performed pursuant to the terms of the arrangement, (iii) amounts are fixed or determinable, and (iv) the collectability of amounts is reasonably assured.

Licensing Fees

We derive revenue primarily from the monetization of acquired patents, either through licensing agreements or outright sales of patents. In general, licensing arrangements provide for the payment of contractually determined fees in consideration for the grant of certain intellectual property rights for patented technologies owned or controlled by the Company. These rights typically include some combination of the following: (i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patented technologies, (ii) a covenant-not-to-litigate, (iii) the release of the licensee from certain claims, and (iv) the dismissal of any pending litigation. The intellectual property rights granted may be perpetual in nature, extending until the expiration of the related patents, or can be granted for a defined period of time, with the licensee possessing the right to renew the agreement at the end of each contractual term for additional payments. The Company recognizes licensing fees when there is persuasive evidence of a licensing arrangement, fees are fixed or determinable, delivery has occurred and collectability is reasonably assured.

Patent Sales

The Company’s patent monetization efforts also include the sale of select patent assets. As patent sales represents a component of the Company’s ongoing major or central operations and activities, the Company records the related proceeds as revenue. The Company recognizes the patent sales revenue when there is persuasive evidence of a sales arrangement, fees are fixed or determinable, delivery has occurred and collectability is reasonably assured. These requirements are generally fulfilled upon closing of the patent sale transaction.

Amounts related to revenue arrangements that do not meet the revenue recognition criteria described above are deferred until the revenue recognition criteria are met.

The Company assesses the collectability of fees receivable based on a number of factors, including past transaction history and credit-worthiness of licensees. If it is determined that collection is not reasonably assured, the fee is recognized when collectability becomes reasonably assured, assuming all other revenue recognition criteria have been met.

Cost of Revenues

Cost of Revenues

Cost of revenues primarily include the costs of patents sold, and other amounts paid to third parties, including technical consultants and intellectual property counsel, under revenue sharing agreements. These costs are included under the caption “Cost of Revenues” in the accompanying Condensed Consolidated Statements of Operations.

Contingent Legal and Consulting Fees

Contingent Legal and Consulting Fees

Contingent legal fees are expensed in the Condensed Consolidated Statements of Operations in the period that such fees are determined to be probable, usually when the related revenues are recognized. In instances where there are no recoveries from potential infringers, no contingent legal and consulting fees are paid; however, the Company may be liable for certain out of pocket legal and consulting costs incurred pursuant to the underlying legal and consulting services agreement.

Cash and cash equivalents

Cash and cash equivalents

The Company considers all highly liquid financial instruments with original maturities of three months or less at the time of purchase to be cash equivalents.

Accounts Receivable

Accounts Receivable

Accounts receivable are stated net of allowances for doubtful accounts. The Company typically grants standard credit terms to customers in good credit standing. The Company generally reserves for estimated uncollectible accounts on a customer-by-customer basis, which requires making a judgment about each individual customer’s ability and intention to fully pay account balances. The Company makes these judgments based on its knowledge of and relationships with each of its customers, as well as current economic trends, and updates these estimates on a monthly basis. Any changes in estimate, which can be significant, are included in earnings in the period in which the change in estimate occurs. As of September 30, 2015, the Company has not established any reserves for uncollectable accounts.

Inventories

Inventories

Inventories consist of finished goods and some component and spare parts. Inventory is valued at the lower of cost or market with cost determined utilizing standard cost which approximates the first-in, first-out (FIFO) method. The Company performs an analysis of slow-moving or obsolete inventory on a regular basis and any changes in valuation reserves, which could potentially be significant, are included in earnings in the period in which the evaluations are completed.

Property and equipment

Property and equipment

Property and equipment are recorded at cost less accumulated depreciation and amortization. Depreciation and amortization are computed using the straight-line method over the estimated useful lives of the assets (or the term of the lease, if shorter), which range from three to five years. Routine maintenance and repair costs are expensed as incurred. The costs of major additions, replacements and improvements are capitalized. Upon retirement or sale, the cost of assets disposed and the related accumulated depreciation is removed and any resulting gain or loss is credited or charged to operations.

Patents

Patents

Patents, including acquisition costs, are stated at cost, less accumulated amortization. Amortization is computed using the straight-line method over the estimated useful lives of the respective assets, generally 7 - 10 years. Upon retirement or sale, the cost of assets disposed and the related accumulated amortization are removed from the accounts and any resulting gain or loss is credited or charged to operations. Patents are utilized for the purpose of generating licensing revenue.

Intangible Assets

Intangible Assets

Intangible assets consist of certain contract rights acquired in the Merger. Intangible assets are amortized on a straight-line basis over their estimated useful life of five years.

Goodwill

Goodwill

Goodwill represents the excess of the aggregate purchase price over the fair value of the net tangible and identifiable intangible assets acquired by the Company. The carrying amount of goodwill will be tested for impairment annually or more frequently if facts and circumstances warrant a review. The Company determined that it is a single reporting unit for the purpose of goodwill impairment tests. For purposes of assessing the impairment of goodwill, the Company estimates the value of the reporting unit using its market capitalization as the best evidence of fair value. This fair value is then compared to the carrying value of the reporting unit.

Impairment of long-lived assets

Impairment of long-lived assets

The Company evaluates the carrying value of long-lived assets on an annual basis, or more frequently should circumstances indicate a long-lived asset may be impaired. When indicators of impairment exist, the Company estimates future undiscounted cash flows attributable to such assets. In the event cash flows are not expected to be sufficient to recover the recorded value of the assets, the assets are written down to their estimated fair value. On December 31, 2014, the Company recorded an impairment charge of $686,350 as a result of terminating an acquired contract in the first quarter of 2015 that provided distribution services of facility security and access control products that the Company inherited as part of the Merger.

Concentration of credit risk

Concentration of credit risk

Financial instruments that potentially subject the Company to a concentration of credit risk consist of cash and cash equivalents. Cash and cash equivalents are deposited with high quality financial institutions. Periodically, such balances are from time to time in excess of federally insured limits.

Stock-based compensation

Stock-based compensation

The Company has a stock option plan under which incentive and non-qualified stock options and restricted stock awards (“RSAs”) are granted primarily to employees. All share-based payments to employees, including grants of employee stock options and RSAs, are recognized in the financial statements based on their respective grant date fair values. The benefits of tax deductions in excess of recognized compensation cost are reported as a financing cash flow.

The Company estimates the fair value of share-based payment awards on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense ratably over the requisite service periods in the Company’s statements of comprehensive income or loss. The Company has estimated the fair value of each option award as of the date of grant using the Black-Scholes option pricing model. The fair value of RSAs is calculated as the fair value of the underlying stock multiplied by the number of shares awarded. The awards issued consist of fully-vested stock awards, performance-based restricted shares, and service-based restricted shares.

Expenses related to stock-based awards issued to non-employees are recognized at fair value on a recurring basis in the periods those awards are expected to vest. The Company estimates the fair value of the awards using the Black-Scholes option pricing model.

Income taxes

Income taxes

The Company accounts for income taxes using the asset and liability method whereby deferred tax asset and liability account balances are determined based on temporary differences between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to affect taxable income. A valuation allowance is established when it is more likely than not that deferred tax assets will not be realized. Realization of deferred tax assets is dependent upon future pretax earnings, the reversal of temporary differences between book and tax income, and the expected tax rates in future periods. The Company has a full valuation allowance on all deferred tax assets.

The Company is required to evaluate the tax positions taken in the course of preparing its tax returns to determine whether tax positions are “more-likely-than-not” of being sustained by the applicable tax authority. Tax benefits of positions not deemed to meet the more-likely-than-not threshold would be recorded as a tax expense in the current year. The amount recognized is subject to estimate and management judgment with respect to the likely outcome of each uncertain tax position. The amount that is ultimately sustained for an individual uncertain tax position or for all uncertain tax positions in the aggregate could differ from the amount that is initially recognized.

Fair value measurements

Fair value measurements

The Company defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs within the fair value hierarchy. Observable inputs are inputs that market participants would use in pricing the asset or liability developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company’s own assumptions about what market participants would use in pricing the asset or liability developed based on the best information available in the circumstances.

The following methods and assumptions were used to estimate the fair value of financial instruments:

¨ Level 1 - Valuation is based upon quoted prices for identical instruments traded in active markets.

¨ Level 2 - Valuation is based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market.

¨ Level 3 - Valuation is generated from model-based techniques that use significant assumptions not observable in the market. These unobservable assumptions reflect management’s estimates of assumptions that market participants would use in pricing the asset or liability. Valuation techniques include use of option pricing models, discounted cash flow models and similar techniques.

The category within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.

Recently Issued Accounting Standards

Recently Issued Accounting Standards

In May 2014, the FASB issued a new financial accounting standard which outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes current revenue recognition guidance. ASU 2014-09 Revenue from Contracts with Customers is effective for annual reporting periods (including interim reporting periods within those periods) beginning after December 15, 2017. Early adoption is not permitted. We are currently evaluating the impact of this accounting standard.

In August 2014, the FASB issued a new accounting standard which requires management to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern for each annual and interim reporting period and to provide related footnote disclosures in certain circumstances. ASU 2014-15 Presentation of Financial Statements - Going Concern is effective for annual reporting periods (including interim reporting periods within those periods) beginning after December 15, 2016. Early adoption is permitted. We are currently evaluating the impact of this accounting standard.

In April 2015, the FASB issued a new accounting standard which changes the presentation of debt issuance costs in financial statements.  Under the new standard, an entity presents such costs in the balance sheet as a direct deduction from the related debt liability rather than as an asset.  Amortization of the costs is reported as interest expense.  The accounting standard is effective for annual reporting periods beginning after December 15, 2015 and interim periods beginning after December 15, 2016.  Early adoption is allowed for all entities so long as they are for financial statements that have not been previously issued.  The adoption of this standard is not expected to have a material impact on the Company’s consolidated financial statements.

XML

Document And Entity Information - shares	9 Months Ended
	Sep. 30, 2015	Nov. 09, 2015
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2015
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q3
Entity Registrant Name	Inventergy Global, Inc.
Entity Central Index Key	0001084752
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Trading Symbol	INVT
Entity Common Stock, Shares Outstanding		42,220,861

XML

Business Combination (Tables)

9 Months Ended

Sep. 30, 2015

Business Combinations [Abstract]

Purchase price allocation

The total purchase consideration and the purchase price allocation were as follows:

Fair value of assumed equity allocated to purchase consideration	$	10,985,867
Total purchase consideration	$	10,985,867
Goodwill	$	8,858,504
Intangible asset contract rights		1,342,000
Other assets acquired		816,045
Liabilities assumed		(30,682)
Total purchase allocation	$	10,985,867

XML

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Revenues	$ 132,500	$ 306,603	$ 4,483,303	$ 353,646
Operating Expenses
Cost of revenues	51,651	339,795	913,800	418,000
Patent amortization expense	377,742	387,585	1,152,365	1,012,956
General and administrative	1,930,705	2,559,474	5,921,212	8,996,860
Total operating expenses	2,360,098	3,286,854	7,987,377	10,427,816
Loss from operations	(2,227,598)	(2,980,251)	(3,504,074)	(10,074,170)
Other income (expense)
Loss on extinguishment of notes payable	0	0	(2,268,373)	(2,403,193)
Decrease in fair value of derivative liabilities	35,010	271,804	47,331	667,448
Other income	1,600	0	1,637	0
Interest expense, net	(1,279,879)	(229,231)	(3,771,868)	(525,391)
Total other income (expense), net	(1,243,269)	42,573	(5,991,273)	(2,261,136)
Loss before provision for income taxes	(3,470,867)	(2,937,678)	(9,495,347)	(12,335,306)
Provision for income taxes	0	0	0	0
Net loss	(3,470,867)	(2,937,678)	(9,495,347)	(12,335,306)
Net loss available to common shareholders	$ (3,470,867)	$ (2,937,678)	$ (9,495,347)	$ (12,335,306)
Basic and diluted loss per share	$ (0.10)	$ (0.15)	$ (0.29)	$ (0.79)
Weighted average shares outstanding, basic and diluted	35,425,200	19,852,019	32,233,484	15,698,206

XML

Stockholders' Equity

9 Months Ended

Sep. 30, 2015

Stockholders Equity Note [Abstract]

Stockholders' Equity

7. Stockholders’ Equity

Common stock

The Company is authorized to issue up to 110,000,000 shares, of which 100,000,000 shares have been designated as common stock and 10,000,000 shares have been designated as preferred stock. Holders of the Company's common stock are entitled to dividends if and when declared by the Board of Directors. The holders of each share of common stock shall have the right to one vote for each share.

Shares of common stock reserved for future issuance were as follows as of September 30, 2015:

Series A convertible preferred stock	528,548
Series B convertible preferred stock	2,395,653
Options to purchase common stock	2,134,291
Shares reserved for issuance pursuant to 2014 Stock Plan	2,278,889
Warrants	1,795,447
Total	9,132,828

On March 31, 2015, the Company entered into a securities purchase agreement (“Purchase Agreement”) with certain investors (the “Purchasers”) pursuant to which the Company sold 4,673,914 shares of its common stock (the “Shares”) at a purchase price of $0.46 per share resulting in gross proceeds to the Company of $2.15 million (the “Registered Direct Offering”). The Registered Direct Offering was effected as a takedown off the Company’s shelf registration statement on Form S-3 (File No. 333-199647), which was declared effective on November 10, 2014, and a related prospectus supplement dated April 2, 2015 in connection with the Registered Direct Offering. The Registered Direct Offering closed on April 6, 2015.

In connection with the Registered Direct Offering, the Company entered into a placement agent agreement (the “Placement Agent Agreement”) with Ladenburg Thalmann & Co. Inc. (the “Placement Agent”) to act as its exclusive placement agent. Pursuant to the Placement Agent Agreement, the Company paid to the Placement Agent $106,000 in cash, issued to the Placement Agent 57,611 five-year warrants with an exercise price of $0.575 per share (the “RD Warrants”) and reimbursed the Placement Agent for certain expenses. In addition, the Company paid to Laidlaw & Company (UK) Ltd. $50,000 in cash and issued 108,697 RD Warrants in connection with certain tail fees owed as a result of the Registered Direct Offering. The RD Warrants allow for cashless exercise in certain situations and contain piggyback registration rights for the seven year period commencing on March 31, 2015.

In addition, the Placement Agent will also be entitled to a tail fee if, within twelve months after the termination of expiration of the Placement Agent Agreement, the Company sells securities to any investor that was introduced to the Company by the Placement Agent and purchased shares in the Registered Direct Offering. The tail fee will be the same as the placement agent’s fee received by the Placement Agent in the Registered Direct Offering, subject to certain reductions described in the Placement Agent Agreement.

In connection with the Registered Direct Offering, the Company entered into a separate waiver agreement with one of its current stockholders pursuant to which the holder waived its right of participation in the Registered Direct Offering (the “Right of Participation”). In consideration for such waiver, the Company paid to the holder $35,000 in cash and waived any trading volume limitations or other lock-up provisions or restrictions imposed on the holder pursuant to an existing securities purchase agreement and an existing lock-up agreement the holder entered into with the Company. The Company also agreed that in the event that the Company obtains a consent, release amendment, settlement or waiver of the Right of Participation from any other stockholder holding such right in connection with the Registered Direct Offering on more favorable terms than in the waiver agreement prior to expiration of the Right of Participation of the holder, the holder will be entitled to the benefit of the more favorable terms. The holder’s Right of Participation terminated on September 8, 2015.

Convertible preferred stock

Convertible preferred stock as of September 30, 2015 consisted of the following:

Convertible	Original		Shares		Shares Originally		Shares		Liquidation
Preferred Stock	Issue Price		Designated		Issued		Outstanding		Preference
Series A-1	$	0.0100		5,000,000		5,000,000		212,466	$	117,158
Series A-2	$	1.6996		1,176,748		1,176,748		161,355	$	274,239
Series B	$	1,000.00		2,750		2,750		1,102	$	1,102,000

During the nine months ended September 30, 2015, 2,168,624 shares of Series A-1 Preferred Stock and 167,245 shares of Series A-2 redeemable convertible preferred stock (the “Series A-2 Preferred Stock”, and together with the Series A-1 Preferred Stock, the “Series A Preferred Stock”) were converted into common stock. See “Note 11. Subsequent Event” below for additional information relating to the conversion of the Series A Preferred Stock and the Series B Preferred Stock to common stock in October 2015.

In conjunction with the issuance of Series A-1 Preferred Stock and Series A-2 Preferred Stock, proceeds of $4,950,000 were received in exchange for the issuance of promissory notes payable. Total proceeds from this transaction were allocated to each instrument using the relative fair value method. Proceeds allocated to Series A-1 Preferred Stock and Series A-2 Preferred Stock were $3,308,874 and $1,134,016, respectively. Following the allocation of fair value, the effective conversion prices per share upon issuance of Series A-1 Preferred Stock and Series A-2 Preferred Stock were $0.55 and $0.96, respectively.

On December 17, 2013, in contemplation of the Merger, the Company issued 2,750 shares of its Series B Preferred Stock (the “Series B Preferred Stock” and collectively with the Series A Preferred Stock, the “Preferred Stock”) at a price of $1,000 per share, subject to the terms of its Certificate of Designations for the Series B Preferred Stock (the “Certificate of Designations”), and warrants to purchase an aggregate of 700,937 shares of the Company’s common stock to certain accredited investors in a private offering transaction for proceeds of $2,750,000. The warrants have an exercise price of $2.66 per common share and expire in June 2016.

The Series B Preferred Stock was repriced at fair value in conjunction with the Merger. The revaluation did not impact earnings per share.

A complete description of the rights, preferences, privileges and restrictions of the Series A Preferred Stock and Series B Preferred Stock are included in the Company’s Fifth Amended and Restated Articles of Incorporation (the “Charter”). The following is a summary of certain rights, privileges, preferences and restrictions:

Liquidation preference

In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Company, the holders of Series A Preferred Stock are entitled to receive an amount equal to the sum of (i) the greater of (x) the product of (I) $0.01 in the event of Series A-1 or $1.6996 in the event of Series A-2 and (II) the number of shares of Series A Preferred Stock then held by each holder and (y) the product of (I) the fair market value of one share of common stock, as mutually determined by the Company and the Preferred Stock holders and (II) the number of shares of common stock issuable upon conversion of such Series A Preferred Stock, and (ii) any declared accrued and unpaid dividends, prior and in preference to any distributions made to the holders of common stock.

In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Company, the holders of Series B Preferred Stock are entitled to receive an amount equal to $1,000 per share. After full payment to the holders of Series A Preferred Stock and Series B Preferred Stock, holders of Series B Preferred Stock shall be entitled to participate in the distribution of any remaining assets of the Company on an as converted basis pari passu with the holders of common stock.

If the assets and funds distributed among the holders of the Preferred Stock are insufficient to permit payment to such holders of the full preferential amount, then the entire assets and funds of the Company legally available for distribution shall be distributed ratably among the holders of the Series A Preferred Stock and Series B Preferred Stock in proportion to the preferential amount each such holder is otherwise entitled to receive.

Conversion

All shares of Series A Preferred Stock are convertible into common stock at the option of the holder at any time after the date of issuance by dividing the stated value of such preferred shares by $0.007073 (reflecting the Reverse Split) in the event of Series A-1 or $1.202065 (reflecting the Reverse Split) in the event of Series A-2 by the conversion amount, each subject to adjustment (including the Reverse Split). All Series B Preferred Stock are convertible, into common stock at the option of the holder, at any time after the date of issuance, by multiplying the conversion amount by the quotient of (x) $1,000 divided by (y) 2.00, each subject to similar adjustment. Each share of the Series A Preferred Stock and Series B Preferred Stock will automatically be converted into common stock, at the then-effective applicable conversion price, upon the occurrence of both i) the full collateralization of the Secured Convertible Notes, and ii) upon the closing of the sale of the Company’s common stock in a firm-commitment, underwritten public offering registered under the Securities Act which results in aggregate proceeds to the Company of at least $20,000,000 at a price per share exceeding such threshold as defined in the Company’s Charter (currently $0.289).

Anti-dilution

Holders of Series A-1 Preferred Stock are entitled to receive certain shares of common stock if and when the Company issues or sells any shares of common stock for a consideration per share less than a certain threshold price (currently $0.289).

As a result of the issuance of the Fortress Shares and warrants as discussed in Note 6, and the Registered Direct Offering (as defined above), the conversion price for the Series B Preferred Stock is $0.46. The conversion price will be further reduced (and the holders of Series B Preferred Stock will be entitled to receive additional shares of common stock upon conversion) if and when the Company issues or sells securities for a consideration per share less than the current conversion price.

Voting rights

Holders of the Series A Preferred Stock are entitled to one vote for each share of common stock into which their shares can be converted. Holders of Series B Preferred Stock are entitled to 403.5 votes for each share of Series B Preferred Stock held.

Substantial Holder Rights

The Certificate of Designations, Preferences and Rights for the Series A Preferred Stock contemplates certain rights for any holder of Series A Preferred Stock that purchased a certain threshold number of shares of Series A Preferred Stock for as long as that holder continued to hold at least twenty percent of shares of Series A Preferred Stock originally purchased (such holders referred to as “Substantial Holders”). As of September 30, 2015, there were no longer any Substantial Holders and the rights afforded to such Substantial Holders are no longer in effect.

Warrants

In January 2014, the Company issued warrants to purchase 238,412 shares of common stock at an exercise price of $3.04 to a placement agent. The warrants expire in January 2019. The exercise price was reduced to its floor of $2.27 as a result of the sale of the Fortress Shares. The warrants may be exercised without cash consideration by forfeiting a portion of shares. The fair value of the warrants at issuance was $348,963, estimated using the Black-Scholes option pricing model. The fair value of the warrants was revalued at September 30, 2015 as discussed in Note 5.

In connection with the Merger, the Company issued warrants to purchase 700,937 shares of common stock at an exercise price of $2.66, of which 586,238 warrants remain outstanding as of September 30, 2015. The warrants expire in June 2016.

On November 1, 2014 the Company issued 277,500 warrants to purchase common stock to advisors in connection with the Fortress Agreement. The warrants have a weighted average exercise price of $2.07, and the fair value of the warrants at issuance was $164,196.

On February 27, 2015, in connection with the Fortress Amended Agreement, the Company sold 500,000 warrants to purchase common stock with an exercise price of $1.14 and issued 26,989 warrants to purchase common stock with an exercise price of $2.00. The fair value of the warrants at issuance was $172,319 and $4,960, respectively.

Common stock warrants outstanding as of September 30, 2015 are listed as follows:

Warrants		Remaining Contractual		Weighted Average
Outstanding		Life (years)		Exercise
	500,000		6.42	$	1.14
	108,697		4.52	$	0.46
	57,611		4.52	$	0.58
	26,989		4.41	$	2.00
	247,500		4.09	$	2.00
	238,412		3.34	$	2.27
	30,000		2.09	$	2.66
	586,238		0.75	$	2.66
	1,795,447		3.56	$	1.88

XML

Borrowing Arrangements

9 Months Ended

Sep. 30, 2015

Debt Disclosure [Abstract]

Borrowing Arrangements

6. Borrowing Arrangements 

On March 26, 2014, notes payable which have since been retired were amended and restated to allow for conversion to common stock and to amend the interest rate. In conjunction with the amendment, the Company recorded a loss on extinguishment of the notes payable of $2,403,193 in the accompanying statements of operations.

On September 23, 2014, the Company entered into a Share Purchase Agreement with the Company’s Chief Executive Officer pursuant to which the Company agreed to issue to the Chief Executive Officer up to 233,640 shares of our common stock at a purchase price of $2.14 per share for aggregate consideration to us of up to $500,000. Pursuant to the terms of such Share Purchase Agreement and concurrently with the execution of the agreement, the Chief Executive Officer made an initial payment of $300,000 to the Company towards the aggregate purchase price. The shares were only to be issued if we did not obtain $6 million or more in debt financing within ten business days of the execution of the agreement. As a result of the Fortress Agreement, the Company was required to return the $300,000 in cash previously prepaid by the Chief Executive Officer. During the quarter ended June 30, 2015, the Company’s Board of Directors approved the application of $100,000 of this amount towards the purchase of shares of the Company’s common stock at price per share equal to the greater of $0.46 per share or a 15% premium to the market price. As a result, on June 26, 2015, the Company sold 217,392 shares of previously unissued common stock at a price of $0.46 per share to the Chief Executive Officer. As of September 30, 2015, repayments of $80,000 have been made to the Chief Executive Officer and the remaining balance of $120,000 has been recorded as a related party loan payable.

On October 1, 2014, the Company entered into the original Fortress Agreement with Fortress, including a Note Purchaser (as defined below) who also serves as collateral agent (the “Collateral Agent”) and a Revenue Participant (as defined below). Pursuant to the original Fortress Agreement, the Company issued an aggregate of $11,000,000 in notes (the “Original Notes”) to the purchasers identified in the Fortress Agreement (the “Note Purchasers”). As a result of the issuance of the Original Notes and the sale of the Fortress Shares (as defined below), after the payment of all purchaser-related fees and expenses relating to the issuance of the Original Notes and Fortress Shares, the Company received net proceeds of $9,964,868 (less issuance costs of $450,253). The Company used the net proceeds to pay off the Secured Convertible Notes and the unsecured promissory note payable from First Republic Bank with an aggregate principal amount of $500,000 and for general working capital purposes. The unpaid principal amount of the Original Notes bears cash interest equal to LIBOR plus 7%. In addition, a 3% per annum paid-in-kind (“PIK”) interest will be paid by increasing the principal amount of the Original Notes by the amount of such interest. The PIK interest shall be treated as principal of the Original Notes for all purposes of interest accrual or calculation of any premium payment.

The principal of the Original Notes and all unpaid interest thereon or other amounts owing hereunder shall be paid in full in cash by the Company on September 30, 2017 (the “Maturity Date”). The Company may prepay the Original Notes in whole or in part, generally without penalty or premium, except that any optional prepayments of the Original Notes prior to October 1, 2015 will be accompanied by a prepayment premium equal to 5% of the principal amount prepaid. In addition, upon the earlier of the date on which the all obligations of the Original Notes are paid in full, or become due, the Company will pay to the Note Purchasers a termination fee equal to $770,000. This was accounted for as a discount on notes payable.

Upon receipt of any revenues generated from the monetization of the Patents (the “Monetization Revenue”) of the patents identified in the Fortress Agreement (the “Patents”), the Company is required to apply, towards its obligations pursuant to the Original Notes, 86% of the difference between (a) any revenues generated from the Monetization Revenue less (b) any litigation or licensing related third party expenses (including fees paid to the original patent owners) reasonably incurred by the Company to earn Monetization Revenue, subject to certain limits (such difference defined as “Monetization Net Revenues”). If Monetization Net Revenue is applied to outstanding principal of the Original Notes (defined as “Mandatory Prepayments”), such Mandatory Prepayments are not subject to the prepayment premium described above. To the extent that any obligations under the Original Notes are past due, including if such payments are past due as a result of the acceleration of the Original Notes or certain conditions of breach or alleged breach have occurred, the percentage will increase from 86% to 100%.

In addition to the Mandatory Prepayments, beginning on the last business day of October 2015 (subsequently amended to December 1, 2015 - See Note 11), the Company shall make monthly amortization payments (the “Amortization Payments”) in an amount equal to (x) the then outstanding principal amount of the Original Notes divided by (y) the number of months left until the Maturity Date.

In connection with the execution of the Fortress Agreement, on October 1, 2014, the Company paid the Note Purchasers a structuring fee of $385,000. This was accounted for as a discount on notes payable.

Pursuant to the Fortress Agreement, the Company granted to the purchasers identified in the Fortress Agreement (“Revenue Participants”) a right to receive a portion of the Company’s Monetization Revenues totaling $5,500,000 (unless the Revenue Participants have not received $5,500,000 by the Maturity Date, in which case the Revenue Participants have a right to receive a portion of Monetization Revenues totaling $8,250,000) (the “Revenue Stream”). The Revenue Participants will not receive any portion of the Revenue Stream until all obligations under the Original Notes are paid in full. Following payment in full of the Original Notes, the Company will pay to the Revenue Participants their proportionate share of the Monetization Net Revenues. The Revenue Participants’ proportionate share is equal to (a) 46% of Monetization Net Revenues until $2,750,000 has been paid to the Revenue Participants, (b) 31% of Monetization Net Revenues until the next $2,750,000 has been paid to the Revenue Participants and (c) 6% of Monetization Net Revenues until the next $2,750,000 has been paid to the Revenue Participants if (a) and (b) have not been fully paid by the Maturity Date. All Revenue Stream Payments will be payable on a monthly basis in arrears. The rights of the Revenue Participants to the Revenue Stream are secured by all of the Company’s patent assets as of October 1, 2014 and the Cash Collateral Account, in each case junior in priority to the rights of the Note Purchasers. In connection with the Revenue Participants’ right to receive a portion of the Company’s Monetization Revenues, the Company has recorded a net liability of $2,478,057, which represents the fair value of the expected Monetization Revenues, discounted 20% over the expected life of the revenue share agreement. 

As part of the Fortress Agreement, the Company and the Collateral Agent entered into a Patent License Agreement (the “Patent License Agreement”), under which the Company agreed to grant to the Collateral Agent a non-exclusive, royalty-free, and worldwide license to certain of its Patents (the “Licensed Patents”), which can only be used by the Collateral Agent following an occurrence and during the continuance of an event of default of the Fortress Agreement. When the Fortress Notes (as defined below) and Revenue Stream are paid in full, the Patent License Agreement will terminate.

As part of the transaction, the Company granted the Note Purchaser and Revenue Participant a first priority security interest in all of the Company’s patent assets owned as of October 1, 2014 and all proceeds thereof, as well as a general security interest in all of the assets of the Company and its subsidiaries. The Note Purchaser and Revenue Participant do not have a security interest in any future patent purchases by the Company.

As part of the transaction, the Company is required to maintain a minimum $1,000,000 in cash reserves. Failure to maintain that minimum cash balance can constitute an event of default under the Fortress Agreement. If we were to default under the Fortress Agreement and were unable to obtain a waiver for such a default, interest on the obligations would accrue at an increased rate. In the case of a default, Fortress could accelerate our obligations under the Fortress Agreement.

Effective February 25, 2015, the Company entered into an Amended and Restated Revenue Sharing and Note Purchase Agreement (the “Fortress Amended Agreement” and together with the original Fortress Agreement, sometimes referred to as the “Fortress Agreement”) with Fortress, under which Fortress agreed to make available to the Company up to an additional $3,000,000 between February 25, 2015 and December 31, 2015 (the “Additional Available Credit”). The Additional Available Credit would be drawn down in the form of senior secured notes (the “Additional Notes” and, together with the Original Notes, the “Fortress Notes”) and the additional amount loaned would be based on revenue the Company generates from certain near-term existing and future license agreements (“Draw Down Licenses”). On February 25, 2015, the Company drew down $1,199,500 from the Additional Available Credit and issued Additional Notes in that principal amount to Fortress. In connection with the issuance of the Additional Available Credit, the Company sold 500,000 warrants to purchase shares of the Company’s common stock. After the payment of all transaction-related fees and expenses relating to such issuances, which amounted to $72,600, the Company received net proceeds of $1,126,900. The Company is using these net proceeds for general working capital purposes.

In connection with the issuance of the Additional Notes and the Revenue Participants’ right to receive a portion of the Company’s Monetization Revenues, the Company has recorded a net liability of $335,762, which represents the fair value of the expected Monetization Revenues, discounted 18% over the expected life of the revenue share agreement. 

In addition to the issuance of the Additional Notes, the Fortress Amended Agreement amended the original Fortress Agreement as follows:

¨ The structuring fee equal to 3.5% of the original principal amount of any such Additional Notes is waived.

¨ The Additional Notes will be repaid from the future licensing payments on the Draw Down Licenses received from those specific Draw Down licensee(s), while the requirements otherwise to pay 86% of the Monetization Net Revenues towards the Original Notes for (i) the upfront payment of the initial Draw Down License and (ii) the remaining future payments of Draw Down Licenses are waived in general.

¨ The Revenue Participants are entitled to receive $7,700,000 (adjusted from the terms of the Original Notes) plus 70% of the Additional Notes as a portion of the Revenue Stream Basis (as defined below) if the Notes and Revenue Stream payments are paid in full by the Maturity Date or $9,350,000 (adjusted from the terms of the Original Notes) plus 85% of the Additional Notes as a portion of the Revenue Stream Basis if the Fortress Notes and Revenue Stream payments are not paid in full by the Maturity Date. The Revenue Stream payments will begin after all obligations on the Fortress Notes are paid in full. The Company is required to apply specified decreasing percentages (46% to 31% to 6%) of its net revenues (net of monetization costs) from monetizing its intellectual property assets on an ongoing basis to meet the Revenue Stream payment obligations. Payment of the full Revenue Stream payments in addition to the Fortress Note obligations by the Maturity Date would ordinarily occur after the Company receives approximately $60,000,000 in gross licensing revenues, assuming an average monetization cost of 33%.

¨ The Company shall not be required to apply the initial installment payment under the first Draw Down License to the Company’s obligations under the Fortress Notes or the Revenue Stream under the Fortress Amended Agreement.

In connection with the February 25, 2015 modification to the original Fortress Agreement and Revenue Participants’ right to receive a portion of the Company’s Monetization Revenues, the Company has recorded a loss of $2,268,373, for the resultant change in the fair value of the expected Monetization Revenues. 

The Fortress Agreement also contemplates the issuance of up to an additional $2,000,000 in notes beyond the Additional Available Credit.

Except as described above, the terms of the Additional Notes are identical to the terms of the original Notes issued pursuant to the original Fortress Agreement. Except as described above, the terms of the Original Fortress Agreement, and the Original Notes and warrants issued thereunder, remain in full force and effect, including the existing Monetization Revenue payments for the original Notes and the calculation of the termination fee based on the principal of the Original Notes.

Unregistered Sales of Equity Securities.

In connection with the execution of the original Fortress Agreement, the Company issued 500,000 shares of its common stock at $2.00 per share to the Revenue Participant for an aggregate purchase price of $1,000,000 (“the Fortress Shares”). The Fortress Shares were issued pursuant to a subscription agreement dated October 1, 2014. The shares were issued by the Company under the exemption from registration afforded by Section 4(a)(2) of the Securities Act and Regulation D promulgated thereunder, as they were issued to accredited investors, without a view to distribution, and were not issued through any general solicitation or advertisement.

On October 1, 2014, the Company paid the holders of the Amended Secured Convertible Notes and the New Secured Convertible Notes $8,000,000, plus interest of $187,351 and issued an aggregate of 1,804,030 shares of common stock to the note holders (who otherwise had the right to convert the existing notes into 1,508,162 shares of common stock until July 2018) as consideration for a waiver from such Secured Convertible Note holders in order for the Company to prepay the remaining outstanding principal and interest on the Secured Convertible Notes. Immediately following the prepayment of the Secured Convertible Notes and the issuance of the shares, the Secured Convertible Notes were deemed paid in full. Further, as a result of the termination of the Secured Convertible Notes, $3,500,000 previously held in a cash collateral account in connection with the Secured Convertible Notes was released to the Company.

In connection with the closing of the transactions contemplated by the original Fortress Agreement, the Company paid a closing fee of $330,000. As discussed in Note 7, the Company also issued a 5 year warrant to purchase 247,500 shares common stock at an exercise price of $2.00 to National Securities Corporation, a wholly-owned subsidiary of National Holdings, Inc. (“National”), who acted as advisor to the Company with respect to the transaction. The warrant meets the requirements to be accounted for as an equity warrant. The Company estimated the fair value of the warrant to be $153,759, using the Black-Scholes option pricing model. The fair value of the warrant as of November 1, 2014, the issue date of the warrant, was estimated using the following assumptions:

Expected volatility	60	%
Risk free rate	1.62	%
Dividend yield	0	%
Expected term (in years)	5.00

The assumptions utilized were derived in a similar manner as discussed in Note 7 related to the fair value of stock options.

On February 27, 2015, in connection with the execution of the original Fortress Amended Agreement, at closing of the transactions with Fortress, the Company sold 500,000 seven-year warrants to purchase shares of the Company’s common stock at an exercise price of $1.14 per share to Fortress for an aggregate purchase price of $40,000. The warrant was issued by the Company under the exemption from registration afforded by Section 4(a)(2) of the Securities Act and Regulation D promulgated thereunder, as they were issued to accredited investors, without a view to distribution, and were not issued through any general solicitation or advertisement.

On February 27, 2015, in connection with the closing of the transactions contemplated by the Fortress Amended Agreement, the Company paid a closing fee of $35,985 and issued a 5-year warrant for the purchase of 26,989 shares of the Company’s common stock with an exercise price of $2.00 per share to National Securities Corporation, a wholly-owned subsidiary of National Holdings, Inc. (“National”). National acted as advisor to the Company with respect to the transaction.

The warrant issuances on February 27, 2015 meet the requirements to be accounted for as equity with a fair value of $172,319 and $4,960, respectively, using the Black-Scholes option pricing model. The fair value of the issued warrants as of February 27, 2015, were estimated using the following assumptions:

				National Securities
	Fortress			Corporation
Expected volatility		60	%		60	%
Risk free rate		1.7	%		1.5	%
Dividend yield		0	%		0	%
Expected term (in years)		5.00			7.00

XML

Stock-Based Compensation (Tables)

9 Months Ended

Sep. 30, 2015

Workers Compensation Discount [Abstract]

Summary of share-based compensation activity

As of September 30, 2015, stock option and restricted stock award activity under the Plan was as follows:

			Options and RSAs Outstanding
					Weighted Average
	Shares Available				Exercise Price Per
	for Grant		Number of Shares		Share
Balance at December 31, 2014		689,529		2,417,918	$	2.59
Additions to 2014 Stock Plan		1,700,000
Options Granted		(1,908,661)		1,908,661	$	1.02
Options Forfeited		646,514		(646,514)	$	1.14
Options Expired		113,113		(113,113)	$	2.63
Options Cancelled		1,432,661		(1,432,661)	$	2.73
Restricted Stock Granted		(394,267)		394,267	$	0.39
Restricted Stock Vested		-		(394,267)	$	0.39
Balance at September 30, 2015		2,278,889		2,134,291	$	1.53
Total vested and expected to vest shares (options)				2,134,291	$	1.53
Total vested shares (options)				1,021,911	$	2.13

Outstanding options

The following table summarizes information with respect to stock options outstanding at September 30, 2015:

Options Outstanding								Options Vested
				Weighted-
				Average		Weighted-				Weighted-
Exercise				Remaining		Average				Average
Price Per		Shares		Contractual		Exercise		Shares		Exercise
Share		Outstanding		Life (Years)		Price		Exercisable		Price Per Share
$	0.56		25,000		1.58	$	0.56		25,000	$	0.56
$	0.69		316,000		9.32	$	0.69		43,250	$	0.69
$	0.77		150,000		9.18	$	0.77		25,000	$	0.77
$	1.14		974,168		8.03	$	1.14		259,538	$	1.14
$	2.05		17,800		8.84	$	2.05		17,800	$	2.05
$	2.27		525,628		8.13	$	2.27		525,628	$	2.27
$	3.04		70,695		1.58	$	3.04		70,695	$	3.04
$	3.85		40,000		7.35	$	3.85		40,000	$	3.85
$	14.30		15,000		0.71	$	14.30		15,000	$	14.30
			2,134,291		7.98	$	1.53		1,021,911	$	2.13

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The fair value of employee stock options granted was estimated using the following weighted-average assumptions for the nine months ended September 30, 2015:

	2015
Expected volatility		64	%
Risk free rate		1.48	%
Dividend yield		0	%
Expected term (in years)		6.06

Schedule Of Stock Based Compensation Of Employees And Non Employees

Stock-based compensation for employees and non-employees related to options and RSAs recognized:

	For the three months ended				For the nine months ended
	September 30				September 30
	2015		2014		2015		2014
General and administrative	$	246,485	$	376,530	$	843,386	$	2,238,184

XML

Patents (Tables)

9 Months Ended

Sep. 30, 2015

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Finite-Lived Intangible Assets

Patent intangible assets consist of the following at September 30, 2015:

	Weighted
	Average	Gross Carrying		Accumulated		Net Carrying
	Useful Life	Amount		Amortization		Amount
Amortizable intangible assets:
Patents	8.0	$	11,893,745	$	(2,846,079)	$	9,047,666
Total patent intangible assets		$	11,893,745	$	(2,846,079)	$	9,047,666

XML

Commitments and Contingencies

9 Months Ended

Sep. 30, 2015

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

10. Commitments and Contingencies

Operating lease

In March 2014, the Company entered into a non-cancelable thirty-eight month lease agreement for offices in Campbell, California commencing June 1, 2014 with escalating rent payments ranging from approximately $9,200 to $9,800 per month and one option to extend the lease term for an additional three years. Included in the lease agreement was a full rent abatement period of two months. Rent expense is recognized on a straight line basis. The Company paid a security deposit of $18,993. The future minimum payments related to this lease are as follows:

Years ending December 31:
2015		28,568
2016		116,201
2017		68,587
Total	$	213,356

Rent expense was approximately $27,152, and $36,202 for the three months ended September 30, 2015 and 2014, respectively, and approximately $81,472, and $81,221 for the nine months ended September 30, 2015 and 2014, respectively.

Guaranteed payments

The Company has entered into agreements to purchase certain patent assets. The Company will be required to pay the remaining future unconditional guaranteed payments of $20,000,000 ($18 million of which is to be paid out of net revenues from patent licensing receipts) through August 31, 2017, such payments representing the purchase of patents and minimum revenue sharing from the Company’s licensing arrangements and/or similar transactions regarding the purchased patents to other parties. The guaranteed payments are accrued on the Company’s accompanying balance sheet as of September 30, 2015 at net present value using a discount rate of 12%. The associated discount is being amortized using the effective interest method. Expenses related to minimum revenue sharing payments are deferred as of September 30, 2015 and will be amortized in correlation with the future payment schedule. Minimum revenue sharing payments are generally due sixty days after fully earned. Future guaranteed payments associated with these agreements are payable as follows:

Years ending December 31:
2015		4,667,415
2016		5,000,000
2017		10,000,000
Less: discount to present value		(1,830,549)
Guaranteed payments, net of discount	$	17,836,866

Pursuant to the patent purchase agreement with Panasonic Corporation (“Panasonic”), a significant portion of the above guaranteed payments are owed to Panasonic.  If the Company’s market capitalization falls below the aggregate dollar amount that the Company owes at that relevant point in time to Panasonic (but only prior to full payment), Panasonic may exercise a limited right to repurchase the Panasonic patent portfolio assets at a purchase price at least equal to the amount the Company paid to purchase the Panasonic patent portfolio. During the three months ended September 30, 2015, the Company was in compliance with the terms of the agreement.

Fortress Notes payable

Pursuant to the Fortress Agreement (as described in Note 6), future debt payments owed to Fortress with respect to the Fortress Notes are as follows:

Years ending December 31:
2015		1,306,629
2016		5,327,055
2017		4,102,810
Total	$	10,736,494

XML

Stock-Based Compensation

9 Months Ended

Sep. 30, 2015

Workers Compensation Discount [Abstract]

Stock-Based Compensation

8. Stock-Based Compensation 

In November 2013, the Board of Directors authorized the 2013 Stock Plan (such plan has since been adopted by the stockholders of the Company in connection with the Merger and renamed the “Inventergy Global, Inc. 2014 Stock Plan”, the “Plan” or the “2014 Plan”). Under the Plan, the Board of Directors may grant incentive stock awards to employees and directors, and non-statutory stock options to employees, directors and consultants as well as restricted stock. The Plan provides for the grant of stock options, restricted stock, and other stock-related and performance awards that may be settled in cash, stock, or other property. An additional 1,700,000 shares were added to the 2014 Plan in September 2015. Following such addition, the Board of Directors reserved 5,305,445 shares of common stock for issuance over the term of the Plan. The exercise price of an option cannot be less than the fair value of one share of common stock on the date of grant for incentive stock options or non-statutory stock options. The exercise price of an incentive stock option cannot be less than 110% of the fair value of one share of common stock on the date of grant for stockholders owning more than 10% of all classes of stock. Options are exercisable over periods not to exceed ten years (five years for incentive stock options granted to holders of 10% or more of the voting stock) from the grant date. Options may be granted with vesting terms as determined by the Board of Directors which generally include a one to five year period or performance conditions or both. The pre-existing options were subsumed under the Plan.

As of September 30, 2015, stock option and restricted stock award activity under the Plan was as follows:

			Options and RSAs Outstanding
					Weighted Average
	Shares Available				Exercise Price Per
	for Grant		Number of Shares		Share
Balance at December 31, 2014		689,529		2,417,918	$	2.59
Additions to 2014 Stock Plan		1,700,000
Options Granted		(1,908,661)		1,908,661	$	1.02
Options Forfeited		646,514		(646,514)	$	1.14
Options Expired		113,113		(113,113)	$	2.63
Options Cancelled		1,432,661		(1,432,661)	$	2.73
Restricted Stock Granted		(394,267)		394,267	$	0.39
Restricted Stock Vested		-		(394,267)	$	0.39
Balance at September 30, 2015		2,278,889		2,134,291	$	1.53
Total vested and expected to vest shares (options)				2,134,291	$	1.53
Total vested shares (options)				1,021,911	$	2.13

As of September 30, 2015, all of the restricted stock granted under the plan had vested. The aggregate intrinsic value of stock options outstanding, stock options vested and expected to vest, and exercisable at September 30, 2015 was $0.

Prior to the plan being established, the Company granted the equivalent of 7,167,585 restricted stock awards (“RSAs”) to employees and non-employees in exchange for services with vesting schedules specific to each individual award. As of September 30, 2015, 4,509,238 shares were vested, and 629,453 shares were cancelled or forfeited (unvested).

As part of the Merger, 15,000 fully vested options with an exercise price of $14.30 were assumed by Inventergy Global, Inc. and remained outstanding as of September 30, 2015.

Cancellation and Issuance of Options

On March 25, 2015, the Company cancelled certain unvested options (totaling 1,432,661) granted to employees and directors under the Company’s 2014 Stock Plan, which had exercise prices ranging from $2.05 to $3.85, 10 year terms and one to four year vesting terms. In addition, on March 25, 2015, the Company issued new options to the same employees and directors under the 2014 Stock Plan. The Company granted an aggregate of 1,269,845 options to its employees, the vesting schedules of which were increased by 12 months as compared to the cancelled options – an increase from an average vesting schedule spanning 2.1 years to 3.1 years. The Company also granted an aggregate of 162,816 options to its directors, the vesting schedules of which were left substantially unchanged as compared to the cancelled options which had been set to align with the service period of each board member. The new options have an exercise price of $1.14 per share, which is a 48% premium to the closing price of the Company’s common stock as of March 25, 2015. This cancellation and issuance of new options resulted in an increase in stock compensation expense of $272,720 which is being recognized over the remaining average vesting period of 3.1 years.

The following table summarizes information with respect to stock options outstanding at September 30, 2015:

Options Outstanding								Options Vested
				Weighted-
				Average		Weighted-				Weighted-
Exercise				Remaining		Average				Average
Price Per		Shares		Contractual		Exercise		Shares		Exercise
Share		Outstanding		Life (Years)		Price		Exercisable		Price Per Share
$	0.56		25,000		1.58	$	0.56		25,000	$	0.56
$	0.69		316,000		9.32	$	0.69		43,250	$	0.69
$	0.77		150,000		9.18	$	0.77		25,000	$	0.77
$	1.14		974,168		8.03	$	1.14		259,538	$	1.14
$	2.05		17,800		8.84	$	2.05		17,800	$	2.05
$	2.27		525,628		8.13	$	2.27		525,628	$	2.27
$	3.04		70,695		1.58	$	3.04		70,695	$	3.04
$	3.85		40,000		7.35	$	3.85		40,000	$	3.85
$	14.30		15,000		0.71	$	14.30		15,000	$	14.30
			2,134,291		7.98	$	1.53		1,021,911	$	2.13

Stock-based compensation expense

The fair value of employee stock options granted was estimated using the following weighted-average assumptions for the nine months ended September 30, 2015:

	2015
Expected volatility		64	%
Risk free rate		1.48	%
Dividend yield		0	%
Expected term (in years)		6.06

The expected term of the options is based on the average period the stock options are expected to remain outstanding based on the option’s vesting term and contractual terms. The expected stock price volatility assumptions for the Company’s stock options were determined by examining the historical volatilities for industry peers, as the Company did not have any trading history for the Company’s common stock. The risk-free interest rate assumption is based on the U.S. Treasury instruments whose term was consistent with the expected term of the Company’s stock options. The expected dividend assumption is based on the Company’s history and expectation of dividend payouts. Forfeitures were estimated based on the Company’s estimate of future cancellations.

Stock-based compensation for employees and non-employees related to options and RSAs recognized:

	For the three months ended				For the nine months ended
	September 30				September 30
	2015		2014		2015		2014
General and administrative	$	246,485	$	376,530	$	843,386	$	2,238,184

In November 2014, the Company modified the terms to an option granted to a former director. The Company determined that there was no incremental compensation expense associated with the modification.

No income tax benefit has been recognized related to stock-based compensation expense and no tax benefits have been realized from exercised stock awards. As of September 30, 2015, there were total unrecognized compensation costs of $1,187,274 related to these stock awards. These costs are expected to be recognized over a period of approximately 1.25 years.

Non-employee stock-based compensation expense

For the three and nine months ended September 30, 2015 and 2014, the Company issued options and restricted stock awards to non-employees in exchange for services with vesting specific to each individual award. Non-employee stock-based compensation expense is recognized as the awards vest and totaled $41,381 and $258,053 for the three and nine months ended September 30, 2015, respectively, and $(67,910) and $1,312,993 for the three and nine months ended September 30, 2014, respectively. The fair value of RSAs is calculated as the fair value of the underlying stock multiplied by the number of shares awarded.

XML

Income Taxes

9 Months Ended

Sep. 30, 2015

Income Tax Disclosure [Abstract]

Income Taxes

9. Income Taxes

On a quarterly basis, the Company records income tax expense or benefit based on year-to-date results and expected results for the remainder of the year. The Company recorded no provision for income taxes for the three- and nine- month periods ended September 30, 2015 and 2014.

Deferred income taxes reflect the tax effect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Based on the Company’s historical net losses during its development stage, the Company has provided a full valuation allowance against its deferred tax assets as of September 30, 2015 and 2014.

The use of the Company’s net operating loss carryforwards is subject to certain annual limitations and may be subject to further limitations as a result of changes in ownership as defined by the Internal Revenue Code and similar state provisions. Such limitations could result in the expiration of net operating loss carryforwards prior to utilization.

The Company files U.S. federal and state tax returns. As of September 30, 2015 and 2014, all tax years remain open in most jurisdictions. The Company is not currently under examination by income tax authorities in federal or state jurisdictions.

XML

Subsequent Events

9 Months Ended

Sep. 30, 2015

Subsequent Events [Abstract]

Subsequent Events

11. Subsequent Events

Conversion of Preferred Stock

 

In October 2015, the Company entered into agreements with holders of all of the outstanding Series A and Series B Preferred Stock pursuant to which the holders agreed to exchange all of their outstanding shares of Series A and Series B Preferred Stock for common stock. As a result, as of October 13, 2015, there were no remaining shares of Series A or Series B Preferred Stock outstanding. The previously-outstanding Preferred Stock amounts, along with the newly-issued common stock amounts, are as follows:

	Outstanding as of Sept. 30, 2015		Newly-Issued Common Stock
Series A-1		212,466		1,412,613
Series A-2		161,355		285,179
Series B		1,102		4,209,560

Modification of Fortress Amended Agreement

On October 30, 2015, the Company and Fortress amended the Fortress Amended Agreement. The amendment deferred the initial Amortization Payment and suspended the requirement to maintain a $1 million minimum cash balance until December 1, 2015. In addition, the parties agreed to decrease the exercise price on the 500,000 warrants issued to Fortress in February 2015 to $0.254 per share.

Settlement of Litigation

On October 27, 2015, the Company and Genband US LLC (“Genband”) settled a patent infringement action brought by Inventergy, Inc. The settlement agreement required Genband, among other provisions, to pay a confidential settlement fee to Inventergy, Inc.

Modification of Patent Payment Terms

On October 30, 2015, the Company and a third party from whom the Company purchased one of its patent portfolios agreed to amend the terms of the original patent purchase agreement under which the Company was required to make a $2,000,000 payment by December 1, 2015. The amendment provides that the Company will make a $550,000 payment on January 31, 2016 and a $1,650,000 payment on July 1, 2016, which amounts include $95,000 in additional interest. These payments may be paid at a 10% discount if paid 45 days or more in advance of their respective due dates.

XML

Summary of Changes in Fair Value of Company's Level 3 Liabilities Measured on Recurring Basis (Detail) - USD ($)	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Convertible Notes Payable [Member]
Fair Value Disclosure [Line Items]
Balance beginning	$ 0	$ 534,975
Extinguishment		(118,300)
Fair value at issuance	0	189,300
Change in fair value	0	(289,775)
Balance ending	0	316,200
Series A Preferred Stock [Member]
Fair Value Disclosure [Line Items]
Balance beginning	0	56,926
Extinguishment		0
Fair value at issuance	0	0
Change in fair value	0	(56,926)
Balance ending	0	0
Common stock warrants [Member]
Fair Value Disclosure [Line Items]
Balance beginning	30,278	0
Extinguishment		0
Fair value at issuance	41,305	466,706
Change in fair value	(47,331)	(320,748)
Balance ending	$ 24,252	$ 145,958

XML

Subsequent Events - Additional Information (Detail) - USD ($)	1 Months Ended
	Oct. 30, 2015	Oct. 31, 2014	Jan. 31, 2014	Dec. 17, 2013
Subsequent Event [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights			$ 3.04	$ 2.66
Minimum [Member]
Subsequent Event [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights		$ 2.27
Subsequent Event
Subsequent Event [Line Items]
Debt Instrument, Fee Amount	$ 2,000,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	500,000
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.254
Deferred Initial Amortization Payment	$ 1,000,000
Long-term Debt, Percentage Bearing Variable Interest, Percentage Rate	10.00%
Debt Instrument, Periodic Payment, Interest	$ 95,000
Subsequent Event | Maximum [Member] | Purchase Agreement [Member]
Subsequent Event [Line Items]
Debt Instrument, Periodic Payment, Principal	1,650,000
Subsequent Event | Minimum [Member] | Purchase Agreement [Member]
Subsequent Event [Line Items]
Debt Instrument, Periodic Payment, Principal	$ 550,000

XML

Borrowing Arrangements (Tables)

9 Months Ended

Sep. 30, 2015

Debt Disclosure [Abstract]

Schedule of warrant fair value assumptions

The fair value of the warrant as of November 1, 2014, the issue date of the warrant, was estimated using the following assumptions:

Expected volatility	60	%
Risk free rate	1.62	%
Dividend yield	0	%
Expected term (in years)	5.00

Schedule of equity warrant fair value assumptions

The fair value of the issued warrants as of February 27, 2015, were estimated using the following assumptions:

				National Securities
	Fortress			Corporation
Expected volatility		60	%		60	%
Risk free rate		1.7	%		1.5	%
Dividend yield		0	%		0	%
Expected term (in years)		5.00			7.00

XML

Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($)	1 Months Ended	3 Months Ended		9 Months Ended		12 Months Ended
	Oct. 01, 2014	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2014	Nov. 09, 2015	Dec. 31, 2013
Summary of Significant Accounting Policies [Line Items]
Cash and Cash Equivalents, at Carrying Value, Total		$ 1,368,118	$ 232,448	$ 1,368,118	$ 232,448	$ 1,443,349		$ 1,518,684
Working Capital Net Amount		(13,243,781)		(13,243,781)
Net Income (Loss) Attributable to Parent, Total		(3,470,867)	$ (2,937,678)	(9,495,347)	(12,335,306)
Retained Earnings (Accumulated Deficit), Total		(52,568,560)		(52,568,560)		(43,073,213)
Debt Instrument, Face Amount		5,500,000		5,500,000
Asset Impairment Charges						$ 686,350
Finite-Lived Intangible Assets, Gross		11,893,745		11,893,745
Guaranteed Benefit Liability, Net		17,836,866		17,836,866
Future Unconditional Guarantee Paid				20,000,000
Additional Working Capital		4,900,000		4,900,000
Employee-related Liabilities, Current		$ 1,900,000		1,900,000
Maintenance Costs				800,000
Other Cost and Expense, Operating				$ 2,200,000
Contingent Fee Description				Litigation costs are based primarily on a contingent fee structure (expected to average less than 20% of license revenue for a portfolio) and as such do not scale significantly with the acquisition of new portfolios.
Cash							$ 1,338,926
Litigation Settlement, Expense				$ 4,600,000
Proceeds from Issuance of Common Stock				1,835,000	$ 6,487,850
Proceeds from Sale of Intangible Assets				$ 4,000,000
Decrease in Level of Anticipated Employee Expenses, Percentage		21.00%		21.00%
Fortress Agreement [Member]
Summary of Significant Accounting Policies [Line Items]
Proceeds from Lines of Credit				$ 1,199,500
Payments for Fees	$ 385,000
Cash Reserves		$ 1,000,000		1,000,000
Patents [Member]
Summary of Significant Accounting Policies [Line Items]
Finite-Lived Intangible Assets, Gross		$ 11,893,745		11,893,745
Future Unconditional Guarantee Paid				20,000,000
Payments for Fees				$ 18,000,000
Minimum [Member] | Patents [Member]
Summary of Significant Accounting Policies [Line Items]
Property plant and equipments estimated useful lives of assets				7 years
Maximum [Member] | Patents [Member]
Summary of Significant Accounting Policies [Line Items]
Property plant and equipments estimated useful lives of assets				10 years

XML

Fortress notes payable (Detail)	Sep. 30, 2015 USD ($)
Commitments and Contingencies [Line Items]
2015	$ 1,306,629
2016	5,327,055
2017	4,102,810
Total	$ 10,736,494

XML

Stock-Based Compensation - Additional Information (Detail) - USD ($)	1 Months Ended	3 Months Ended		9 Months Ended
	Mar. 25, 2015	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	Nov. 30, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, capital shares reserved for future issuance		9,132,828		9,132,828
Share-based compensation arrangement by share-based payment award, options, forfeitures in period				629,453
Share-based compensation arrangement by share-based payment award, options, vested, number of shares				4,509,238
Share Based Compensation Arrangements By Share Based Payment Award Options Assumed In Merger Weighted Average Exercise Price				$ 14.30
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Assumed In Merger				15,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value		$ 0		$ 0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross				7,167,585
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit	$ 2.05
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit	$ 3.85
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term				7 years 11 months 23 days
2013 Stock Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Employee service share-based compensation, nonvested awards, compensation cost not yet recognized, period for recognition				1 year 3 months
Non-employee service share-based compensation, nonvested awards, compensation not yet recognized, stock options		$ 41,381	$ (67,910)	$ 258,053	$ 1,312,993
Non employee service share based compensation nonvested awards total compensation cost not yet recognized period for recognition1				$ 1,187,274
2013 Stock Plan [Member] | Board of Directors [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, capital shares reserved for future issuance						5,305,445
2014 Stock Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	1,432,661
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	10 years
Share Based Compensation Arrangement By Share Based Payment Award Shares Available For Grant Addition to Twenty Fifteen Stock Plan In Period				1,700,000
Stock option one [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	1,269,845
Stock option one [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	3 years 1 month 6 days
Stock option one [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	2 years 1 month 6 days
Stock Option Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage for closing price of common stock	48.00%
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	162,816
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price	$ 1.14
Cancellation And Issuance [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	3 years 1 month 6 days
Increase in stock compensation expense	$ 272,720

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Cash flows from operating activities
Net loss	$ (9,495,347)	$ (12,335,306)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation expense	12,753	5,668
Loss on extinguishment of notes payable	2,268,373	2,403,193
Decrease in fair value of derivative liabilities	(47,331)	(667,448)
Amortization of discount on notes payable	2,191,248	298,885
Amortization of patents and acquired contracts	1,237,115	1,102,423
Net cost of patents sold	215,372	0
Stock-based compensation	843,386	2,238,184
Changes in operating assets and liabilities
Accounts receivable	219,851	(245,558)
Inventories	130,155	47,294
Prepaid expenses and other current assets	(21,441)	(155,523)
Deferred expenses	300,833	0
Deposits and other assets	(10,000)	(17,484)
Accounts payable	114,512	1,386,113
Accrued expenses and other current liabilities	483,961	549,294
Accrued interest on notes payable	0	73,065
Deferred revenue	746,429	0
Net cash used in operating activities	(810,131)	(5,317,200)
Cash flows from investing activities
Restricted cash	0	(3,500,000)
Purchases of property and equipment	0	(52,186)
Issuance of short-term note receivable, related party	0	(3,000,000)
Cash and other assets received in acquisition	0	790,172
Net cash used in investing activities	0	(5,762,014)
Cash flows from financing activities
Proceeds from issuance of common stock, net of issuance costs	1,835,000	6,487,850
Proceeds from issuance of convertible notes payable, net of issuance costs	0	2,905,128
Proceeds from issuance of notes payable	1,126,900	500,000
Payments on short-term notes payable, related party	(80,000)	(100,000)
Payments on Fortress notes payable	(2,147,000)	0
Net cash provided by financing activities	734,900	9,792,978
Net decrease in cash and cash equivalents	(75,231)	(1,286,236)
Cash and cash equivalents, beginning of period	1,443,349	1,518,684
Cash and cash equivalents, end of period	1,368,118	232,448
Supplemental disclosures of cash flow information
Cash paid for interest	631,471	$ 159,822
Cash paid for income taxes	0
Supplemental disclosures of non-cash investing and financing activities
Accrued guaranteed payments and deferred expenses associated with purchased patent assets	923,928	$ 3,951,870
Conversion of portion of short-term note payable, related party, to purchase common stock	100,000	0
Offset of short-term related party notes payable and receivable	0	3,000,000
Transfer of Series A redeemable convertible preferred stock to preferred stock	0	3,392,950
Fair value of convertible notes payable redemption derivative liability	0	316,200
Fair value of common stock warrants	41,305	145,958
Acquisition of patents	$ 0	$ 2,653,533

XML

Fair Value Measurements

9 Months Ended

Sep. 30, 2015

Fair Value Disclosures [Abstract]

Fair Value Measurements

5. Fair Value Measurements

The following tables summarize the Company's assets and liabilities measured at fair value on a recurring basis at September 30, 2015 and December 31, 2014:

September 30, 2015	Fair Value		(Level 1)		(Level 2)		(Level 3)
Common stock warrants	$	24,252	$	-	$	-	$	24,252
Total	$	24,252	$	-	$	-	$	24,252

December 31, 2014	Fair Value		(Level 1)		(Level 2)		(Level 3)
Common stock warrants	$	30,278	$	-	$	-	$	30,278
Total	$	30,278	$	-	$	-	$	30,278

Prior to the Merger, the Company issued senior secured promissory notes (the “Senior Secured Notes”) with an aggregate principal amount of $5,000,000 which were redeemable upon an event of default. The Senior Secured Notes were later exchanged in favor of amended senior secured promissory notes (the “Amended Secured Convertible Notes”), resulting in an extinguishment of the related derivative liability for the prior Senior Secured Notes. The Company then issued new secured convertible notes (the “New Secured Convertible Notes”, and together with the Amended Secured Convertible Notes, the “Secured Convertible Notes”) with an aggregate principal amount of $3,000,000 which may be redeemed upon an event of default. Since the Secured Convertible Notes were issued at a substantial discount and the event of default clause may require accelerated repayment, the Secured Convertible Notes include an embedded derivative that is not clearly and closely related to the host contract. Accordingly, the Company bifurcated the embedded derivative from the host contract and recognized a derivative liability at fair value upon issuance of the Secured Convertible Notes. The Company estimated the fair value of the derivative liability using a valuation model which included the weighted probability of the amount of redemption and the time until redemption occurs over the note term. The Secured Convertible Notes were paid in full on October 2, 2014, resulting in an extinguishment of the related derivative liability, see Note 6 below.

In May 2013, the Company sold Series A-1 redeemable convertible preferred stock (“Series A-1 Preferred Stock”) which contained provisions for anti-dilution protection in the event the Company issues common stock at a price below a price per share formula, as defined. At September 30, 2015, the threshold price was $0.289 per share. The anti-dilution protection requires the Company to issue the holders of Series A-1 Preferred Stock shares of common stock or in the event that not enough shares of common stock are authorized and unissued, cash. The anti-dilution provision represents an embedded derivative as it is not clearly and closely related to the host contract. Accordingly, the Company bifurcated the embedded derivative from the host contract and recognized a derivative liability at fair value upon issuance of the Series A-1 Preferred Stock. The Company estimated the fair value of the derivative liability using the Monte Carlo option pricing valuation model which included a probability weighted present value calculation. Post-Merger, the Series A-1 Preferred Stock are no longer redeemable.

As discussed in Note 7, in January 2014, the Company issued warrants to purchase 238,412 shares common stock at an exercise price of $3.04 to a placement agent. The exercise price is subject to adjustment and the warrants may be exercised without cash consideration by forfeiting a portion of shares. Accordingly, the Company recognized a derivative liability at fair value upon issuance of the warrants. The exercise price was reduced to its floor of $2.27 as a result of the sale of the Fortress Shares in October 2014 (see Note 6). The Company estimated the fair value of the derivative liability using the Black-Scholes option pricing model. The fair value of the derivative liability as of September 30, 2015 was estimated using the following assumptions:

Expected volatility	60	%
Risk free rate	0.96	%
Dividend yield	0	%
Expected term (in years)	3.3253

The assumptions utilized were derived in a similar manner as discussed in Note 7 related to the fair value of stock options.

The Company revalues the derivative liabilities at the end of each reporting period using the same models as at issuance, updated for new facts and circumstances, and recognizes the change in the fair value in the statements of operations as other income (expense). The following sets forth a summary of changes in fair value of the Company’s level 3 liabilities measured on a recurring basis for the nine months ended September 30, 2014 and September 30, 2015:

			Series A-1
	Convertible		Preferred		Common
	Notes Payable		Stock		Stock
	Derivative Liability		Derivative Liability		Warrants
Balance at December 31, 2013	$	534,975	$	56,926	$	-
Extinguishment		(118,300)		-		-
Fair value at issuance		189,300		-		466,706
Change in fair value		(289,775)		(56,926)		(320,748)
Balance at September 30, 2014	$	316,200	$	-	$	145,958

			Series A-1
	Convertible		Preferred		Common
	Notes Payable		Stock		Stock
	Derivative Liability		Derivative Liability		Warrants
Balance at December 31, 2014	$	-	$	-	$	30,278
Fair value at issuance		-		-		41,305
Change in fair value		-		-		(47,331)
Balance at September 30, 2015	$	-	$	-	$	24,252

XML

Business Combination - Additional Information (Detail)	9 Months Ended	12 Months Ended
	Sep. 30, 2015 USD ($) shares	Dec. 31, 2014 USD ($) shares	Jun. 06, 2014 shares
Business Acquisition [Line Items]
Stockholders' equity note, stock split, conversion ratio	1.4139
Common Stock, Shares, Issued | shares	36,313,509	27,997,128	20,018,028
Class of Warrant or Right, Outstanding | shares			700,937
Debt Instrument, Face Amount	$ 5,500,000
Business Acquisition, Goodwill, Expected Tax Deductible Amount	8,858,504
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill	1,342,000
Business Combination, Acquisition Related Costs	1,237,641
Asset Impairment Charges		$ 686,350
Cortelco Holding [Member]
Business Acquisition [Line Items]
Initial Amount Of Contingent Note	11,000,000
Debt Instrument, Face Amount	$ 300,000
Series A Preferred Stock [Member]
Business Acquisition [Line Items]
Preferred Stock, Shares Issued | shares			6,176,748
Preferred Class B [Member]
Business Acquisition [Line Items]
Preferred Stock, Shares Issued | shares			2,231
Placement Agents [Member]
Business Acquisition [Line Items]
Class of Warrant or Right, Outstanding | shares			238,412

XML

Shares of Common Stock Reserved for Future Issuance (Detail)	Sep. 30, 2015 shares
Shares Of Common Stock Reserved For Future Issuance [Line Items]
Options to purchase common stock	2,134,291
Shares reserved for issuance	9,132,828
Warrants
Shares Of Common Stock Reserved For Future Issuance [Line Items]
Shares reserved for issuance	1,795,447
2014 Stock Plan
Shares Of Common Stock Reserved For Future Issuance [Line Items]
Shares reserved for issuance	2,278,889
Series A Convertible Preferred Stock [Member]
Shares Of Common Stock Reserved For Future Issuance [Line Items]
Convertible preferred stock	528,548
Series B Convertible Preferred Stock [Member]
Shares Of Common Stock Reserved For Future Issuance [Line Items]
Convertible preferred stock	2,395,653

XML

Fair Value Measurements (Tables)

9 Months Ended

Sep. 30, 2015

Fair Value Disclosures [Abstract]

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis

The following tables summarize the Company's assets and liabilities measured at fair value on a recurring basis at September 30, 2015 and December 31, 2014:

September 30, 2015	Fair Value		(Level 1)		(Level 2)		(Level 3)
Common stock warrants	$	24,252	$	-	$	-	$	24,252
Total	$	24,252	$	-	$	-	$	24,252

December 31, 2014	Fair Value		(Level 1)		(Level 2)		(Level 3)
Common stock warrants	$	30,278	$	-	$	-	$	30,278
Total	$	30,278	$	-	$	-	$	30,278

Schedule Of Changes In Fair Value Derivative Liability

The fair value of the derivative liability as of September 30, 2015 was estimated using the following assumptions:

Expected volatility	60	%
Risk free rate	0.96	%
Dividend yield	0	%
Expected term (in years)	3.3253

Schedule of Changes in Fair Value of Company's Level 3 Liabilities

The following sets forth a summary of changes in fair value of the Company’s level 3 liabilities measured on a recurring basis for the nine months ended September 30, 2014 and September 30, 2015:

			Series A-1
	Convertible		Preferred		Common
	Notes Payable		Stock		Stock
	Derivative Liability		Derivative Liability		Warrants
Balance at December 31, 2013	$	534,975	$	56,926	$	-
Extinguishment		(118,300)		-		-
Fair value at issuance		189,300		-		466,706
Change in fair value		(289,775)		(56,926)		(320,748)
Balance at September 30, 2014	$	316,200	$	-	$	145,958

			Series A-1
	Convertible		Preferred		Common
	Notes Payable		Stock		Stock
	Derivative Liability		Derivative Liability		Warrants
Balance at December 31, 2014	$	-	$	-	$	30,278
Fair value at issuance		-		-		41,305
Change in fair value		-		-		(47,331)
Balance at September 30, 2015	$	-	$	-	$	24,252